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Abstract
Studies on new bioactive non-ribosomal peptides and 
Polyketides from marine-derived Streptomyces spp.
Munhyung Bae
Natural Products Science Major
College of Pharmacy
Doctoral Course in the Graduate School
Seoul National University
During my doctoral course, my research works were concentrated to 
secondary metabolites derived from marine-bacteria, which have been regarded 
as a prolific sources for drug discovery. Especially, my targeted compounds 
were divided into non-ribosomal peptides (Part A) and polyketides (Part B) 
from marine bacteria. 
Part A. Non-ribosomal peptides from marine Streptomyces spp. 
Nature creates a vast diversity of secondary metabolites by 
assembling acetate building blocks to polyketides using polyketide 
synthases (PKSs), by assembling amino acids to peptides using non-
ribosomal peptides synthases (NRPSs). Peptide natural products are 
generally biosynthesized through the NRPSs with amino acids less than 40, 
showing characteristic UV spectra originated from aromatic amino    
acids and large molecular ions. Peptide natural products are structurally and 
biologically diverse due to incorporation of regular and non-proteinogenic 
amino acids As part of my efforts to search for new bioactive peptides, 
actinomycete strains were selectively isolated from uncommon marine 
II
environments, intertidal mudflat. The application of a chemical analysis-
based discovery strategy using LC/MS chemical profiles allowed us to 
discover marine Streptomyces sp., producing three kinds of structurally 
novel peptides.  Mohangamides A and B, new dilactone-tethered pseudo-
dimeric peptides, were discovered from an intertidal mud flat in Buan, 
Republic of Korea. WS9326F-I, which are new members of WS9326 class, 
were also obtained from strain SNM55. Additional variation of cultural 
condition resulted in the discovery of new antibiotic cyclic depsipeptides, 
hormaomycins B and C. The planar structures of those compounds were 
determined by 1D and 2D NMR spectroscopy, UV spectroscopy, and mass 
spectrometry. Mohangamides A and B are first dimeric/pseudo-dimeric 
peptides of WS9326s class bearing two unusual acyl chains and 14 amino 
acid residues. WS9326F-I were elucidated as new analogues of WS9326A 
bearing an unusual acyl chain and 6~7 amino units. Especially, WS9326I 
incorporates an unprecedented 4-amino-2,4-dihydro-3H-pyarzol-3-one and a 
sugar-derived moiety. Hormaomycins B and C are the first natural analogues 
belonging to the hormaomycin peptide class bearing structurally unique 
units, such as 4-(Z)-propenylproline, 3-(2-nitrocyclopropyl)alanine, 5-
chloro-1-hydroxypyrrol-2-carboxylic acid, and b-methylphenylalanine. 
Determination of absolute configurations of amino acids were established 
by derivatization of Marfey’s reagents and 2,3,4,6-tetra-O-acetyl-β-d-
glucopyranosyl isothiocyanatederivatiztion (GITC), followed by LC-MS 
analysis. The absolute configuration of additional chiral centers of 
mohangamide A were determined by chemical derivatizations including 
methanolysis, acetylation, OsO4 oxidation, and bis-benzoyl esterification 
followed by chromatographic and spectroscopic analyses. The absolute 
configuration of WS9326I were established by four of chemical steps 
including acetonide protection, acetylation, acetonide deprotection, and 
MTPA esterifications. The absolute configurations of hormaomycins B and 
C were determined by the comparison of ECD spectrum of hormaomycin. 
Mohangamide A displayed displayed strong inhibitory activity against 
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Candida albicans isocitrate lyase. WS9326F-I exhibited remarkable 
antiangiogenic activity. Hormaomycins B and C showed significant 
antibacterial activity. 
Part B. Polyketides from marine Streptomyces spp. 
Polyketides are any of a large class of diverse compounds that are 
characterized by more than two carbonyl groups connected by a intervening 
carbon atoms and generally biosynthesized by PKSs. Especially, NRPS-
PKSs hybrid synthase are mega-synthases involved in the biosynthesis of 
pharmaceutically important natural products such as cyclosporin, rifamycin 
and erythromycin. Focusing on NRPS and PKS compounds   provides 
better understanding on their biosynthetic mechanisms, contributing 
massive production and diverse derivatives    by combinatorial 
biosynthesis. As part of my efforts to search for PKS compounds, I collected 
sediments from uninvestigated environments such as mudflat and volcanic 
Islands. Mohangic acids were isolated from a Streptomyces sp. SNM31 
collected from mud flat in Buan, Korea. Comprehensive analysis of 
spectroscopic data revealed that mohangic acids A-E are new members of p-
aminoacetophenonic acid class. The relative and absolute configurations of 
mohangic acids were established by chemical derivatization, application of 
chiral NMR solvent, and circular dichroism spectroscopy. Mohangic acid E 
displayed significant quinone reductase induction activity. Further 
investigation of Streptomyces sp. strain isolated from Jeju Island discovered 
new polyene polyols compounds, succinilenes A-D. Determination of 
geometry of succinilenes were performed by quantum-mechanics-driven 1H 
iterative full spin analysis (QM-HiFSA).  The absolute configuration of 
succinilenes were established by chemical derivatizations and chiroptical 
spectroscopy. Succinilenes showed significant anti-inflammatory activity 
except succinilene D. Ullengacenes A and B, new benz[a]anthracene dimer 
compounds linked by mono-sulfide bond, were isolated from sediment in 
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Ul-leungdo, Korea. The exact components of compounds were identified by 
energy dispersive X-ray experiments. The absolute configuration of 
ullengacenes were determined by combination of ECD calculations and DP4 
calculations. Ullengacene A exhibited quinone reductase induction activity 
while ullengacene B displayed remarkable antiangiogenic activity. 
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Over the past several decades, natural products derived from 
microbes have served as the most efficient natural source for drug discovery 
and development because of relatively convenient production of lead 
compounds by microbial cultivation.1 Despite the previous success of 
microbial natural products, the constant clinical need for bioactive 
compounds with structural novelty has led natural product chemists to 
search for chemically prolific microorganisms such as actinomycetes that 
inhabit relatively uninvestigated environments.2 Marine ecosystems, 
covering 70% of the surface of the earth and possessing great biological 
diversity, have been regarded as under-investigated sources of 
microorganisms with biosynthetic machinery for bioactive secondary 
metabolites.3 Although only a small portion of marine microbes have been 
chemically studied because of limited accessibility and technical problems, 
the discovery of promising drug leads, including an anticancer drug 
candidate, salinosporamide A,4 and an antibiotic drug candidate, 
thiocoraline,5 from marine actinomycetes has revealed that marine 
actinomycetes are particularly prolific in their production of structurally and 
biologically unique secondary metabolites with pharmaceutical potential. 
The most of secondary metabolites produced by microbes were 
synthesized by two biosynthetic pathways. One is polyketide synthases 
(PKSs) which assemble acetate building blocks to polyketides and the other 
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is non-ribosomal peptides sythases (NRPSs) which assemble amino acids to 
peptides. Non-ribosomal peptide products are structurally and biologically 
diverse due to incorporation of regular and non-proteinogenic amino acids. 
Vancomycin are the representative peptide compound treated as most 
important antibiotic against penicillin-resistant pathogenic bacteria.6
Polyketide are any of a large class of diverse compounds that are 
characterized by more than two carbonyl groups by intervening carbon 
atoms and generally biosynthesized by PKSs. Interestingly, non-ribosomal 
peptide synthase and polyketide synthase are sometimes incorporated as 
NRPS-PKS hybrid synthases. These are mega-synthases involved in the 
biosynthesis of pharmaceutically important natural products such as 
cyclosporine,7 rifamycin,8 and erythromycin.9 Therefore, Focusing on NRPS 
and PKS compounds provides better understanding on their    
biosynthetic mechanisms, contributing massive production and diverse 
derivatives by combinatorial biosynthesis.
As part of my efforts to discover new bioactive compounds from 
marine microorganisms, we isolated actinomycete strains from the intertidal 
mudflat in Buan and volcanic Islands including Jeju and Ul-lengdo, 
Republic of Korea and studied their chemical profiles by LC/MS. In search 
for structurally novel compounds, de-repeplication step was performed by 
utilizing UV spectra. Woodward’s rule may calculate lmax values from 
chromophores but it is difficult to predict the shapes of UV spectra. Even 
lmax values of two compounds are identical, these are completely different 
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compounds if the shapes of UV spectra are different. According to 
dereplication based on shapes of UV spectra and compounds data base, I 
discovered six class of novel peptides and polyketides. 
Here, I report the structural elucidation based on the spectroscopic 
data, the determination of absolute configuration, and the biological 
activities of those compounds. 
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Part A
Non-ribosomal peptides from marine Streptomyces spp. 
5
I. Mohangamides A and B, dilactone-tethered pseudo-
dimeric peptides inhibiting Candida albicans isocitrate lyase
6
I. I. Results and discussion
Mohangamide A (1) was isolated as a white powder (yield: 0.7 mg/L). 
The molecular formula of 1 was determined to be C107H139N17O26 by 
1H and 
13C nuclear magnetic resonance (NMR) (Table 1) and high-resolution fast 
atom bombardment MS (HRFAB-MS) data (observed [M]+ ion at m/z 
2078.0071, calculated [M]+ ion at 2078.0077). Careful analysis of the 
complicated 2D NMR spectra, including COSY, TOCSY, HSQC, and 
HMBC, clarified the existence of DMe tyrosine,10 two leucine, two 
phenylalanine, two asparagine and two serine residues.
The amino acid composition was identical to that of WS9326A but 
was doubled, indicating that mohangamide A (1) possibly possessed a 
dimeric feature of WS9326A. Despite its dimeric feature, the 1H and 13C 
NMR spectra of 1 indicated asymmetric portions of the molecule because 
the numbers of 1H and 13C peaks were not half of the numbers of atoms 
indicated in its molecular formula. One of the asymmetric por-tions was 
elucidated as 3-[2-(1(Z)-pentenyl)phenyl]-2(E)-propenoic acid.11 The last 
partial structure, which is an unu-sual acyl chain, was established by further 
2D NMR analyses. First, based on COSY, a C5 (C-63 to C-67) chain was 
easily constructed. Additional 1H-1H correlations between H-63 and H-62 
secured the connectivity of the chain to C-62. The H-61/H-62 correlation 
extended this partial structure to C-61. These connectivities were also 
supported by TOCSY from H-61 to H-67. The COSY correlations be-tween 
H-56 and H-57 verified that C-56 is located adja-cent to C-57. The 1H-1H 
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coupling constant (8.5 Hz) of the doublet olefinic signals (H-59 and H-60) 
secured their con-nectivity and indicated that they belong to a six-membered 
ring, not a linear chain. Further analysis of the HMBC spectrum assigned 
the dihydropyridine moiety and con-nected the amide carbon (C-55) to the 
ring through C-56 and C-57 (Figure 1). The double bond geometries in the 
acyl chain were established as 57E, 59Z, and 63Z by H-57/H-59 and H-
63/H-64 NOESY and ROESY correlations.12
Figure 1. Key 1H-1H COSY/TOCSY and HMBC correlations of the acyl 
chain bearing dihydropyridine.
Once the partial structures were elucidated, I analyzed the HMBC 
correlations to connect the amino acids and the acyl chains. The sequence of 
the amino acids, -Thr-DMeTyr-Leu-Phe-Thr-Asn-Ser-, was repeated. The 
first acyl chain, 3-[2-(1(Z)-pentenyl)phenyl]-2(E)-propenoic acid, was 
connected to 1Thr by the HMBC correlation from 16-NH to C-1. Similarly 
to the sequence of the first mole-cule half, the other acyl chain bearing 
dihydropyridine was assigned next to 8Thr by the HMBC correlation from 
69-NH to C-55, which completed two acyl chain-Thr-DMeTyr-Leu-Phe-Thr-
Asn-Ser- substructures. These two substruc-tures were assembled through 
two ester linkages at 1Thr-14Ser and 7Ser-8Thr based on the H-17/C-105 and 
H-70/C-52 HMBC couplings, thus finalizing the planar structure of 
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mohangamide A (1). The structure was further confirmed by full NMR 
assignment of the methanolysis products, 3a and 3b. The absolute 
configurations of the amino acids in 1 were determined using the advanced 
Marfey’s method.13 Phenylalanine possessed a D-configuration, whereas the 
other residues (Thr, Leu, Asn, and Ser) corresponded to L-amino acids. 
Futher analysis by 2,3,4,6-tetra-O-acetyl-β- D-glucopyranosyl isothiocyanate 
(GITC) derivatization14 of 1 disclosed that mohangamide A contains two 
allo- L-Thr and L-Thr (see Table 3). These L-Thr and allo- L-Thr units were 
distinguished by J-based configuration analyses (Figure 2).15
Figure 2. Key ROESY correlations of piperadine in 5.
Although I determined the absolute configuration of the amino acids 
of 1, the stereochemistry of the asymmetric carbon at C-62 in the 
dihydropyridine ring required fur-ther identification. Thus I designed a four-
step derivatization procedure of 1 (Scheme 1). First, mohangamide A (1) 
was subjected to methanolysis to yield products 3a and 3b, which were 
utilized to confirm the planar structure of 1 vide supra.  Product 3b, which 
bears the C-62 stereogenic center, was acetylated. The major product, 
tetraacetate 4, deprived of hydroxyl groups, was then oxidized by using 
OsO4
16 to introduce vic-inal diol groups into the double bond in the 
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dihydropyridine ring. After 3 hours, the major product (compound 5) was 
obtained, in which original olefinic methines in the dihy-dropyridine ring 

















Scheme 1. A four-step derivatization scheme to determine the absolute 
configuration of dihydropyridine in 1.
The relative configurations of the ring in 5 were established as 59S*, 
60S*, 62S* by analyzing the ROESY data (Figure 2). Finally, I derivatized 
the introduced diol in 5 with 4-(dimethylamino) benzoyl chloride (DMAB-
Cl) to form a DMAB diester and induce exciton coupling in circular 
dichroism (CD).17 The CD spectrum of 6 exhibited a negative bisignate 
signal and established the anticlockwise configuration of the diol (Figure 3). 
Therefore, the absolute configurations of the stereogenic centers in the ring 
of 5 were determined as 59S, 60S, and 62S and were finally assigned as 62S
in mohangamide A (1). 
Figure 3. The exciton coupling CD spectrum of 6 to determine the absolute 
configuration of C-62 in 1. 
Mohangamide B (2) was obtained as a white powder (yield: 0.4 
mg/L). The molecular formula, C106H139N17O26, was determined based on 
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1H and 13C spectroscopic data (Table 2) and HRFAB-MS (observed 
[M+Na]+ ion at m/z 2088.9971, calculated [M+Na]+ at 2088.9975). The 
planar structure of 2 was determined by careful comparison of the 1D and 
2D NMR data of 1 and 2, which revealed that the 8Thr and 9DMeTyr 
residues in 1 were respectively replaced by 8Ser and 9N-MeTyr in 2. 
Determination of the absolute configuration of the amino acids in 2 was 
conducted using the same procedure as for 1. The absolute configurations of 
the amino acid units commonly existing in 1 and 2 were identical. Different 
units, such as 8Ser and 9N-MeTyr, were determined to be the L-form. The 
absolute configuration of the dihydropyridine ring was determined to be the 
same as 1 based on the identical 1H and 13C NMR chemical shifts, 1H-1H 
coupling constants and their common biosynthetic origin.
The structures of the mohangamides are unique in several ways. In 
my comprehensive literature search, comparable or similar structures to that 
of the unusual acyl chain-bearing dihydropyridine discovered in 1 and 2 
could not be found. Moreover, the dilactone-tethered, pseudo-dimeric 
feature is extremely rare. To my best knowledge, the only class of peptide 
dimer natural products connected with dilactone is echinomycin and its 
analogues.18 Furthermore, the mohangamides bear 14 amino acid units, 
whereas the echinomycin class incorporates ten amino acids in total. 
Therefore, the mohangamides are the largest characterized dilactone-
tethered, dimeric cyclic peptides. For echinomycin, its biosynthetic modules 
iterate the synthesis of two peptide chains, and the terminal thioesterase 
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domain catalyzes the dimerization of the peptide chain and concomitant 
cyclization.19 Therefore, dimeric peptides have not been detected together 
with their monomers. Surprisingly, the mohangamides were discovered with 
their monomer WS9326A, which is unprecedented and intriguing regarding 
the specificity of iteration and the function of thioesterase in nonribosomal 
peptide biosynthesis. 
The biological activities of the mohangamides were pri-marily 
evaluated against C. albicans ICL. Mohangamide A (1) displayed significant 
inhibition against ICL with an IC50 value of 4.4 mM, which was three times 
more potent than the positive control, 3-nitropropionate (IC50 = 14.1 mM). 
Mohangamide B (2) exhibited moderate ICL inhibition (IC50 = 20.5 mM). 
Interestingly, the monomeric compound WS9326A, methanolysis products 
3a and 3b and tetraacetate (4) did not inhibit ICL (IC50 > 100 mM), 
indicating that the dimeric feature is required for ICL inhibition. Overall, my 
evaluation suggests that the mohangamides could represent the first peptide 
class of ICL inhibitors, as peptide-derived compounds have not been 
reported to inhibit ICL. 
I further investigated the biological activities of 1 and 2 in cell-based 
antifungal assays against C. albicans, Aspergillus fumigatus, Trichophyton 
rubrum, and T. mentagrophytes. However, these compounds did not show 
sig-nificant antifungal activity when the fungi were fed glucose. 
Interestingly, mohangamide A (1) inhibited C. albicans grown on acetate, 
which indicates that the ICL is crucial in the proliferation of the fungus on 
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C2 substrates (Figure 4).
Figure 4. Inhibitory activity of mohangamide A against the growth of C. 
albicans wild-type and ∆icl mutants. C. albicans strain SC5314 (wild-type), 
MRC10 (∆icl), and MRC11 (∆icl + ICL) were grown in a 6.7% YNB 
containing 2% glucose for 24 h at 28 °C, collected by centrifugation, and 
washed twice with sterile distilled water.* Cells (104 cells/mL) were 
cultured on YNB agar plates containing the indicated carbon source (2% 
glucose or 2% sodium acetate) with or without mohangamide A for 60 h at 
28 °C.
*It is widely known that a number of “macromolecules’, primarily 
microbes and their toxins, manage to enter the organism through cell 
physical barriers by endocytotic mechanisms. For the mechanisms of 
macromolecule delivery, please see the review papers:
14
- Belting, M.; Sandgren, S.; Wittrup, A. Nuclear delivery of 
macromolecules: barriers and carriers. Advanced Drug Delivery Reviews
2005, 57, 505-527. 
- Conner, S. D.; Schimid, S. L. Regulated portals of entry into the cell. 
Nature 2003, 422, 37-44. 
Yeasts also have endocytotic mechanism. Please see the review paper:
- Boettner, D. R.; Chi, R. J.; Lemmon, S. K. Lessons from yeast for 
clathrin-mediated endocytosis. Nature Cell Biology 2012, 14, 2-10.
The fact that mohangamide A inhibited the Candida mutant and wild 
type strains on acetate also indicates its internalization to the cells.
The mohangamides did not display antibacterial activity against 
Staphylococcus aureus, Bacillus subtilis, Kocuria rhizophila, Salmonella 
enterica, Proteus hauseri, or Escherichia coli. In addition, the 
mohangamides showed no cytotoxicity against the tested human carcinoma 
cell lines, A549, HCT116, SNU638, K562, SK-HEP1, or MDA-MB231. 
In conclusion, I discovered mohangamides A and B (1-2) as inhibitors 
of C. albicans ICL from a marine actinomycete Streptomyces sp. derived 
from an intertidal mud flat. Mohangamides are structurally novel and 
biosynthetically interesting because they possess a unique dihydro-pyridine 
acyl chain and a dilactone-tethered, dimeric cyclic peptide structure 
discovered along with a monomeric structure.
15
Table 1. 1H and 13C NMR Data of 1 in DMSO-d6
a
No. dH, mult (J in Hz) dC No. dH, mult (J in Hz) dC
1 – 171.5, s 55 – 171.6, s
2 6.94, 1H, d (15.0) 125.8, d 56 2.83, 1H, m 34.5, t
3 7.30, 1H, m 129.3, d 3.08, 1H, m
4 – 141.5, s 57 5.10, 1H, m 119.5, d
5 7.28, 1H, m 126.7, d 58 – 137.2, s
6 7.15, 1H, t (7.5) 126.8, d 59 6.39, 1H, d (8.5) 124.2, d
7 7.09, 1H, t (7.5) 126.0, d 60 5.83, 1H, d (8.5) 132.8, d
8 6.99, 1H, d (7.5) 129.7, d 61 2.88, 2H, brs 36.5, t
9 – 137.1, s 62 3.03, 1H, m 37.5, d
10 6.31, 1H, d (10.5) 129.3, d 63 5.17, 1H, m 132.3, d
11 5.63, 1H, m 132.7, d 64 5.18, 1H, m 129.2, d
12 1.95, 1H, m 30.5, t 65 1.85, 2H, m 29.3, t
2.03, 1H, m 66 1.23, 2H, m 22.5, t
13 1.35, 2H, m 22.8, t 67 0.77, 3H, t (7.5) 22.3, q
14 0.83, 3H, t (7.5) 14.3, q 68 – 169.7, s
15 – 169.7, s 69 5.19, 1H, d (8.0) 53.5, d
16 5.22, 1H, d (8.0) 53.4, d 69- 8.37, 1H, brs
16- 8.39, 1H, brs NH
NH 70 4.91, 1H, m 73.6, d
17 4.97, 1H, m 73.7, d 71 1.08, 3H, d (6.0) 17.2, t
18 1.11, 3H, d (6.0) 17.0, q 72 2.98, 3H, s 34.5, t
19 2.97, 3H, s 34.7, q 73 – 166.1, s
20 – 166.2, s 74 – 129.0, s
21 – 128.9, s 75 6.00, 1H, s 132.2, d
22 5.99, 1H, s 132.0, d 76 – 123.5, s
23 – 123.3, s 77 7.24, 1H, d (8.0) 132.4, d
24 7.35, 1H, d (8.0) 132.3, d 78 6.62, 1H, d (8.0) 115.4, d
25 6.60, 1H, d (8.0) 115.5, d 79 – 158.4, s
26 – 158.5, s 80 6.62, 1H, m 115.4, d
27 6.60, 1H, m 115.5, d 81 7.24, 1H, m 132.4, d
28 7.35, 1H, m 132.3, d 82 – 172.4, s
29 – 172.6, s 83 4.04, 1H, m 54.2, d
30 4.07, 1H, m 54.0, d 83- 9.22, 1H, brs
30- 9.23, 1H, brs NH
NH 84 1.25, 2H, m 39.6, t
31 1.26, 2H, m 39.5, t 85 0.87, 1H, m 23.4, d
32 0.87, 1H, m 23.6, d 86 0.67, 3H, d (7.0) 23.4, q
33 0.65, 3H, d (7.0) 23.2, q 87 0.74, 3H, d (7.5) 22.4, q
34 0.75, 3H, d (7.5) 22.2, q 88 – 170.6, s
35 – 170.7, s 89 4.33, 1H, m 56.4, d
36 4.35, 1H, m 56.5, d 89- 9.13, 1H, brs
36- 9.18, 1H, brs NH
NH 90 2.75, 1H, m 36.7, t
37 2.72, 1H, m 36.9, t 3.28, 1H, m
3.26, 1H, m 91 – 139.3, s
38 – 139.5, s 92 7.31, 1H, m 129.6, d
39 7.32, 1H, m 129.5, d 93 7.26, 1H, m 128.6, d
40 7.27, 1H, m 128.5, d 94 7.19, 1H, m 126.3, d
41 7.20, 1H, m 126.5, d 95 7.26, 1H, m 128.6, d
42 7.27, 1H, m 128.5, d 96 7.31, 1H, m 129.6, d
43 7.32, 1H, m 129.5, d 97 – 170.4, s
44 – 170.5, s 98 4.27, 1H, m 57.5, d
45 4.32, 1H, m 57.7, d 98- 7.61, 1H, brs
45- 7.59, 1H, brs NH
NH 99 4.14, 1H, m 68.5, d
46 4.20, 1H, m 68.6, d 100 0.58, 3H, m 22.2, q
47 0.56, 3H, m 22.3, q 101 – 171.9, s
48 – 172.0, s 102 4.41, 1H, m 51.2, d
49 4.46, 1H, m 51.3, d 102- 8.27, 1H, brs
49- 8.32, 1H, brs NH
NH 103 2.40, 2H, m 36.9, t
50 2.42, 2H, m 37.2, t 104 – 171.7, s
51 – 171.6, s 105 – 169.3, d
52 – 169.5, s 106 4.29, 1H, m 56.0, d
53 4.38, 1H, m 55.7, d 106- 8.26, 1H, brs
53- 8.44, 1H, brs NH
NH 107 2.97, 2H, m 61.1, t
54 3.26, 2H, m 61.4, t
a 1H and 13C NMR were recorded at 900 and 225 MHz, respectively.
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Table 2. 1H and 13C NMR Data of 2 in DMSO–d6
a
No. dH, mult (J in Hz) dC No. dH, mult (J in Hz) dC
1 – 172.7, s 55 – 172.5, s
2 6.83, 1H, d(15.0) 125.8, d 56 2.78, 1H, m 36.5, t
3 7.24, 1H, m 127.3, d 3.08, 1H,
4 – 141.6, s dd (16.0, 8.0)
5 7.17, 1H, d (7.5) 129.2, d 57 5.24, 1H, m 118.9, d
6 7.14, 1H, m 129.9, d 58 – 137.0, s
7 7.07, 1H, t (7.5) 125.9, d 59 6.26, 1H, d (8.0) 124.7, d
8 6.98, 1H, d (7.5) 126.9, d 60 5.76, 1H, d (8.0) 132.8, d
9 – 137.2, s 61 2.86, 2H, m 36.2, t
10 6.29, 1H, d (10.5) 129.3, d 62 2.97, 1H, m 37.6, d
11 5.60, 1H, m 132.8, d 63 5.08, 1H, 132.3, d
12 1.98, 1H, m 30.5, t dd (10.5, 6.5)
2.03, 1H, m 64 5.13, 1H, m 129.3, d
13 1.33, 2H, m 22.8, t 65 1.83, 2H, m 37.3, t
14 0.82, 3H, t (7.5) 23.8, q 66 1.18, 2H, m 29.4, t
15 – 169.7, s 67 0.76, 3H, t (7.5) 22.8, q
16 5.17, 1H, d (8.0) 53.4, d 68 – 170.4, s
16- 8.37, 1H, brs 69 4.99, 1H, d (8.0) 48.5, d
NH 69- 8.73, 1H, brs
17 4.91, 1H, m 73.5, d NH
18 1.07, 3H, d (6.0) 16.9, q 70 2.00, 1H, m 73.6, d
19 2.94, 3H, s 34.7, q 3.77, 3H, d (6.0) 17.2, q
20 – 170.0, s 71 2.60, 3H, s 28.9, q
21 – 129.2, s 72 – 169.3, s
22 5.96, 1H, s 132.0, d 73 5.41, 1H, m 61.9, d
23 – 123.3, s 74 2.92, 2H, m 33.2, t
24 7.24, 1H, m 132.5, d 75 – 123.3, s
25 6.58, 1H, d (7.5) 115.5, d 76 7.03, 1H, d (7.5) 132.6, d
26 – 158.5, s 77 6.61, 1H, d (7.5) 115.2, d
27 6.58, 1H, d (7.5) 115.5, d 78 – 158.5, s
28 7.24, 1H, m 132.3, d 79 6.61, 1H, d (7.5) 115.2, d
29 – 173.0, s 80 7.03, 1H, d (7.5) 132.6, d
30 4.03, 1H, m 54.1, d 81 – 170.6, s
30- 9.15, 1H, brs 82 4.33, 1H, m 50.5, d
NH 82-
31 1.24, 2H, m 29.6, t NH 8.90, 1H, brs 50.5, d
32 0.85, 1H, m 23.9, d 83 1.23, 2H, m 39.2, t
33 0.63, 3H, d (7.0) 23.4, q 84 1.18, 1H, m 24.4, d
34 0.75, 3H, d (7.5) 22.5, q 85 0.70, 3H, d (7.0) 22.8, q
35 – 170.7, s 86 0.70, 3H, d (7.0) 22.8, q
36 4.33, 1H, m 56.5, d 87 – 170.8, s
36- 9.11, 1H, brs 88 4.57, 1H, m 53.9, d
NH 88- 8.07, 1H, brs
37 2.69, 1H, m 36.8, t NH
3.25, 1H, m 89 2.80, 1H, m 36.5, t
38 – 139.5, s 3.22, 1H, m
39 7.32, 1H, m 129.8, d 90 – 138.5, s
40 7.26, 1H, m 128.5, d 91 7.31, 1H, m 129.8, d
41 7.20, 1H, m 126.5, d 92 7.25, 1H, m 128.6, d
42 7.26, 1H, m 128.5, d 93 7.20, 1H, m 126.3, d
43 7.32, 1H, m 129.8, d 94 7.25, 1H, m 128.6, d
44 – 170.4, s 95 7.31, 1H, m 129.8, d
45 4.27, 1H, m 57.6, d 96 – 171.3, s
45- 7.58, 1H, brs 97 4.38, 1H, m 57.5, d
NH 97- 6.83, 1H, brs
46 4.13, 1H, m 68.6, d NH
47 0.57, 3H, d (5.0) 22.3, t 98 4.14, 1H, m 68.5, d
48 – 172.0, s 99 0.94, 3H, m 21.2, q
49 4.39, 1H, m 51.3, d 100 – 172.4, s
49- 8.26, 1H, brs 101 4.69, 1H, m 51.8, d
NH 101- 8.81, 1H, brs
50 2.38, 2H, 37.2, t NH
dd (14.5, 9.0) 102 2.54, 2H, m 37.0, t
51 – 171.8, s 104 – 169.4, s
52 – 169.5, s 105 4.36, 1H, m 57.0, d
53 4.26, 1H, m 55.9, d 105- 8.35, 1H, brs
53- 8.25, 1H, brs NH
NH 106 3.60, 2H, m 61.3, t
54 2.90, 2H, m 61.5, t
a 1H and 13C NMR were recorded at 900 and 225 MHz, respectively.
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Table 3. LC/MS analysis of the FDAA derivatives of mohangamides A and 
B (1 and 2).















Thr (L) L → D 10.5 13.0 Thr (L) L → D 10.5 13.0
Leu (L) L → D 25.0 29.0 Leu (L) L → D 25.0 29.0
Phe (D) D → L 28.4 25.0 Phe (D) D → L 28.4 25.0
allo Thr 
(L)
L → D 9.9 11.7 allo Thr 
(L)
L → D 9.9 11.7
Asp (L) L → D 10.8 11.4 Asp (L) L → D 10.8 11.4
Ser (L) L → D 9.7 10.0 Ser (L) L → D 9.7 10.0
N-MeTyr 
(L)
L → D 9.7 9.9
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II. WS9326F-I, antiangiogenic peptides belonging to 
WS9326 peptide class 
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II. I. Results and discussion
WS9326F (7) was obtained as a white powder, having the molecular 
formula as C53H68N8O13 (unsaturation number: 24) determined by HR-FAB 
mass spectroscopy (obsd [M+H]+ at m/z 1025.4983, calcd [M+H]+
1025.4984), and 1H and 13C NMR data (Table 4). The 1H NMR spectrum 
showed a highly analogous pattern of WS9326A, including six NH signals 
(δH 9.18, 9.17, 8.90, 8.56, 8.51, and 7.28) and seven α-proton signals (δH
5.52, 5.33, 4.81, 4.70, 4.43, 4.41, and 4.33). The 13C NMR spectrum 
indicated that there exist nine carbonyl signals (δC 172.2, 171.4, 170.7, 
170.3, 170.2, 169.7, 169.4, 166.4, and 166.3) and ten carbons in the 
resonance region of α–carbons or oxygenated carbons (69.2, 63.7, 61.6, 60.8, 
56.9, 56.1, 56.0, 52.8, 51.1, and 48.1). 
Because the major metabolite, WS9326A was already reported 
previously, the planar structure of WS9326F (7) was assigned by careful 
comparison of 1D and 2D NMR spectra including COSY, HSQC, HMBC, 
and TOCSY between with those of WS9326A. In addition, comparing their 
molecular formulae (C53H68N8O13 for 7) and (C54H68N8O13 for WS9326A) 
clearly indicated that WS9326F (7) possesses one carbon and two hydrogen 
atoms less than WS9326A. Detailed analysis of the NMR spectra of 7
revealed that one methyl group and one double bond are mixing, thus 
accounting for the difference between 7 and WS9326A. After 1-bond C-H 
correlations were completely assigned based on the HSQC NMR spectrum, 
COSY, HMBC, and TOCSY NMR spectra were analyzed to elucidate seven 
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amino acid units and one acyl chain. WS9326F was revealed to incorporate 
two serine, an N-Me-tyrosine, a leucine, a phenylalanine, a threonine, and an
asparagine units as well as 3-[2-(1(Z)-pentenyl)phenyl]-2(E)-propenoic acid. 
These units accounted for 23 of 24 double bond equivalents deduced from 
the molecular formula with three aromatic rings (12 equivalents), two 
double bonds (two equivalents), nine carbonyl functional groups (9 
equivalents). Therefore the structure of 7 must possess an additional ring to 
explain the last double bond equivalent. 
Figure 5. Key COSY and HMBC correlations for the structures elucidations 
of 7-10.
Even though the amino acid sequence of 7 was expected to be similar to 
that of WS9326A, the existence of two serine units, one of which replaced a 
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threonine, required a comprehensive analysis of HMBC correlations to 
determine the sequence of the seven amino acid residues and the acyl chain 
(Figure 4). First, 16-NH (δH 9.17) of Ser-1 showed an HMBC correlation 
with the C-1 carbonyl carbon (δC 166.4). The olefinic protons (H-2; δH 6.44, 
H-3; δH 7.77) belonging to 3-[2-(1(Z)-pentenyl)phenyl]-2(E)-propenoic acid 
(PPPA) also displayed clear cross peaks with C-1 in the HMBC spectrum, 
indicating that the acyl group is connected directly to Ser-1. Furthermore the 
α–proton of Ser-1 (δH 5.33) showed an HMBC correlation with C-15 (δC
170.2; carbonyl carbon of Ser-1), which also correlated with N-Me protons
(H3-18; δH 2.62) of N-Me-Tyr in the HMBC spectrum, establishing the 
connectivity between Ser-1 and N-Me-Tyr. The amino acid residue next to 
N-Me-Tyr was assigned as Leu based on the HMBC correlation from 29-
NH (δH 9.18; the amide proton of Leu) and H-20 (δH 5.52; a-proton of N-
Me-Tyr) to C-19 (δC 166.3; the amide carbon of N-Me-Tyr). The Phe unit
was connected to Leu on the basis of the HMBC correlation from the amide 
proton of Phe (35-NH; δH 8.56) and the α-proton of Leu (H-29; δH 4.33) to 
the carbonyl carbon of Leu (C-28; δC 169.4). The HMBC signals from 44-
NH (the amide proton of Thr; δH 7.28) and H-35 (the α-proton of Phe; δH
4.81) to C-34 (the amide carbon of Phe; δC 170.3) clarified the sequence 
from Phe to Thr. The 2-bond 1H−13C coupling from 48-NH (δH 8.90) and H-
44 (δH 4.41) to C-43 (δC 170.7) established the connectivity Asn next to Thr. 
Further analysis of HMBC NMR data elucidated the connectivity between 
Asn and Ser-2 based on the HMBC correlation from NH of Ser-7 at δH 8.51 
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and the α–proton of Asn-6 at δH 4.70 to the amide carbon of Asn-6 (C-47; δC
172.2). Finally, Ser-2 was revealed to cyclize the peptide chain to Ser-1 by 
an ester linkage based on the HMBC signals from H2-17 (δH 3.80; δH 1.97) 
to C-51 (δC 169.7), thus completing the planar structure of WS9325F (7).
WS9326G (8) was isolated as a white powder. The molecular formula of 
8 was established as C51H65N7O12 based on the analysis of HRFAB mass 
spectroscopic data (obsd [M+Na]+ at m/z 990.4598, calcd [M+Na]+
990.4589) along with the NMR spectra (Table4). The difference between the 
molecular formulae of 7 and 8 was C2H3NO, which could not be explained 
simply by the disappearance of an amino acid. The comparing analysis of 
1D and 2D NMR data including HSQC, COSY, TOCSY, and HMBC spectra 
of 7 and 8 identified two Thr, DN-Me-Tyr, Leu, Phe, and Asn residues as 
well as 3-[2-(1(Z)-pentenyl)phenyl]-2(E)-propenoic acid (PPPA) in 
WS9326G (2). The sequence of the amino acids and the acyl chain was 
assigned based on HMBC correlations. Therefore the structure of WS9326G 
(2) was determined as a linear peptide with the sequence of PPPA, Thr, DN-
Me-Tyr, Leu, Phe, Thr, and Asn. The structural difference of 8 compared 
with 7 was originated from the replacement of Ser-1 and N-Me-Tyr in 7
with Thr and DN-Me-Tyr and the loss of Ser-2 from 8.
WS9326H (9) was isolated as a white powder, of which molecular 
formula, C50H63N7O12, was assigned by the analysis of HRFAB mass 
spectroscopic data (obsd [M+Na]+ at m/z 976.4438, calcd [M+Na]+
976.4432) and 1H and 13C NMR spectra (Table1). The difference in the 
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molecular formulae of 8 and 9 was just CH2, which indicated a loss of 
methyl or methylene group. By extensive comparison of COSY, HSQC, 
HMBC, and TOCSY, one of the methyl groups in the two Thr units in 8
disappeared and an additional methylene group (δH 3.53, δH 3.74; δC 61.2)
showed up instead, proving that one of the threonines of 2 was replaced 
with Ser in 9. Further analysis of HMBC correlations elucidated the 
sequence of the discrete units. The sequence indicated that the Thr residue 
next to the acyl chain in 8 was replaced by Ser in 9.
WS9326I (10) was purified as a white powder, having having the 
molecular formula as C63H84N12O19 determined by HR-FAB mass 
spectroscopy (obsd [M+Na]+ at m/z 1335.5966, calcd [M+Na]+ 1335.5878), 
and 1H and 13C NMR data (Table 4). Careful comparison of NMR 
spectroscopic data revealed that amino units were identical with those of 
WS9326A but interestingly, WS9326I (10) incorporates an unprecedented 4-
amino-2,4-dihydro-3H-pyarzol-3-one and a sugar-derived moiety. It is first 
WS9326 analogue which has modified starting unit, not amino units. 
Further analysis of 15NHSQC identified all of nitrogen signals including 
pyrazole NH2 protons (δH 2.72), indicating δH 2.72 was real signal related on 
pyrazolone moiety. However, there was a problem in constructing the 
pyrazolne ring by HMBC correlations. None of HMBC signals from 
pyrazole NH2, amide nitrogens (δH 12.76 and δH 8.87) were not correlated 
with quaternary carbon (δC 156.1) in pyrazolone ring. To confirm the planar 
sturucture of pyrazolone ring, carbon-nitrogen selective hydrogenation using 
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NaBH3CN was conducted (Figure 6).
20 The hydrogenation product (11) was 
successfully purified and analyzed by HSQC and HMBC NMR data, 
establishing 4-amino-1H-pyrazol-5-one ring structure. 
Figure 6. The elucidation of the 4-amino-2,4-dihydro-3H-pyrazol-3-one 
ring by 15NHSQC and imine-selective reduction followed by COSY and 
HMBC experiments
The absolute configurations of the amino acid residues in WS9326F (7) 
were established by the advanced Marfey’s method.13 WS9326F (7) was
hydrolyzed in 6 N HCl at 115 °C for 2 h and the hydrolysate was derivatized 
with L- and D-FDAA ((1-fluoro-2,4-dinitrophenyl-5)-L-alanine amide). The 
derivatives were subsequently analyzed by LC/MS, clarifying the L-
configurations for Ser-1, N-Me-Tyr, Leu, Thr, Asn, and Ser-2. The Phe 
residue was assigned to possess D-configuration (Table 4). Because Thr has 
an additional stereogenic center at the b-position, the retention times of L-
and D-FDAA adducts of authentic L-Thr and L-allo-Thr were compared in 
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the LC/MS analysis. But the difference of retention times of products was 
not clear to determine whether L-Thr or L-allo-Thr is. To overcome the 
problem, I decide to apply O-marfey’s method which was reported in 
mylaboratory previously. O-marfey’s method was developed to determine 
the absolute configurations of a-hydroxy acids attaching L-FDAA to 
hydroxy groups. Because threonine has b-hydroxy group, not a-position, I
planned to attach L-FDAA to both of side including nitrogen at amide bond. 
Fortunately, I could obtain both of L-FDAA derivatives and L-Thr-L-FDAA-
L-FDAA derivatives successfully. Through LC/MS analysis, I found out L-
Thr-L-FDAA-L-FDAA product eluted 1.5 min later than L-allo-Thr-L-
FDAA-L-FDAA product. Based on the retention times, WS9326F (1) turned 
out to bear L-allo-Thr, not Thr. The absolute configurations of amino acids 
in 8, 9 and 10 were also determined by the same method. As expected by 
their identical biosynthetic origin with 7, their amino acids turned out to 
have L-configuration except Phe. The Thr residue between D-Phe and Asn in 
8 was elucidated as L-allo-Thr, thus establishing the sequence of PPPA, L-
Thr, DN-Me-Tyr, L-Leu, D-Phe, L-allo-Thr, and L-Asn. Analogously, the 
complete sequence of 9 was assigned as PPPA, L-Ser, DN-Me-Tyr, L-Leu, D-
Phe, L-allo-Thr, and L-Asn. Following the above derivatives, the complete 
sequence of 10 was determined as PPPA, L-Thr, DN-Me-Tyr, L-Leu, D-Phe, 
L-allo-Thr, L-Asn, and L-Ser.
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Scheme 2. A four-step derivatization shceme to determine the absolute 
configuration of aminosugar in 10.
However, determination of absolute configurations of additional chiral 
centers in modified starting unit of 10 was challenging problem. I decided to 
determine the absolute configuration of aminosugar moiety initially by four 
steps of chemical derivatization (Scheme 2). First, WS9326I (10) was 
subjected to acetonide to yield product 12, which protected 1,3 diols in 
aminosugar moiety in 10. Then, 1H and HSQC NMR spectra of the 
acetonide derivative (12) displayed that the 1H and 13C chemical shifts of 
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two acetonide methyl groups are almost identical (dC 25.6−dH 1.31; dC
25.6−dH 1.31), indicating an anti relationship of the 1,3-hydroxy groups 
(Figure 7).21 The relative configuration of second hydrolxyl group was 
determined on the basis of the small 3JH20H21 value (4.5 Hz) and large 
3JH21H22 value (9.0 Hz), establishing the relative configurations of hydroxyl 
groups as S*, R*, and S*. After then, the hydroxyl groups in product 12 was 
acetylated except protected 1,3 diols. The main product, pentaacetate 13, 
was then deprotected by PPTS to restore 1,3 diols for Mosher derivatization. 
Finally, I derivatized deprotected 1,3 diols in product 14 with methoxy-α-
trifluoromethylphenylacetyl chloride (MTPA-Cl) to form MTPA diester and 
analyzed product 15 and 16, determining the absolute configurations of 
three hydroxyl groups as S, R, and S.
Figure 7. 1H and 13C NMR chemical shifts of acetonide derivative (12)
indicating anti relationship of 1,3-diol with J value analysis.
After determination of the absolute configuration of aminosugar in 10, I
had to identify the remained stereogenic centers in pyrazolone ring. Due to 
quaternary position of C-17, it was hard to find applicapable chemical 
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derivatization. Consequently, DP4 calculation which was developed by Prof. 
Goodman group to support the prediction of NMR shielding tensor was 
conducted.22 For accuracy of DP4 calculation, the molecular weight of 
target structure was limited under 500 dalton. Four of target structures were 
modeled and the conformational search was conducted. Accodingly, DP4 
possibility analyses were conducted on 120 possible conformers of four 
models with experimental and predicted chemical values. Interestingly, the 
outcome indicated that isomer 4 model with 3S, 17S was most relavant with 
a probability of 99.6 % (Figure 8). This result was completely supported by 
the analysis of ROESY NMR data of 10, indicating the absolute 
configuration of five stereogenic centers was 3S, 17S, 20S, 21R, and 22S.
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DP4 Calculation result
both carbon and proton data : Diastereomer 1 (RR) - 0.0%
Diastereomer 2 (RS) - 0.4%
Diastereomer 3 (SR) - 0.0%
Diastereomer 4 (SS) - 99.6%
carbon data only : Diastereomer 1 (RR) - 0.2%
Diastereomer 2 (RS) - 0.0%
Diastereomer 3 (SR) - 2.0%
Diastereomer 4 (SS) - 97.9%
proton data only : Diastereomer 1 (RR) - 0.0%
Diastereomer 2 (RS) - 2.1%
Diastereomer 3 (SR) - 0.0%
Diastereomer 4 (SS) - 97.9%
Diastereomer 1 (RR) Diastereomer 2 (RS)
Diastereomer 3 (SR) Diastereomer 4 (SS)
Figure 8. Four plausible diastereomer of 10 used for the DP4 application.
After determining the absolute configurations of stereogenic centers, I
wondered the entire conformations of WS9326G and H (8 and 9) would be 
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folded as structure of WS9326A or linear structures with different 
conformations because there have been no reports to analyze three-
dimensional structures of WS9326s insightfully.  For this reason, deep-
analysis of ROESY correlations of 8 was conducted initially. Interestingly, I
revealed crucial evidences indicating real conformations of 8 might be 
complicated feature seemed to be like M-form, not folded inside like what 
WS9326s were represented previously (Figure 9). First, the direction of acyl 
chain group was revised to be vertical on the basis of ROESY correlations 
between H-1’’ (δH 6.51), H-2’’ (δH 5.75), and H-3 (δH 7.54), not with H-4 (δH
6.90). Additional analysis of ROESY correlations between H-3, 5 (δH 6.70) 
of NMeTyr, a-position proton (δH 4.63) of Phe, nitrogen proton (δH 7.98) of 
allo-Thr, and a-position proton (δH 4.19) of Asn revealed that the 
conformation of NMeTyr was converted to inside of structure. Furthermore, 
methyl group (δH 0.70) of Leu exhibited the ROESY correlations with H-3 
of acyl chain, and methyl group (δH 1.07) of Thr, indicating that 
conformation of Ser was also converted to inside as NMeTyr was. Due to 
analysis of key ROESY correlations of 8, entire conformations of 8 was 
identified as S-form not like cyclic form reported previously, and the 
analysis of ROESY signals of NH of amino acids supported its results. 
Conformational study of 9 was completed with same procedure, displaying 
similar feature of 8. These results might demonstrate how amino acids of 



































Figure 9. Proposed conformations of WS9326G and H (8 and 9) with key 
ROESY correlations.
The major metabolite, WS9326A was originally reported from 
Streptomyces violaceusniger as a tachykinin antagonist.23 An additional 
study about the bioactivities of WS9326 derivatives, WS9326A-E from 
another Streptomyces strain, revealed that WS9326D inhibited Brugia 
malayi asparaginyl-tRNA synthetase and killed the adult B. malayi parasite. 
For the biological evaluation of the new compounds (7-10), cytotoxic 
effects against human carcinoma cell lines such as A549, HCT116, SNU638, 
K562, SK-HEP1, and MDA-MB231 were tested. However, WS9326F-G (7-
10) did not exhibit significant cytotoxicity against the tested human cancer 
cells (IC50 > 10 mM). In antibacterial and antifungal assays, WS9326F-H (7-
10) did not display any significant inhibitory activity either. Because these 
compounds were not virtually cytotoxic, I decided to evaluate 
antiangiogenic activity of 7-10 along with the known derivatives. Tumor 
angiogenesis has been known to play an important role in the growth of 
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tumor cells and its metastasis because receiving nutrients and oxygen 
through new vessels can promote the growth of cancer cells.24 Therefore, 
inhibition of angiogenesis of tumor has been regarded as a promising 
strategy for treatment of cancer in a recent.25 To test the effect of WS9326F-
H (7-10) and WS9326A-E for antiangiogenic activity in endothelial cells, I
evaluated the capillary tube formation assay of HUVEC under VEGF 
induced condition. All of WS9326s showed potent antiangiogenic activity 
but the suppression ratio of the WS9326F (7) at 20 μM exhibited inhibition 
of endothelial cell network formation, which was similar with VEGF 
negative condition (Figure 10). In this assay, WS9326F (7) was observed to 
inhibit capillary tube formation of the HUVEC in dose-dependent manner. 
By contrast, WS9326G, H, and I (8,9, and 10) displayed weak or no 
inhibition activity at the test concentration. These results indicated that 
cyclic ring formation and chiral center of N-methyl tyrosine could be 
significant factor for antiangiogenesis activity and cytotoxicity of WS9326s. 
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Figure 10. Effect of WS9326F-I on capillary tube formation by endothelial 
cells. In a 96-well plate coated with matrigel, HUVECs and each 
concentration of WS9326F-I were added and then incubated for 4-8 h at 
37℃. The capillary structures were photographed and quantified. 
The depsipeptides synthesized by interaction of PKS and NRPS 
pathway existed rarely in nature. WS9326F-H, which were isolated from 
intertidal mudflat-derived Streptomyces sp., were consist of 6-7 amino acids 
with unique acyl chain moiety. To my best knowledge, there were reported 
the only three classes having this moiety, pepticinamin,26 skyllamycin,27 and 
WS9326s. Aaccording to my paper studies, dehydrotyrosine were 
discovered in the diketopiperazine compound from a marine sponge, but it 
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was first class of large peptides which have a dehydrotyrosine in nature. 
Furthermore, additional modification including an unprecedented 4-amino-
2,4-dihydro-3H-pyarzol-3-one of WS9326I was first reported moiety in 
natural products except synthetic compounds. The structurally novel 
bioactive peptides discovered from mudflat implicate that searching for 
unconventional environments of bacteria can be pioneer in discovery of 
progressive drug candidates. 
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Table 4. 1H and 13C NMR Data for 7 and 8 in DMSO-d6
a
7 8
position C/H dH, mult (J in Hz) dC dH, mult (J in Hz) dC
Acyl 1 – 166.4, s – 165.6, s
2 6.44, 1H, d (15.0) 120.0, d 6.90, 1H, d (15.0) 122.8, d
3 7.77, 1H, d (15.0) 139.8, d 7.54, 1H, d (15.0) 137.5, d
4 – 132.9, s – 133.2, s
5 7.28, 1H, m 126.0, d 7.61, 1H, d (7.0) 126.2, d
6 7.15, 1H, t (7.5) 127.5, d 7.34, 1H, m 127.7, d
7 7.09, 1H, t (7.5) 129.5, d 7.36, 1H, m 129.3, d
8 6.99, 1H, d (7.5) 129.9, d 7.21, 1H, m 130.0, d
9 – 137.5, s – 138.1, d
10 6.31, 1H, d (10.5) 127.0, d 6.51, 1H, d (11.5) 127.1, d
11 5.63, 1H, m 134.2, d 5.75, 1H, m 134.4, d
12 2.04, 2H, m 29.7, t 1.97, 2H, m 30.2, t
13 1.39, 2H, m 22.6, t 1.34, 2H, m 22.2, t
14 0.83, 3H, t (7.5) 14.0, q 0.79, 3H, t (7.5) 13.7, q
1Ser/1Thr NH 9.17, 1H, brs 8.30, 1H, brs
a 5.33, 1H, t (8.0) 48.1, d 4.93, 1H, m 55.1, d
b 1.97, 1H, m 63.7, t 4.09, 1H, m 66.6
3.80, 1H, m
g 1.07, 3H, d (6.0) 20.4, t
CO – 170.2, s – 171.1, s
2NMeTyr NMe 2.62, 3H, s 28.2, q 2.87, 3H, s 33.9, q
/DMeTyr a 5.52, 1H, m 61.6, d – 131.5, s
b 2.94, 2H, m 33.4, t 6.56, 1H, s 131.9, d
1 – 127.2, s – 123.6, s
2,6 6.98, 2H, d (8.5) 130.2, d 7.24, 2H, m 131.0, d
3,5 6.68, 2H, d (8.5) 115.7, d 6.70, 2H, d (8.5) 115.5, d
4 – 156.4, s – 159.2, s
CO – 166.3, s – 172.4, s
3Leu NH 9.18, 1H, brs 8.60, 1H, brs
a 4.33, 1H, m 56.0, d 4.42, 1H, m 51.2, d
b 1.06, 2H, m 39.7, t 0.94, 1H, m 40.6, t
1.44, 1H, m 1.24, 1H, m
g 1.06, 1H, m 23.9, d 1.22, 1H, m 24.3, d
d 0.71, 3H, d (6.5) 22.5, q 0.70, 3H, d (6.5) 21.4, q
0.71, 3H, d (6.5) 22.5, q 0.70, 3H, d (6.5) 21.4, q
CO – 169.4, s – 172.0, s
4Phe NH 8.56, 1H, brs 8.42, 1H, brs
a 4.81, 1H, m 52.9, d 4.63, 1H, m 54.4, d
b 2.69, 1H, m 36.4, t 2.70, 1H, m 38.2, t
3.35, 1H, m 3.12, 1H, m
1 – 138.5, s – 138.2, s
2,6 7.21, 1H, m 129.2, d 7.28, 1H, d (6.5) 129.6, d
3,5 7.23, 1H, m 127.7, d 7.21, 1H, m 128.2, d
4 7.17, 1H, t (7.5) 126.2, d 7.13, 1H, t (6.5) 126.3, d
CO – 170.3, s – 171.5, s
5alloThr NH 7.28, 1H, brs 7.98, 1H, brs
a 4.41, 1H, m 56.9, d 4.11, 1H, m 59.2, d
b 3.19, 1H, m 69.2, d 3.67, 1H, m 68.0, d
g 0.77, 3H, d (6.5) 21.5, q 0.94, 3H, d (6.5) 19.6, q
CO – 170.7, s – 171.4, s
6Asn NH 8.90, 1H, brs 7.74, 1H, brs
a 4.70, 1H, m 51.2, d 4.19, 1H, m 52.5, d
b 2.50, 1H, m 36.8, t 2.35, 1H, m 38.2,  t
2.63, 1H, m 2.50, 2H, m
gCO – 171.4, s – 173.3, s
CO – 172.2, s – 173.0, s
7Ser NH 8.51, 1H, brs –
a 4.43, 1H, m 56.0, d
b 3.60, 2H, m 60.8, t
CO – 169.7, s
a1H and 13C data were recorded at 600 and 125 MHz, respectively.
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Table 5. 1H and 13C NMR Data for 9 in DMSO-d6
a
9
position C/H dH, mult (J in Hz) dC
Acyl 1 – 165.6, s
2 6.70, 1H, d (15.0) 122.4, d
3 7.56, 1H, d (15.0) 126.3, d
4 – 133.2, s
5 7.58, 1H, d (8.0) 126.3, d
6 7.33, 1H, t (8.0) 127.7, d
7 7.37, 1H, t (8.0) 129.4, d
8 7.20, 1H, m 130.0, d
9 – 137.4, s
10 6.53, 1H, d (11.5) 127.2, d
11 5.78, 1H, m 134.5, d
12 1.98, 2H, m 30.1, t
13 1.36, 2H, m 22.4, t
14 0.82, 3H, t (7.5) 13.8, q
1Ser/1Thr NH 8.57, 1H, brs
a 5.07, 1H, m 55.1, d
b 3.53, 1H, m 61.2, t
3.74, 1H, m
g   
CO – 172.2, s
2NMeTyr NMe 2.84, 3H, s 33.7, q
/DMeTyr a – 132.0, s
b 6.76, 1H, s 131.9, d
1 – 124.3, s
2,6 7.28, 2H, m 129.5, d
3,5 6.65, 2H, d (8.5) 115.2, d
4 – 158.5, s
CO – 172.5, s
3Leu NH 8.72, 1H, brs
a 4.24, 1H, m 52.1, d
b 1.08, 1H, m 40.0, t
1.29, 1H, m
g 1.18, 1H, m 24.1, d
d 0.72, 3H, d (6.5) 21.7, q
0.72, 3H, d (6.5) 21.7, q
CO – 172.1, s
4Phe NH 8.43, 1H, brs
a 4.62, 1H, m 54.4, d
b 2.71, 1H, m 38.1, t
3.12, 1H, m
1 – 138.5, s
2,6 7.26, 1H, m 129.4, d
3,5 7.23, 1H, m 128.2, d
4 7.14, 1H, t (6.5) 126.3, d
CO – 171.3, s
5alloThr NH 8.01, 1H, brs
a 4.21, 1H, m 58.4, d
b 3.63, 1H, m 67.2, d
g 0.92, 3H, d (6.5) 19.7, q
CO – 171.5, s
6Asn NH 8.10, 1H, brs
a 4.52, 1H, m 49.2, d
b 2.55, 1H, m 36.7
2.58, 1H, m
gCO – 173.2, s
CO – 173.0, s
a1H and 13C data were recorded at 600 and 150 MHz
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Table 6. 1H and 13C NMR Data for 10 in pyridine-d5
a
10
position C/H dH, mult (J in Hz) dC position C/H dH, mult (J in Hz) dC
Acyl 1 – 170.8, s 3Leu NH 9.81, 1H, brs
2 4.57, 1H, dd 39.1, t a 4.71, 1H, m 56.3, d
(15.0, 8.5) b 1.71, 1.33, 1H, m 40.5, t
3.37, 1H, dd g 1.19, 1H, m 24.6, d
(15.0, 3.5) d 0.69, 3H, d (6.5) 22.7, q
3 4.72, 1H, dd 47.1, d 0.58, 3H, d (6.5) 23.7, q
(8.5, 3.5) CO – 174.3, s
4 – 136.5, s 4Phe NH 10.0, 1H, brs
5 8.76, 1H, d (8.0) 130.0, d a 5.12, 1H, m 58.7, d
6 8.30, 1H, t (8.0) 129.0, d b 4.18, 1H, m 37.6, t
7 7.26, 1H, t (8.0) 127.6, d 4.08, 1H, m
8 7.16, 1H, d (8.0) 130.0, d 1 – 130.6, s
9 – 139.7, s 2,6 7.67, 2H, d (8.0) 130.2, d
10 6.99, 1H, d (10.5) 130.6, d 3,5 7.30, 2H, t (8.0) 128.6, d
11 5.59, 1H, m 133.8, d 4 7.24, 1H, t (8.0) 126.5, d
12 2.16, 2.06, 2H, m 30.7, t CO – 173.6
13 1.30, 1.26, 2H, m 23.3, t 5alloThr NH 9.54, 1H, brs
14 0.74, 3H, t (6.5) 14.2, q a 5.62, 1H, dd 59.9, d
15 – 176.9, s  (9.0, 9.0)   
15-NH 12.79, 1H, s b 4.33, 1H, m 70.8, d
16 – 159.6, s g 1.73, 3H, d (6.5) 21.9, q
17 – 62.8, s CO – 173.8, s
17-NH 2.75, 2H, brs 6Asn NH 10.55, 1H, brs
18 – 173.4, s a 6.08, 1H, dd 52.6, d
18-NH 8.89, 1H, brs  (8.5, 3.5)
19 4.98, 1H, m 46.4, t b 3.71, 1H, dd 37.6, t
4.11, 1H, dd (15.5, 3.5)
(11.0, 3.5) 3.51, 1H, dd
20 4.76, 1H, ddd 46.4, s (15.5, 8.5)
(8.0, 4.5, 3.5) gCO – 174.5, s
20-OH 6.5, 1H, brs CO – 172.7
21 4.44, 1H, dd 75.3, d NH2 8.72, 2H, brs
(10.5, 4.5) 7Ser NH 9.56, 1H, brts
21-OH 6.47, 1H, brs a 5.18, 1H, m 57.7, d
22 4.59, 1H, m 74.9, d b 4.46, 4.35, 2H, m 63.2, t
22-OH 6.24, 1H, brs OH 6.25, 1H, brs
23 4.51, 4.35, 2H, m 65.2, t CO – 170.7, s
23-OH 6.19, 1H, brs
1Thr NH 8.53, 1H, d (9.5)
a 5.39, 1H, d (9.5) 53.4, d  
b 5.82, 1H, q (6.5) 72.7, d  
g 0.54, 3H, d (6.5) 15.8, q
CO – 171.4, s
2NMeTyr NMe 3.07, 3H, s 34.8, q
a – 131.6, s  
b 6.71, 1H, s 130.6, d  
1 – 131.6, s
2,6 7.48, 2H, d (8.0) 131.3, d
3,5 7.25, 2H, d (8.0) 116.4, d
4 – 159.9, s
4-OH 11.70, 1H, brs
CO – 166.8, s  
a1H and 13C data were recorded at 900 and 225 MHz,
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III. Hormaomycins B and C: antibiotic cyclic 
depsipeptides from a marine mudflat-derived 
Streptomyces sp. SNM55
39
III. I. Results and discussion
Hormaomycin B (18) was isolated as a white powder with the 
molecular formula C54H67ClN10O14 on the basis of HRFABMS (obsd 
[M+H]+ at m/z 1115.4611, calcd for 1115.4605) coupled with 1H and 13C 
NMR spectroscopy (Table 7). The 1H spectrum of 18 in CDCl3 presented six 
amide protons at dH 8.98, 8.16, 7.31, 6.85, 6.79, and 6.26, indicating its 
peptide-derived nature. Consistently, the 13C NMR of 18 also showed seven 
amide/ester carbons at dC 172.2, 171.8, 171.5, 171.1, 169.3, 168.8, and 
167.9. The analysis of 1H, 13C, and HSQC NMR spectra clarified the 
peptide-derived features of hormaomycin B. As a peptide-derived molecule, 
hormaomycin B exhibited seven methine signals composing a-positions of 
amino acids (dH/dC 5.14/51.2, 3.52/52.2, 4.64/54.5, 4.55/58.4, 4.48/56.4, 
4.33/60.8, and 4.26/61.7). Seven amide/ester carbons and seven a-position 
methines enabled us to deduce that hormaomycin B (18) bears seven or 
more amino acid units. Further analysis of one-bond correlations identified 
NMR signals that do not belong to ordinary amino acids units. In particular, 
two olefinic methines (dH/dC 5.64/128.8 and 5.26/127.8) and two methines 
(dH/dC 0.28/20.2 and -0.66/17.7) and one methylene (dH/dC 0.56 and -
0.26/33.4) in the distinctive upfield suggested the existence of unusual units 
in the molecules. Additionally, two aromatic methines (dH/dC 6.68/109.8 and 
6.08/103.5) with 4.5 Hz 1H-1H coupling indicated the existence of a five-
membered aromatic ring, which does not correspond to any proteinogenic 
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amino acid. Based on the overall analysis of the 1H, 13C NMR, and HSQC 
spectra of 18, along with the existence of a chlorine atom in the molecular 
formula, hormaomycin B was expected to be a peptide-derived compound 
bearing several highly modified amino acid residues. 
Figure 11. The structures of hormaomycins B and C (18 and 19).
Further analysis of HSQC spectral data revealed all of the one-bond 
1H-13C correlations in 18. Subsequent interpretation of the COSY, TOCSY, 
and HMBC NMR spectra established eight partial structures dissected by 
amide bonds. These include a 4-(Z)-propenylproline ((4-Pe)Pro), a 
b-methylphenylalanine ((b-Me)Phe), two 3-(2-nitrocyclopropyl)alanines 
((3-Ncp)Ala), and a 5-chloro-1-hydroxypyrrol-2-carboxylic acid (Chpca), as 
well as three common amino acids: an isoleucine (Ile), a phenylalanine
(Phe), and a threonine (Thr).
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Figure 12. Determination of the unusual partial structures of 18. (a) 4-(Z)-
propenylproline, (b) 3-(2-nitrocyclopropyl)alanine I and II, and (c) 5-chloro-
1-hydroxypyrrol-2-carboxylic acid.
Specifically, the COSY NMR spectrum exhibited correlations from 
H2-3 (dH 2.37, 1.80) to H-2 (dH 4.26) and H-4 (dH 3.27), showing the 
connectivity from C-2 (dC 61.7) to C-4 (dC 36.9) through C-3 (dC 34.9). 
Further COSY correlations of H-4 to H2-5 (dH 3.98, 3.31) and H-6 (dH 5.26) 
revealed that C-4 was located immediately adjacent to C-5 (dC 53.0) and C-
6 (dC 127.8). The 
1H-1H couplings from H-7 (dH 5.64) to H-6 and H-8 (dH
1.68) and HMBC correlations from H-8 to two olefinic carbons C-6 and C-7 
(dC 128.8) established the propenyl substructure connected to C-4. The 
1H-
1H coupling constant (J = 9.5 Hz) between H-6 and H-7 determined the Z
configuration of the C-6 double bond. The 13C NMR chemical shift of C-5 
(dC 53.0) indicated that this carbon is bound to a nitrogen atom. Because 
there was no detected NH signal in this unit, a proline-type moiety was 
expected. The HMBC correlation from the a-proton (H-2; dH 4.26) to C-5 
supported the hypothesis that H-2 and H-5 share one nitrogen to form a 
pyrrolidine. Furthermore, H-2 displayed a HMBC correlation to the C-1 
carbonyl carbon (dC 171.8), completing a 4-(Z)-propenylproline ((4-Pe)Pro) 
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unit (Figure 12a). This unit was further confirmed by TOCSY correlations 
from H-2 to H-8. 
The next unusual unit was composed of distinctively shielded protons 
of H2-26 (dH 0.56, -0.26), H-27 (dH 0.28), and H2-29 (dH 1.02, -0.66), along 
with 25-NH (dH 6.26), H-25 (dH 3.52), and H-28 (dH 2.92), based on COSY 
and TOCSY NMR spectra. In particular, strong COSY correlations among 
H-27, H-28, and H2-29 and their low chemical shifts revealed that this 
amino unit possesses a cyclopropane. Additionally, the 13C chemical shift 
(dC 58.7) of the C-28 methine in the cyclopropane indicated that this carbon 
is directly connected to a heteroatom. The IR spectrum exhibited a strong 
absorption band at 1543 cm-1, which corresponds to a nitro functional group. 
Therefore, C-28 was determined to bind to a nitro group. These assignments 
eventually elucidated a 3-(2-nitrocyclopropyl)alanine ((3-Ncp)Ala) unit 
(Figure 12b). Interestingly, the second (3-Ncp)Ala unit was also identified 
based on COSY and TOCSY correlations, even though the 1H chemical 
shifts of the second unit differ significantly from those of the first (3-
Ncp)Ala residue (Figure 12b, Table 7). 
Hormaomycin B (18) possesses eighteen sp2 carbons. Twelve of these 
were assigned in the two benzene rings in a phenylalanine and a b-
methylphenylalanine, and two olefinic carbons were used in (4-Pe)Pro. 
Then, four sp2 carbons, including two methines, C-51 (dC 109.8) and C-52 
(dC 103.5), and two quaternary carbons, C-50 (dC 119.8) and C-53 (dC
121.5), remained unassigned. These methine protons, H-51 (dH 6.68) and H-
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52 (dH 6.08), were coupled to each other (4.5 Hz). This coupling constant 
strongly suggested that these atoms are part of a five-membered aromatic 
ring. Furthermore, HMBC correlations from H-51 to C-50 and C-53 and 
from H-52 to C-50 and C-53 established the C-50-C-51-C-52-C-53 
connectivity. The last position of the five-membered aromatic ring could be 
a nitrogen atom rather than an oxygen or sulfur atom based on the 13C 
chemical shifts of the four sp2 carbons, indicating a pyrrole ring.28 This 
pyrrole ring is connected to C-49 (dC 159.7) at C-50 according to the HMBC 
correlation from H-51 to C-49. This downfield carbon at dC 159.7 was 
assigned as an amide carbonyl carbon based on the heteronuclear coupling 
from the amide proton 44-NH (dH 8.16) to this carbon. The remarkable 
shielding of C-49 (dC 159.7) in the 
13C NMR spectrum compared to the 
chemical shifts of the other seven amide carbons (dC 172.2, 171.8, 171.5, 
171.1, 169.3, 168.8, and 167.9) might be attributed to the conjugation effect 
of the pyrrole ring. Detailed examination of the mass and NMR data 
suggested that the quaternary carbon C-53 and the nitrogen atom in the 
pyrrole ring should be substituted with heteroatoms. Finally, partial 
structures dissected by amide bonds were established, and one chlorine atom 
and one hydroxy group in the molecular formula were not assigned. 
Considering the chemical shift of C-53 enabled a chlorine atom to be 
located at C-53. Subsequently, the hydroxy group was assigned to be bound 
to the nitrogen atom as an oxime functional group. Therefore, 5-chloro-1-
hydroxypyrrol-2-carboxylic acid (Chpca) was eventually assembled (Figure 
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2c). 
The sequence of eight partial structures ((4-Pe)Pro, Ile, Phe, (bMe)Phe, 
(3-Ncp)Ala I and II, Thr, and Chpca) was determined on the basis of HMBC 
correlations. The long-range 1H-13C coupling from the a-proton of (4-
Pe)Pro (H-2; dH 4.26) to the carbonyl carbon of Ile (C-9; dC 171.5) 
connected (4-Pe)Pro to Ile. The HMBC correlations from 10-NH (dH 7.31) 
and H-16 (dH 4.33) to C-15 (dC 167.9) clarified the attachment of (bMe)Phe 
to Ile. (3-Ncp)Ala I was directly connected to (bMe)Phe based on the 
HMBC correlations from 16-NH (dH 6.85) and H-25 (dH 3.52) to C-24 (dC
169.3), which belonged to (3-Ncp)Ala I. Phe was positioned next to (3-
Ncp)Ala I by 1H-13C long-range coupling from NH-25 (dH 6.26) and H-31 
(dH 4.48) to C-30 (dC 168.8). The HMBC correlations from 31-NH (dH 6.79) 
and H-40 (dH 4.55) to C-39 (dC 171.1) revealed the sequence from Phe to 
Thr. In addition, the NH proton (dH 8.98) of Thr and the a-proton (dH 5.14) 
of (3-Ncp)Ala II displayed HMBC signals linking them to the carbonyl 
carbon C-43 of (3-Ncp)Ala II, clarifying the connection between Thr and (3-
Ncp)Ala II. Chpca was directly connected to (3-Ncp)Ala II on the basis of 
the HMBC correlations from 44-NH (dH 8.16) of (3-Ncp)Ala II (dH 8.16) 
and H-51 (dH 6.68) of Chpca to the carbonyl carbon C-49 (dC 159.7) 
belonging to Chpca. Finally the long-range HMBC correlation from H-41 
(dH 5.40) to the carbonyl carbon at 171.8 ppm (C-1) closed a macrocyclic 
lactone ring, indicating the planar structure of hormaomycin B (18) in a 
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cyclic depsipeptide (Figure 3).
Hormaomycin C (19) was isolated as a white powder, and the 
molecular formula was deduced as C54H67ClN10O14 by analyzing 
HRFABMS (obsd [M+Na]+ at m/z 1137.4432, calcd [M+Na]+ 1137.4424) 
and 1H and 13C NMR data (Table 7). The molecular formula of 19 was 
identical to that of hormaomycin, and it was predicted that hormaomycin C 
(19) would be very similar to 18. Careful comparison of 1D and 2D NMR 
data revealed that all eight partial structures identified in hormaomycin B 
also exist in 19. However, the extensive analysis of the HMBC NMR 
spectra showed that the sequence of the units was different. Specifically, the 
methyl group (17-Me; dH 1.29) of (bMe)Phe and the methylene signal (H2-
32; dH 2.79, 3.38) of Phe were replaced with a methylene (H2-17; dH 2.91, 
2.97) and a methyl group (32-Me; dH 1.40) in 19, indicating the switched
positions of (bMe)Phe and Phe between these compounds. The order of the 
other units was assigned based on further HMBC spectroscopic analysis, 
completing the planar structure of hormaomycin C (19). 
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Figure 13. Key HMBC correlations of hormaomycin B (18).
During cultivation of the strain SNM55, hormaomycin, which was 
previously discovered from Streptomyces griseoflavus, was identified along 
with these new compounds. Hormaomycin is a cyclic depsipeptide that 
bears almost exclusively uncommon amino acids, such as (4-Pe)Pro and (3-
Ncp)Ala, as well as Chpca. Because of its structural novelty and remarkable 
biological activity, chemical synthesis29 and biosynthetic modifications30
have been studied in recent decades. However, although artificial analogues 
have been reported during the total synthesis and biosynthetic engineering 
of hormaomycin,29,30 no natural analogues have been discovered. To my best 
knowledge, hormaomycins B and C are the first natural analogues of 
hormaomycin that have been obtained without chemical modification or 
gene cluster manipulation. Hormaomycin possesses two (bMe)Phe units, 
whereas both hormaomycins B and C bear one (bMe)Phe and one Phe. 
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Therefore, hormaomycin was utilized to determine the absolute 
configurations of hormaomycins B and C (18 and 19). The 1H and 13C NMR 
data and CD spectrum of hormaomycin were carefully compared with those 
of 18 and 19. Based on the close similarity between the NMR data and CD 
spectra (Figure 4), as well as their common biosynthetic origin, the absolute 
configurations of hormaomycins B and C were determined to be identical to 
that of hormaomycin, which was determined by total synthesis.29
l (nm)




















Figure 14. The CD spectra of the hormaomycins in MeOH.
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III. II. Bioactivities of hormaomycins
Hormaomycin (17) was previously reported to exhibit remarkable 
antibacterial effects.31 Therefore, the biological activities of the 
hormaomycins found here were evaluated with regard to their antimicrobial 
activities against various pathogenic bacterial strains, including 
Staphylococcus aureus ATCC 25923, Bacillus subtilis ATCC 6633, Kocuria 
rhizophila NBRC 12708, Streptococcus pyogenes ATCC 19615, Klebsiella 
pneumoniae ATCC10031, Salmonella enterica ATCC 14028, Proteus 
hauseri NBRC 3851, and Escherichia coli ATCC 25922 (Table 2). 
Hormaomycin exhibited more potent antibacterial activities against the 
tested Gram-positive bacteria than against the tested Gram-negative bacteria, 
particularly against S. aureus and K. rhizophila, exhibiting MIC values of 
0.4 μM and 0.03 μM, respectively. Hormaomycin also exhibited significant 
antibacterial effects against Gram-negative P. hauseri. Hormaomycins B 
and C (18 and 19) displayed potent activity against K. rhizophila but 
showed antibacterial activities against the tested bacteria that were generally 
4~32 times weaker than those of hormaomycin. Accordingly, it was 
hypothesized that the existence of the methyl groups at C-17 and C-32, 
which form (bMe)Phe, play an important role in the antibacterial potency of 
the hormaomycins. Further investigations of the antifungal activity were 
conducted against the pathogenic fungi Aspergillus fumigatus, Trichophyton 
rubrum, T. mentagrophytes, and Candida albicans, but no significant 
inhibitory activity was observed to result from the hormaomycin treatments.
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Table 7. 1H (600 MHz) and 13C NMR (150 MHz) data 18 and 19 in CDCl3
C/H
18 19
dH, mult (J in Hz) dC type dH, mult (J in Hz) dC type
(4–Pe)Pro 1 – 171.8 C – 171.6 C
2 4.26, 1H, m 61.7 CH 4.26, 1H, dd (11.0, 6.5) 61.8 CH
3 2.37, 1H, m 34.9 CH2 2.36, 1H, m 35.8 CH2
1.80, 1H, m 1.81, 1H, m
4 3.27, 1H, m 36.9 CH 3.25, 1H, m 37.0 CH
5 3.98, 1H, m 53.0 CH2 3.98, 1H, m 53.0 CH2
3.31, 1H, m 3.27, 1H, m 
6 5.26, 1H, dd (9.5, 9.5) 127.8 CH 5.26, 1H, dd (9.0, 9.0) 127.9 CH
7 5.64, 1H, dq (9.5, 7.0) 128.8 CH 5.63, 1H, dq (9.0, 7.0) 128.8 CH
8 1.68, 1H, d (7.0) 13.5 CH3 1.66, 1H, d (7.0) 13.5 CH3
Ile 9 – 171.5 C – 171.5 C
10 4.64, 1H, m 54.5 CH 4.64, 1H, m 54.9 CH
10–NH 7.31, 1H, brs – 7.23, 1H, brs –
11 1.88, 1H, m 38.6 CH 1.90, 1H, m 38.2 CH
12 1.54, 1H, m 25.0 CH2 1.55, 1H, m 25.0 CH2
1.29, 1H, m 1.30, 1H, m
13 0.90, 3H, d (7.0) 10.8 CH3 0.89, 3H, d (7.0) 10.8 CH3
14 1.04, 3H, d (7.0) 15.2 CH3 1.02, 3H, d (7.0) 15.3 CH3
(bMe)Phe/Phe 15 – 167.9 C – 171.3 C
16 4.33, 1H, m 60.8 CH 4.58, 1H, m 55.2 CH
16–NH 6.85, 1H, brs – 6.91, 1H, brs –
17 3.02, 1H, m 44.6 CH 2.91, 1H, m 38.0 CH2
17-Me 1.29, 3H, d (6.5) 18.0 CH3 2.97, 1H, m
18 – 141.9 C – 136.5 C
19 7.11, 1H, d (8.5) 129.0 CH 7.11, 1H, d (8.0) 129.5 CH
20 7.13, 1H, t (8.5) 127.5 CH 7.15, 1H, t (8.0) 129.0 CH
21 7.03, 1H, t (8.5) 127.6 CH 7.09, 1H, t (8.0) 127.7 CH
22 7.13, 1H, t (8.5) 127.5 CH 7.15, 1H, t (8.0) 129.0 CH
23 7.11, 1H, d (8.5) 129.0 CH 7.11, 1H, d (8.0) 129.5 CH
(3–Ncp)AlaⅠ 24 – 169.3 C – 168.2 C
25 3.52, 1H, m 52.2 CH 3.55, 1H, m 52.8 CH
25–NH 6.26, 1H, brs – 6.37, 1H, brs –
26 0.56, 1H, m 33.4 CH2 0.78, 1H, m 33.0 CH2
-0.26, 1H, m 0.13, 1H, m
27 0.28, 1H, m 20.2 CH 0.58, 1H, m 20.4 CH
28 2.92, 1H, m 58.7 CH 3.04, 1H, m 58.6 CH
29 -0.66, 1H, m 17.7 CH2 -0.34, 1H, m 17.4 CH2
1.02, 1H, m 1.13, 1H, m
Phe/(bMe)Phe 30 – 168.8 C – 168.3 C
31 4.48, 1H, m 56.4 CH 4.48, 1H, m 60.6 CH
31–NH 6.79, 1H, brs – 6.79, 1H, brs –
32 2.79, 1H, m 38.7 CH2 3.67, 1H, m 37.1 CH
3.38, 1H, m 1.40, 3H, d (6.5) 13.7 CH3
33 – 137.3 C – 142.6 C
34 7.22, 1H, m 129.3 CH 7.24, 1H, m 127.9 CH
35 7.23, 1H, m 127.8 CH 7.25, 1H, m 128.8 CH
36 7.15, 1H, t (8.5) 127.2 CH 7.17, 1H, t (8.5) 127.3 CH
37 7.23, 1H, m 127.8 CH 7.25, 1H, m 128.8 CH
38 7.22, 1H, m 129.3 CH 7.24, 1H, m 127.9 CH
Thr 39 – 171.1 C – 171.1 C
40 4.55, 1H, m 58.4 CH 4.52, 1H, m 55.8 CH
40-NH 8.98, 1H, brs – 8.95, 1H, brs –
41 5.40, 1H, m 69.4 CH 5.38, 1H, m 69.6 CH
42 1.52, 3H, m 17.2 CH3 1.48, 3H, m 17.3 CH3
(3–Ncp)AlaⅡ 43 – 172.2 – 172.1
44 5.14, 1H, m 51.2 CH 5.09, 1H, m 51.5 CH
44-NH 8.16, 1H, brs – 7.96, 1H, brs –
45 1.80, 1H, m 35.5 CH2 1.83, 1H, m 35.2 CH2
1.60, 1H, m 1.61, 1H, m
46 1.93, 1H, m 21.7 CH 1.91, 1H, m 21.7 CH
47 4.04, 1H, m 59.8 CH 4.05, 1H, m 59.6 CH
48 1.95, 1H, m 17.8 CH2 1.95, 1H, m 17.9 CH2
1.02, 1H, m 1.01, 1H, m
Chpca 49 – 159.7 C – 160.1 C
50 – 119.8 C – 119.8 C
51 6.68, 1H, d (4.5) 109.8 CH 6.81, 1H, d (4.5) 109.8 CH
52 6.08, 1H, d (4.5) 103.5 CH 6.13, 1H, d (4.5) 104.0 CH
53 – 121.5 C – 120.5 C
NOH 10.8, 1H, brs – 10.8, 1H, brs –
50




















Hormaomycin 0.4 1.8 0.03 1.8 >113 >113 0.9 >113
Hormaomycin 
B
7 14 0.4 14 >115 29 29 >115
Hormaomycin 
C
7 56 0.23 8 >114 114 14 >114
Ampicillin <0.17 0.17 <0.17 0.17 45.9 3.7 <0.17 11.5
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I. II. Experimental section
General experimental procedures. Optical rotations were measured 
using a Jasco P–1020 polarimeter (sodium light source, JASCO, Easton, PA, 
USA) with a 1 cm cell. Infrared (IR) spectra were acquired using a Thermo 
N1COLET iS10 spectrometer (Thermo, Madison, CT, USA). UV spectra 
were obtained with a Perkin Elmer Lambda 35 UV/VIS spectrometer 
(Perkin Elmer, Waltham, MA, USA). Electrospray ionization (ESI) low–
resolution LC/MS data were recorded using a matrix-assisted laser 
desorption/ionization (MALDI) mass spectrometer (AB SCIEX, 
Framingham, MA, USA) at the National Center for Inter–University 
Research Facilities (NCIRF) and an Agilent Technologies 6130 Quadrupole 
mass spectrometer (Agilent Technologies, Santa Clara, CA, USA) coupled 
with an Agilent Technologies 1200 series high-performance liquid 
chromatography (HPLC) instrument using a reversed–phase C18 column 
(Phenomenex Luna, 100 × 4.6 mm). High-resolution fast atom 
bombardment (HR–FAB) mass spectra were recorded using a Jeol JMS–
600W high-resolution mass spectrometer (Jeol, München, Germany) at 
NCIRF. One- and two-dimensional (1D and 2D, respectively) nuclear 
magnetic resonance (NMR) spectra were obtained using Bruker Avance 500 
MHz and Bruker Avance 600 MHz NMR spectrometer (Bruker, Billerica, 
MA, USA) at NCIRF (National Center for Inter–University Research 
Facilities) and a Bruker Avance 900 MHz NMR spectrometer (Bruker, 
52
Billerica, MA, USA) at Korea Basic Science Institute (KBSI) at Ochang.
Isolation of the bacterial strain. A sediment sample was collected 
from a mud flat in Buan, Republic of Korea in a 40 mL sterilized plastic 
tube. The sample (1 g) was diluted and mixed in 4 mL of sterilized artificial 
seawater. The mixture was spread on Actinomycete Isolation Agar, A4 
medium (1 L seawater, 18 g agar, 100 mg/L cycloheximide), A5 medium 
(750 mL seawater, 250 mL distilled water, 18 g agar, 100 mg/L 
cycloheximide), and Chitin–based Agar. The bacterial strain SNM55 was 
isolated on A5 media as a single strain. The strain was identified as a 
Streptomyces sp. based on the 16S rDNA sequence data (most closely 
related to Streptomyces javenis by 99% identity).
Cultivation and extraction of the bacterial strain. The SNM55 
strain was cultivated in 50 mL of yeast extract-malt extract (YEME) 
medium (4 g yeast extract, 10 g malt extract, and 4 g glucose in 1 L artificial 
seawater) in a 125 mL Erlenmeyer flask. After cultivation for 3 days on a 
rotary shaker at 160 rpm at 30 °C, 20 mL of the SNM55 liquid culture was 
inoculated in a 500 mL Erlenmeyer flask containing 200 mL of YEME 
medium. After a 2-day incubation, 30 mL of the culture were inoculated in 1 
L YEME medium in 2.8 L Fernbach flasks (12 ea × 1 L, total volume 12 L). 
After 7 days, the entire culture was extracted with 18 L of ethyl acetate. The 
ethyl acetate layer was separated and removed using anhydrous sodium 
sulfate. The ethyl acetate extract was concentrated in vacuo to yield 4 g of 
dried material. This procedure was repeated 6 times (72 L culture in total) to 
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obtain enough mohangamide mass for structural elucidation and for 
bioassays.
Isolation of mohangamides A and B (1 and 2). The crude extract 
was adsorbed onto Celite, loaded on a 2 g Sep-Pak C18 cartridge, and 
fractionated with 100 mL each of 20%, 40%, 60%, 80%, and 100% MeOH 
in water. Mohangamides A and B (1–2) were detected in the 60% and 80% 
MeOH/water fractions. To isolate 1 and 2, the 60% and 80% fractions were 
subjected to reversed–phase HPLC (Kromasil C18 (2): 250 × 10 mm, 5 μm) 
with a gradient solvent system (65% MeOH/water to 90% MeOH/water 
over 40 min and 90% MeOH/water from 40 to 50 min, UV 280 nm 
detection, flow rate: 2 mL/min). Two peaks at retention times of 34.5 and 
44.3 min were collected. These compounds were further purified using a 
C18 HPLC column (Kromasil C18 (2): 250 × 10 mm, 5 μm) under isocratic 
conditions in 55% MeOH/water (UV 280 nm detection, flow rate: 2 
mL/min). Finally, mohangamides A (50 mg) and B (29 mg) (1-2) were 
isolated at retention times of 20.3 and 26.0 min, respectively. 
Mohangamides A and B are barely soluble in water. However, they are 
soluble in DMSO, pyridine, methanol, and ethyl acetate.
Mohangamide A (1). [α]D ¬-82 (c 0.1, MeOH); UV (MeOH) lmax (log 
e) 236 (4.93), 280 (4.64) nm; IR (neat) nmax 3292, 1648, 1513, 1249 cm
-1; 
for 1H and 13C NMR data, see Table 1; HRFABMS m/z 2078.0071 [M]+ 
(calcd for C107H139N17O26 2078.0077).
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Mohangamide B (2). [α]D -54 (c 0.1, MeOH); UV (MeOH) lmax  (log 
e 236 (4.91), 280 (4.38) nm; IR (neat) nmax 3297, 1648, 1516, 1251 cm
-1; for 
1H and 13C NMR data, see Table 2; HRFABMS m/z 2088.9971 [M+Na]+ 
(calcd for C106H139N17O26Na 2088.9975).
Methanolysis of mohangamide A (3a and 3b). Mohangamide A (1) 
(20 mg) was dissolved in 2 mL of MeOH, and 28 mg of NaOMe was added 
to the vial to prepare a 0.5-M NaOMe solution. The reaction mixture was 
stirred at room temperature for 3 h, and the reaction was quenched with 1 N 
HCl. The methanolysis product was extracted using water–ethyl acetate 
partition after evaporating MeOH in vacuo. After removing the solvent, the 
methanolysis products 3a (7 mg) and 3b (9 mg) were purified by reversed–
phase HPLC (Kromasil C18 (2): 250 × 10 mm, 5 μm, UV 280 nm detection, 
55%–70% acetonitrile/water gradient solvent system over 40 min, flow rate: 
2 mL/min) at retention times of 18 and 23 min, respectively. The structures 
of 3a and 3b were assigned after 1D and 2D NMR and ESI mass spectra 
(for 3a, [M+H]+ m/z at 1069, molecular formula; C55H72N8O14 / 3b 
[2M+H]+ m/z at 2147, molecular formula; C54H75N9O14) analyses.
Acetylation of 3b (4). The methanolysis product 3b was dried in 
vacuo for 24 h. Product 3b was dissolved in 1 mL of distilled anhydrous 
pyridine. After flushing with argon gas, 1 mL of acetic anhydride was added 
and stirred at room temperature for 5 h. The solution was evaporated under 
high vacuum for 4 h. The product was purely isolated by reversed–phase 
HPLC (Kromasil C18 (2): 250 × 10 mm, 5 μm) with a gradient solvent 
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system (60% acetonitrile/water to 95% acetonitrile/water over 40 min, UV 
280 nm detection, flow rate: 2 mL/min). Tetraacetate 3b (4) (7.5 mg) eluted 
at 30.8 min, and its structure was determined by 1H NMR spectroscopy and 
by low-resolution ESI-MS ([M+H]+ m/z at 1242, molecular formula; 
C62H83N9O18). 
Tetraacetate (4) : 1H NMR (600 MHz, DMSO–d6) d 8.39–8.27 (m, 
4H), 8.13 (brs, 1H), 8.08 (brs, 1H), 7.37–7.15 (m, 7H), 7.01 (d, J=8.5, 2H), 
6.92 (brs, 1H), 6.60 (s, 1H), 6.53 (d, J =14.5, 1H), 5.63 (brs, 1H), 5.21–5.18 
(m, 2H), 5.10–5.05 (m, 3H), 4.99 (m, 1H), 4.76–4.70 (m, 2H), 4.67 (m, 1H), 
4.59 (m, 1H), 4.28–4.22 (m, 2H), 3.64 (s, 3H), 3.10–3.07 (m, 2H), 2.92 (s, 
3H), 2.90–2.85 (m, 4H), 2.73 (brs, 1H), 2.54 (m, 1H), 2.46 (m, 1H), 2.28 (s, 
3H), 2.00 (s, 3H), 1.92 (s, 3H), 1.87 (m, 2H), 1.77 (s, 3H), 1.30–1.20 (m, 
4H), 1.13 (m, 1H), 1.07 (m, 3H), 1.05 (m, 3H), 0.80 (t, J =7.5, 3H), 0.69 (d, 
J =7.5, 3H), 0.69 (d, J =7.5, 3H).
OsO4 oxidation of 4 (5). Tetraacetate (4) (7.5 mg) was dissolved in 2 
mL acetone in a 40-mL vial, and 5 mg of NMO (4–methylmorpholine N–
oxide) and 20 μL of OsO4 in H2O solution were added to the vial. The 
reaction was conducted at 40 °C for 3 h. The mixture was dried under low 
pressure and purified by HPLC using a gradient solvent system (65% 
MeOH/water to 90% MeOH/water over 40 min, C18 reversed–phase column 
250 × 10 mm, 5 μm, UV 280 nm detection, flow rate: 2 mL/min). The OsO4
oxidation product 5 (4 mg) was isolated at a retention time of 41.5 min. The 
planar structure of 5 was confirmed by 1D and 2D NMR and ESI mass 
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spectral ([M+H]+ m/z at 1276, molecular formula; C62H85N9O20. Compound 
5 was stable during further acylation and subsequent CD spectroscopic 
measurement.
Esterification of 5 (6). A 4 mg quantity of OsO4 oxidation product 
(5) was completely dried in vacuo for 24 h and dissolved in 1 mL of 
distilled anhydrous pyridine. A catalytic amount of DMAP 
(dimethylaminopyridine) and 20 mL of DMAB-Cl (4–(dimethylamino) 
benzoyl chloride) were added to the solution under argon gas. The reaction 
mixture was stirred at 40 °C for 5 h. The mixture was then dried and 
redissolved in MeOH. The dissolved material was injected on reversed–
phase HPLC (Kromasil C18 (2): 250 × 10 mm, 5 μm, UV 280 nm detection, 
40%–90% acetonitrile/water gradient system, flow rate: 2 mL/min). The bis-
benzoyl ester product (6) was purified at 37 min. The structure of 6 was 
confirmed by 1H NMR and ESI mass spectral ([M+H]+ m/z at 1570, 
molecular formula; C80H103N11O22) analyses.
Bis–benzoyl ester (6) : 1H NMR (500 MHz, DMSO– d6) d 8.43–8.32 
(m, 6H), 8.03 (d, J=8.5, 2H), 7.94 (d, J =8.5, 2H), 7.36–7.20 (m, 5H), 6.93 
(brs, 2H), 6.83 (d, J =8.5, 2H), 6.79(d, J =8.5, 2H), 6.62 (brs, 2H), 6.26 (s, 
1H), 5.85 (brs, 1H), 5.48 (brs, 1H), 5.30 (d, J=6.0, 1H), 5.15–5.00 (m, 4H), 
4.76–4.54 (m, 5H), 4.28–4.24 (m, 3H), 3.62 (s, 3H), 3.09 (s, 3H), 3.09 (s, 
3H), 3.08–3.04 (m, 2H), 3.02 (s, 3H), 3.02 (s, 3H), 2.89 (s, 3H), 2.88–2.83 
(m, 4H), 2.73 (brs, 1H), 2.54 (m, 1H), 2.46 (m, 1H), 1.99 (s, 3H), 1.98 (s, 
3H), 1.90 (s, 3H), 1.85 (m, 2H), 1.78 (s, 3H), 1.31–1.23 (m, 5H), 1.04 (m, 
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3H), 1.02 (m, 3H), 0.83 (t, J=7.5, 3H), 0.69 (m, 3H), 0.69 (m, 3H).
Advanced Marfey’s method. Mohangamide A (1) (3 mg) was 
hydrolyzed in 0.5 mL of 6 N HCl at 115 °C. After 2 h, the reaction vial was 
cooled down in ice water for 3 min. Then the HCl was removed in vacuo
and the dry material was resuspended in 0.5 mL of H2O, and dried three 
times to remove residual HCl completely. After the hydrolysate was 
lyophilized for 24 h, it was divided into two portions each in an 8 mL vial, 
and was dissolved in 100 μL of 1 N NaHCO3, followed by the addition of 
50 μL of either 10 mg/mL L-FDAA (1-fluoro-2,4-dinitrophenyl-5-L-alanine 
amide) or D-FDAA (1-fluoro-2,4-dinitrophenyl-5-D-alanine amide) in 
acetone, respectively. The reaction mixtures were incubated in a water bath 
at 80 °C for 3 min. Then 50 μL of 2 N HCl was added to quench the 
reaction by neutralization. Additionally, 300 μL of aqueous 50% CH3CN 
was added to the solution to dissolve the mixture. A 10 μL aliquot of each 
reaction mixture was analyzed by LC/MS with a gradient solvent system 
(20% to 60% CH3CN with 0.1% formic acid over 40 min, C18 reversed-
phase column 100 × 4.6 mm, UV detection at 340 nm). The elution 
sequences of the FDAA derivatives in the LC/MS analysis established that 
phenylalanine possessed a D-configuration, whereas the other residues (Thr, 
Leu, Asn, and Ser) corresponded to L-amino acids (Table S4). For the 
absolute configurations of mohangamide B (2), the same procedures above 
were performed. The absolute configurations of the amino acid units 
commonly existing in 1 and 2 were identical. Different units, such as 8Ser 
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and 9N-MeTyr, were determined to be the L-form. 
GITC derivatization. The hydrolysate of mohangamide A (1) was 
dissolved in H2O (1 mg/mL) in an 8 mL vial. Then 100 μL of 1% GITC 
(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl isothiocyanate) in acetone and 
100 μL of 6% triethylamine were added to the vial. The reaction mixture 
was stirred for 15 min at room temperature. After stirring, 100 μL of 5% 
acetic acid was added to dilute the reaction mixture. The reaction mixture 
was analyzed by LC/MS with a gradient solvent system (10% to 100% 
CH3CN with 0.1% formic acid over 20 min, C18 reversed-phase column 100 
× 4.6 mm, UV detection at 254 nm). The authentic standards of L-Thr and 
allo-L-Thr were also derivatized by using the identical method. The GITC 
derivatives of the hydrolysate were injected simultaneously with those of 
the standard L-Thr and allo-L-Thr. The GITC derivatives of authentic L-Thr 
and allo-L-Thr eluted at 10.6 min and 10.3 min, respectively. The GITC 
derivatives of the hydrolysate of 1 displayed two retention times identical to 
those of L-Thr and allo-L-Thr (10.6 and 10.3 min), indicating mohangamide 
A (1) possesses both of them in its amino acid residues.
Isocitrate Lyase (ICL) activity assay. The 1-mL reaction volume 
consisted of 20 mM sodium phosphate buffer (pH 7.0), 1.27 mM threo-DL-
(+)-isocitrate, 3.75 mM MgCl2, 4.1 mM phenylhydrazine, and 2.5 μg/mL of 
recombinant ICL. The reaction was immediately initiated following the 
addition of substrate with or without a prescribed concentration of the 
inhibitor dissolved in DMSO (final concentration, 0.5%). Glyoxylate 
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phenylhydrazone formation was spectrophotometrically assessed at 324 nm 
after incubation at 37 °C for 30 min. Protein concentrations were measured 
using the Bradford method with the Bio-Rad protein assay kit (Bio-Rad) and 
bovine serum albumin as the standard. An inhibitor-free control was also 
prepared, and the percent inhibition of ICL enzyme activity for each 
compound was calculated relative to the inhibitor-free control. 3-
Nitropropionic acid was used as a positive control.
Antibacterial activity Assay. Gram-positive bacteria (Staphylococcus 
aureus ATCC 25923, Bacillus subtilis ATCC 6633, and Kocuria rhizophila
NBRC 12708) and gram-negative bacteria (Salmonella enteric ATCC 
14028, Proteus hauseri NBRC 3851, and Escherichia coli ATCC 25922) 
were used for the antimicrobial activity tests.22 The bacteria were incubated 
overnight in Luria Bertani (LB) broth at 37 °C, harvested by centrifugation, 
and washed twice with sterile distilled water. The compound solutions were 
prepared in DMSO. Each solution was diluted with Plate Count Broth 
(Difco) to generate serial 2-fold dilutions in the range of 50 to 0.8 μg/mL. 
Aliquots (10 μL) of the broth containing the test bacteria were added to each 
96-well microtiter plate at a final concentration of 5 × 105 colony-forming 
units (cfu)/mL. The plates were incubated for 12 h at 37 °C. The MIC 
values were determined as the lowest concentration at which there is no 
visible growth. Ampicillin was used as a reference compound.
Cytotoxicity assay. The cytotoxicity for cultured cancer cells of 
compounds 1 and 2 was evaluated with a sulforhodamine B (SRB) assay. 
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Six human cancer cell lines (HCT116, MDA-MB231, SNU638, A549, 
K562, and SK-HEP1) were seeded into 96-well plates at 3 × 104 cells/mL 
and incubated with various concentrations of each compound at 37 °C in a 
humidified atmosphere with 5% CO2. After 72 h, the cells were fixed with a 
10% TCA solution for 1 h, and the cellular proteins were stained with 0.4% 
SRB in 1% acetic acid. The stained cells were dissolved in 10 mM Tris 
buffer (pH 10.0). The effects of 1 and 2 on cell cytotoxicity were calculated 
as a percentage relative to the solvent-treated control. The IC50 values were 
determined by non-linear regression analysis (percent survival versus
concentration). Etoposide was used as positive control.
Plate assay. C. albicans strains were grown in a 6.7% yeast nitrogen 
base (YNB) containing 2% glucose at 28 °C for 24 h, harvested by 
centrifugation, and washed twice with sterile distilled water. Mohangamide 
A was dissolved in DMSO and added to YNB agar plates containing 2% 
glucose or 2% potassium acetate with serial two-fold dilutions in the range 8 
× IC50-1 × IC50. Five microliters of the broth containing each strain was 
added to each plate (final concentration, 1 × 104 cells/mL), and the culture 
plates were incubated for 60 h at 28 °C.
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II. II. Experimental section
Isolation of WS9326F-I (7–10). The crude extract was concentrated 
with celite and loaded on a 2 g Sep-Pak C18 cartridge. The yellow powder 
was fractionated with 100 mL each of 20%, 40%, 60%, 80%, and 100% 
MeOH in water. WS9326F–H (1–3) were obtained in the 60%–80% 
MeOH/H2O fractions. The 60% and 80% fractions were separated by semi-
preparative reversed–phase HPLC (Kromasil C18 (2): 250 × 10 mm, 5 μm) 
using a gradient solvent system (65% MeOH/water to 90% MeOH/water 
over 40 min and 90% MeOH/water from 40 to 50 min, UV 280 nm 
detection, flow rate: 2 mL/min) to yield 7 (8 mg, tR 37.2 min), 8 (6.5 mg, tR
35.5 min), 9 (7 mg, tR 35.2 min), and 10 (5.5 mg, tR 17.5 min),. Each of 
compounds were further purified with a C18 HPLC column (Kromasil C18
(2): 250 × 10 mm, 5 μm) using isocratic conditions in 50% ACN/water (UV 
280 nm detection, flow rate: 2 mL/min). WS9326F–I (7–10) were collected 
as pure compounds at retention times of 34.3min, 29.5, 26.2, and 15.7 min, 
respectively.
WS9326F (7): White powder; [α]25D +56 (c 0.5, MeOH); UV (MeOH) λmax 
(log ε) 285 (4.46) nm; IR (neat) νmax 3286, 2956, 1653, 1547, 1252 cm
-1; 1H 
and 13C NMR data, see Table 4; HRFABMS m/z 1025.4983 [M + H]+ (calcd 
for C53H68N8O13, 1025.4984).
WS9326G (8): White powder; [α]25D +32 (c 0.5, MeOH); UV (MeOH) λmax 
(log ε) 285 (4.28) nm; IR (neat) νmax 3297, 2958, 1650, 1546, 1395 cm
-1; 1H 
and 13C NMR data, see Table 4; HRFABMS m/z 990.4598 [M + Na]+ (calcd 
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for C51H65N7O12Na, 990.4589).
WS9326H (9): White powder; [α]25D +48 (c 0.5, MeOH); UV (MeOH) λmax 
(log ε) 285 (4.5) nm; IR (neat) νmax 3284, 2957, 1655, 1548, 1278 cm
-
1; 1H and 13C NMR data, see Table 5; HRFABMS m/z 976.4438 [M + Na]+ (
calcd for C50H63N7O12Na, 976.4432).
WS9326I (10): White powder; [α]25D +37 (c 0.5, MeOH); UV (MeOH) λmax
(log ε) 285 (4.12) nm; IR (neat) νmax 3275, 2954, 1650, 1544, 1264 cm
-
1; 1H and 13C NMR data, see Table 6; HRFABMS m/z 1335.5966 [M + Na]+
(calcd for C63H84N12O19Na, 1335.5878).
Preparation of hydrogenated derivative of 10 (11). WS9326I (10) 
(1.5 mg) was prepared in a 40 mL vial and dried under high vacuum for 24 h. 
Then, compound 10 was dissolved in 2:1 mixture of acetic acid and 
methanol (1 mL) with sodium cyanoborohydride (3 mg). The solution was 
stirred at rt under argon for 4 h. To quench the reaction, 10 % HCl aqueous 
solution was added. The reaction mixture was fractionated by flash column 
reversed-phase chromatography using a gradient solvent system of 
MeOH/H2O (20%, 40%, 60%, 80%, and 100%). The product 11 was 
purified by re by reversed-phase HPLC (Phenomenex Luna 5 μm C18 (2) 
250 × 10.0 mm, flow rate 2 mL/min, UV 254 nm detection) with a gradient 
solvent system (15% to 85% ACN/H2O) for 40 min. The acetonide product 
(12) eluted at a retention time of 20.6 min (1 mg, 67 %) under the HPLC 
conditions. The molecular formula of 11 was confirmed as C63H86N12O19 by 
ESIMS analysis ([M + H] + m/z at 1314).
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Hydrogenated product (11). 1H NMR (600 MHz, pyridine-
d5) ) dH 12.15 (s, 1H), 11.82 (br, 1H), 10.42-10.40 (br, 2H), 9.49-
9.46 (m, 2H), 8.76-
74 (br, 2H), 8.31 (br, 1H), 8.07 (br, 1H), 7.96 (br, 1H), 8.32 (br, 1H), 8.16 (b
r, 1H), 7.64-7.60 (m, 3H), 7.37-7.34 (m, 4H), 7.27-7.25 (m, 4H), 7.11-
7.07 (m, 3H), 6.85 (d, J = 10.5, 1H), 6.03 (m, 1H), 5.71 (m, 2H), 5.48 (m, 1
H), 5.40 (d, J = 10.5 Hz, 1H), 5.27 (m, 1H), 5.12 (m, 1H), 4.76 (m, 1H), 4.6
0 (m, 1H), 4.50-4.46 (m, 3H), 4.42-4.41 (m, 2H), 4.37-4.34 (m, 3H), 4.46-
4.44 (m, 2H), 4.31-4.28 (m, 2H), 4.26-
4.21 (m, 2H), 3.91 (m, 1H), 3.77 (m, 1H), 3.60 (m, 2H), 3.55 (m, 1H), 3.50 (
m, 1H), 3.39-3.35 (m, 2H), 2.98 (s, 3H), 2.81 (m, 1H), 2.45 (br, 2H), 2.06-
2.04 (m, 2H), 1.52 (d, J = 6.5 Hz, 3H), 1.41 (m, 1H), 1.33 (s, 1H), 1.20-
1.15 (m, 2H), 0.62 (d, J = 6.5 Hz, 6H), 0.55 (d, J = 6.5 Hz, 3H), 0.48 (d, J =
6.5 Hz, 3H). 
Advanced Marfey’s method. Each of 2 mg of WS9326F, G, H, and I 
(7, 8, 9, and 10) were hydrolyzed in 0.5 mL of 6 N HCl at 115 °C. After 
stirring mixtures for 2 h, the reaction vial were cool down rapidly in the ice 
box for 3min and concentrated in vacuo. For removing residual HCl entirely, 
0.5 mL of H2O was added to each of vials and removed the solvent three 
times. The hydrolysates were lyophilized for 24 h. After lyophilization, each 
of hydrolysates were separated into two 8 mL vials, and were soluble in 100 
μL of 1 N NaHCO3. And then, 50 μL of either 10mg/mL L-FDAA (1-fluoro-
2,4-dinitrophenyl-5-L-alanine amide) or D-FDAA (1-fluoro-2,4-
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dinitrophenyl-5-D-alanine amide) in acetone was added to each of vials. The 
vials were placed in 80 °C water bath for 3 min. Then, 50 μL of 2 N HCl 
was added to neutralize the solvent and 300 μL of aqueous 50% CH3CN was 
added. A 10 μL aliquot of each reaction mixture was injected to LC-MS and 
analyzed with a gradient solvent system (20% to 60% ACN with 0.1% 
formic acid over 40 min, C18 reversed-phase column 100 × 4.6mm, UV at 
340 nm). The absolute configuration of all of the amino acid residues in 7-
10 were confirmed as L, except phenylalanine (as D) as same as WS9326A.
Preparation of acetonide derivative of 10 (12). WS9326I (10) (5 mg) 
was prepared in a 40 mL vial and dried under high vacuum for 24 h. After 
adding pyridinium p-toluenesulfonate (1 mg), the mixture was dissolved in
anhydrous MeOH (200 μL) and anhydrous CH2Cl2 (2 mL) at rt. Then, 2,2-
dimethoxypropane (4 mL) was added to the reaction vial. The solution was 
stirred at rt under argon for 48 h. To quench the reaction, a saturated 
NaHCO3 aqueous solution was added. The reaction mixture was 
fractionated by flash column reversed-phase chromatography using a 
gradient solvent system of MeOH/H2O (20%, 40%, 60%, 80%, and 100%). 
The acetonide derivative (12) was eluted in the 80% and 100% MeOH/H2O 
fractions. The final product (12) was purified by reversed-phase HPLC 
(Phenomenex Luna 5 μm C18 (2) 250 × 10.0 mm, flow rate 2 mL/min, UV 
254 nm detection) with a gradient solvent system (25% to 65% ACN/H2O) 
for 40 min. The acetonide product (12) eluted at a retention time of 29.3 min 
(3.5 mg, 83%) under the HPLC conditions. The molecular formula of 12
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was confirmed as C66H88N12O19 by ESIMS analysis ([M + H]
+ m/z at 1353).
Acetonide product (12). 1H NMR (600 MHz, pyridine-d5) ) dH 12.84 (s, 1H), 
11.73 (s, 1H), 10.55 (br, 1H), 10.02 (br, 1H), 9.88 (br, 1H), 9.58-9.56 (br, 
2H), 9.52 (br, 1H), 8.56 (br, 1H), 8.32 (br, 1H), 8.16 (br, 1H), 7.75-7.67 (m, 
3H), 7.48-7.46 (m, 2H), 7.32-7.26 (m, 7H), 7.02-7.00 (m, 2H), 6.72 (d, J =
10.5, 1H), 6.11 (m, 1H), 5.84 (m, 2H), 5.61-5.58 (m, 3H), 5.40 (d, J = 10.5 
Hz, 1H),  4.78-4.72 (m, 5H), 4.61-4.53 (m, 3H), 4.46-4.44 (m, 2H), 4.37-
4.32 (m, 5H), 4.20-4.04 (m, 3H), 3.71 (m, 1H), 3.62 (m, 1H), 3.52 (m, 1H), 
3.38 (m, 1H), 3.08 (s, 3H), 2.17 (m, 2H), 2.06-2.04 (m, 2H), 1.73 (d, J = 6.5 
Hz, 3H), 1.41 (s, 3H), 1.31 (s, 3H), 1.28-1.25 (m, 5H), 0.74 (t, J = 6.5 Hz, 
3H), 0.69 (d, J = 6.5 Hz, 3H), 0.58 (m, 6H). 
Acetylation of 12 (13). The acetonide product 12 was dried in vacuo
for 24 h. Product 12 was dissolved in 1 mL of distilled anhydrous pyridine. 
After flushing with argon gas, 1 mL of acetic anhydride was added and 
stirred at room temperature for 5 h. The solution was evaporated under high 
vacuum for 4 h. The product was purely isolated by reversed–phase HPLC 
(Kromasil C18 (2): 250 × 10 mm, 5 μm) with a gradient solvent system 
(45 % acetonitrile/water to 95 % ACN/H2O over 40 min, UV 280 nm 
detection, flow rate: 2 mL/min). Pentaacetate 12 (13) (3 mg) eluted at 32.8 
min, and its structure was determined by 1H NMR spectroscopy and by low-
resolution ESI-MS ([M+H]+ m/z at 1562, molecular formula; 
C76H98N12O24).
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Pentaacetate (13). 1H NMR (600 MHz, pyridine-d5) ) dH 13.14 (s, 1H), 
10.33 (s, 1H), 10.05 (d, J = 6.5 Hz, 1H), 10.02 (br, 1H), 9.52 (d, J = 7.5 Hz, 
1H), 9.34 (d, J = 9.0 Hz, 1H) 8.95 (br, 1H), 8.74-8.72 (br, 2H), 8.36 (d, J =
8.5 Hz, 1H), 8.06 (d, J = 7.5 Hz, 1H) 7.84 (d, J = 8.0 Hz, 2H), 7.62 (br, 1H), 
7.39 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 7.5 Hz, 2H), 7.31 (m, 1H), 7.24 (m, 
1H), 7.16-7.14 (m, 2H), 7.13 (d, J = 7.5 Hz, 1H), 6.97 (d, J = 10.0 Hz, 1H), 
6.76 (s, 1H), 5.96-5.93 (m, 3H), 5.81 (m, 1H), 5.77 (m, 1H), 5.66 (m, 1H), 
5.52-5.49 (m, 2H), 5.37 (d, J = 10.0 Hz, 1H), 5.07 (m, 2H), 4.70-4.67 (m, 
3H), 4.62-4.56 (m, 2H), 4.28-4.24 (m, 3H), 4.14-4.09 (m, 4H), 3.59-3.51 (m, 
3H), 3.26 (m, 1H), 3.13 (s, 3H), 2.71 (br, 2H), 2.22 (s, 3H), 2.18 (m, 2H), 
2.12-2.10 (m, 2H), 2.00 (s, 3H), 1.83 (s, 3H), 1.70 (d, J = 6.5 Hz, 3H), 1.69 
(s, 3H), 1.42 (s, 3H), 1.32-1.30 (m, 2H), 1.28 (s, 3H), 1.24-1.22 (m, 2H), 
0.85 (d, J = 6.5 Hz, 3H), 0.76 (t, J = 6.5 Hz, 3H), 0.60 (d, J = 6.5 Hz, 3H), 
0.49 (d, J = 6.5 Hz, 3H). 
Preparation of Acetonide deprotection product of 13 (14). Product 
13 (3 mg) was prepared in a 40 mL vial and dried under high vacuum for 24 
h. After adding pyridinium p-toluenesulfonate (1 mg), the mixture was 
dissolved in anhydrous MeOH (1 mL) at rt. The solution was stirred at rt 
under argon for 4 h. To quench the reaction, a saturated NaHCO3 aqueous 
solution was added. The reaction mixture was fractionated by flash column 
reversed-phase chromatography using a gradient solvent system of 
MeOH/H2O (20%, 40%, 60%, 80%, and 100%). The final product (14) was 
eluted in the 80% and 100% MeOH/H2O fractions. The product 14 was 
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isolated by reversed-phase HPLC (Phenomenex Luna 5 μm C18 (2) 250 × 
10.0 mm, flow rate 2 mL/min, UV 254 nm detection) with a gradient solvent 
system (45% to 95% ACN/H2O) for 40 min. The product 14 eluted at a 
retention time of 26.5 min (1.5 mg, 50 %) under the HPLC conditions. The 
molecular formula of 14 was confirmed as C73H94N12O24 by ESIMS analysis 
([M + H] + m/z at 1522).
Acetonide deprotected product (14). 1H NMR (600 MHz, pyridine-d5) ) 
dH 13.15 (s, 1H), 11.64 (s, 1H), 10.44 (br, 1H), 9.93 (br, 1H), 9.84 (br, 1H), 
9.52 (br, 1H), 9.25 (br, 1H), 8.93 (br, 1H), 8.76 (br, 1H), 8.40 (br, 1H), 8.32 
(br, 1H), 8.24 (br, 1H), 7.81 (d, J = 8.0, 2H), 7.55-7.53 (m, 2H), 7.48-7.46 
(m, 2H), 7.39-7.36 (m, 2H), 7.33 (t, J = 8.0, 1H ), 7.21 (m, 1H), 7.00 (J =
8.0, 2H), 6.80 (d, J = 10.5 Hz, 1H), 6.72 (s, 1H), 6.27 (m, 1H), 5.88 (m, 2H), 
5.77-5.67 (m, 3H), 5.50 (t, J = 6.5 Hz, 1H), 5.34 (d, J = 10.5 Hz, 1H),  5.17 
(m, 1H), 5.06 (m, 1H), 4.63 (m, 1H), 4.57-4.53 (m, 3H), 4.36-4.29 (m, 2H), 
4.23-4.21 (m, 3H), 4.16 (m, 1H), 4.09-4.01 (m, 3H), 3.55 (m, 1H), 3.49 (m, 
1H), 3.39 (m, 1H), 3.30 (m, 1H), 3.00 (s, 3H), 2.29 (m, 2H), 2.14 (s, 3H), 
2.06-2.04 (m, 2H), 1.98 (s, 3H), 1.69 (s, 3H), 1.64 (d, J = 6.5 Hz, 3H), 1.41 
(s, 3H), 1.33-1.28 (m, 2H), 1.23 (s, 3H), 1.16-1.14 (m, 2H), 0.76 (t, J = 6.5 
Hz, 3H), 0.64 (d, J = 6.5 Hz, 3H), 0.50 (m, 6H). 
MTPA esterification of 14 (15, 16). The acetonide deprotected pr
oduct 14 were prepared individually in 40-mL vials (two 1-mg sample
s for each compound) and dried completely under high vacuum overni
ght. After adding catalytic amounts of crystalline dimethylaminopyridin
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e (DMAP) to each reaction vial, freshly distilled anhydrous pyridine 
(1 mL) was added under argon gas. The reaction mixtures were stirre
d at room temperature for 5 min. After 5 min, R- and S-a-methoxy t
rifluoromethyl-phenylacetic acid (MTPA) chloride (20 µL) were added,
respectively. The reactions were carried out for 3 h at room temperat
ure with stirring. The reactions were quenched by adding 50 µL of 
MeOH. The reaction products were purified by HPLC using gradient 
elution conditions of 40% to 100% aqueous acetonitrile over 20 min 
with a reversed-phase C18 column (Kromasil C18 (2): 250 × 10 mm, 
5 μm; flow rate: 2 mL/min; UV detection at 280 nm). The di-S- and
di-R-MTPA esters (15 and 16) of 14 eluted at 30.3 and 32.2 min, res
pectively. The ΔδS-R values around the stereogenic centers of the MTP
A esters were assigned based on the analysis of 1H and 1H-1H COSY
NMR spectra. 
The molecular formula of 15 and 16 was confirmed as C93H109F6N12O28
by ESIMS analysis ([M + H] + m/z at 1955).
S-MPTA ester of 14 (15). 1H NMR (600 MHz, pyridine-d5) ) dH 13.25 (s, 
1H), 11.54 (s, 1H), 10.63 (br, 1H), 10.31 (br, 1H), 10.26 (br, 1H), 9.69 (br, 
1H), 9.13 (br, 1H), 8.93 (br, 1H), 8.63 (br, 1H), 8.59 (br, 1H), 8.22 (br, 1H), 
7.87 (d, J = 8.0, 2H), 7.54-7.48 (m, 8H), 7.42-7.38 (m, 8H), 7.33-7.27 (m, 
3H), 7.05 (J = 10.5, 1H), 6.88 (s, 1H), 6.01-5.99 (m, 2H), 5.90 (m, 1H), 5.85 
(m, 1H), 5.77-5.67 (m, 4H), 5.58-5.55 (m, 2H), 5.50 (m, 1H), 5.44 (m, 1H), 
5.34 (m, 1H), 5.25 (m, 1H), 5.17 (m, 1H), 4.79 (m, 1H), 4.71 (m, 1H), 4.63 
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(m, 1H), 4.39 (m, 1H), 4.34 (m, 1H), 4.25 (m, 1H), 4.15 (m, 1H), 4.08 (m, 
1H), 3.53 (s, 3H), 3.51 (s, 3H), 3.41 (m, 1H), 3.32-3.31 (m, 2H), 3.13 (s, 
3H), 2.35 (m, 2H), 2.19 (s, 3H), 2.15 (s, 3H), 2.03 (s, 3H), 1.77 (s, 3H), 1.64 
(d, J = 6.5 Hz, 3H), 1.47 (s, 3H), 1.34-1.32 (m, 2H), 1.31 (s, 3H), 1.22-1.20 
(m, 2H), 0.82 (t, J = 6.5 Hz, 3H), 0.72 (d, J = 6.5 Hz, 3H), 0.58 (d, J = 6.5 
Hz, 3H), 0.52 (d, J = 6.5 Hz, 3H). 
R-MPTA ester of 14 (16). 1H NMR (600 MHz, pyridine-d5) ) dH 13.26 (s, 
1H), 11.47 (s, 1H), 10.28 (br, 1H), 9.73 (br, 1H), 9.64 (br, 1H), 9.15 (br, 1H), 
8.96-8.85 (m, 2H), 8.50 (br, 1H), 8.39 (br, 1H), 8.06 (br, 1H), 7.78-7.76 (m, 
4H), 7.60-7.56 (m, 4H), 7.50-7.36 (m, 6H), 7.42-7.38 (m, 5H), 7.33-7.27 (m, 
2H), 7.01 (J = 8.0, 1H), 6.94 (s, 1H), 5.94-5.89 (m, 2H), 5.69-5.64 (m, 5H), 
5.55-5.52 (m, 4H), 5.12-5.10 (m, 4H), 4.85 (m, 1H), 4.81 (m, 1H), 4.64-4.62 
(m, 2H), 4.57-4.55 (m, 2H), 4.24 (br, 2H), 4.10 (m, 1H), 3.82 (m, 1H), 3.72 
(m, 1H), 3.62 (s, 3H), 3.56 (s, 3H), 3.13 (s, 3H), 2.32 (m, 2H), 2.23 (s, 3H), 
2.06 (s, 3H), 1.94 (s, 3H), 1.71 (s, 3H), 1.65 (d, J = 6.5 Hz, 3H), 1.52 (s, 3H), 
1.40-1.38 (m, 2H), 1.34 (s, 3H), 1.29-1.27 (m, 2H), 0.82 (t, J = 6.5 Hz, 3H), 
0.60 (m, 6H), 0.54 (d, J = 6.5 Hz, 3H).
DP4 analysis. For the DP4 application, conformers of diastereomers of 
four models within 10 kJ/mol found in the MMFF force field were regarded 
and the geometry of the conformers was optimized at the B3LYP/6-31G++ 
level in the gas phase. The shielding tensor values of the optimized 
conformers were computed at the B3LYP/6-31++ level. These values were 
averaged based on the Boltzmann population in the associated Gibbs free 
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energy and utilized for DP4 analysis facilitated by an Excel sheet provided 
by the original authors.
Antifungal activity assay. Candida albicans ATCC 10231 was 
cultivated with YPD medium (1% yeast extract, 2% peptone, and 2% 
dextrose). After incubation for 48 h at 28 °C, the cells were harvested by 
centrifugation and washed twice with sterile distilled water. Aspergillus 
fumigatus HIC 6094, Trichophyton rubrum NBRC 9185, and T. 
mentagrophytes IFM 40996 were plated onto potato dextrose agar plates and 
incubated for 2 weeks at 28 °C. Spores were harvested and washed twice 
with sterile water, and then the spores were resuspended in water to an 
initial inoculum concentration of 5 × 105 spores/mL. In each well of a 96-
well plate, 10 μL of the cell suspension was mixed with 90 μL of potato 
dextrose broth (Difco) (5 × 104 cells/mL) containing the test compound in 
DMSO solutions (final concentration, 0.5%).22 A culture containing DMSO 
(0.5%) and a culture supplemented with amphotericin B were used as a 
solvent control and as a positive control, respectively.
In vitro capillary tube formation assay. Matrigel (70 μl/well) was 
coated on 96-well plate and polymerized for 30 min at 37 ℃. HUVECs (1.5 
× 104 cells/well) and WS9326A-E, WS9326F-I (7-10) (0-20μM) were 
seeded onto each well of the Matrigel-coated 96-well plate with EBM-2 
medium . Then, cells were incubated for 8hrs. The formation of endothelial 
cell tubular structure was visualized under an inverted microscope and 
photographed. Furthermore, tube formation was quantified by calculating 
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the tube number and was expressed as a percentage by normalization with 
untreated control cells.
III. III. Experimental section
Isolation of the hormaomycins. The extract of SNM55 (one sixth of 
the 4 g of dry material collected) was absorbed on Celite and loaded on a 2 g 
Sep-Pak C18 cartridge. Then, the extract was fractionated with 20 mL each 
of 20%, 40%, 60%, 80%, and 100% MeOH in water and 1:1 
MeOH/dichloromethane. The hormaomycins were detected in the 80% and 
100% MeOH/water fractions by LC/MS. The 80% and 100% fractions were 
combined into one vial and subjected to semi-preparative reversed–phase 
HPLC (Kromasil C18 (2): 250 × 10 mm, 5 μm) using a gradient solvent 
system (65% MeOH/H2O to 90% MeOH/H2O over 40 min and 100% 
MeOH from 40 min to 50 min, UV 280 nm detection, flow rate: 2 mL/min). 
Three fractions containing the hormaomycins were collected at retention 
times of 43 min, 45 min, and 52 min. Each of the hormaomycins was 
purified by an isocratic solvent system (75% acetonitrile/H2O, UV 280 nm 
detection, flow rate: 2 mL/min) using a reversed–phase C18 column 
(Kromasil C18 (2): 250 × 10 mm, 5 μm). Hormaomycins B (18) (4 mg),
hormaomycin C (19) (3 mg), and hormaomycin (6 mg) eluted as pure 
compounds at retention times of 14.5 min, 15.2 min, and 18.4 min,
respectively, under the final purification conditions. 
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Hormaomycin B (18): [α]D 21.9, (c 0.025, MeOH); UV (MeOH) λmax 
(log ε) 208 (4.57), 271 (4.08) nm; IR (neat) νmax 3309, 2958, 1626, 1543, 
1369 cm-1; for 1H and 13C NMR data, see Table 1; HRFABMS m/z
1115.4611 [M+H]+ (calcd for C54H68ClN10O14 1115.4605).
Hormaomycin C (19): [α]D 29.9, (c 0.025, MeOH); UV (MeOH) λmax 
(log ε) 208 (4.57), 271 (4.09) nm; IR (neat) νmax 3343, 2931, 1627, 1554, 
1362 cm-1; for 1H and 13C NMR data, see Table 1; HRFABMS m/z
1137.4432 [M+Na]+ (calcd for C54H67ClN10O14Na 1137.4424).
Conclusions. As one approach to maximize microbial chemical 
diversity, altering the culture conditions of a chemically prolific marine 
actinomycete strain (SNM55) led us to discover hormaomycins B and C (18 
and 19). These hormaomycins are structurally unique cyclic depsipeptides 
that incorporate various unusual units, such as 4-(Z)-propenylproline, 3-(2-
nitrocyclopropyl)alanine, b-methylphenylalanine and 5-chloro-1-
hydroxypyrrol-2-carboxylic acid. The hormaomycins inhibited various 
pathogenic Gram-positive and Gram-negative bacteria. To the best of my 
knowledge, hormaomycins B and C are the first natural analogues of 
hormaomycin. The discovery of these new members of the hormaomycin 
family provides additional evidence that marine actinomycetes possess the 
potential to produce still-untapped bioactive secondary metabolites, which 




Polyketides from marine Streptomyces spp.
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I. Mohangic acids A-E, p-aminoacetophenonic acids 
from a marine mudflat-derived Streptomyces sp. SNM31
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I. I. Results and discussion
Mohangic acid A (20) was isolated as a yellow gum with a molecular 
formula of C26H37NO6 according to
1H and 13C NMR and high-resolution 
FAB mass spectroscopy. The 1H NMR (in CD3OD) spectrum of 20 showed 
each of two overlapped aromatic protons at dH 7.77 and 6.64, six olefinic 
protons from 6.26 to 5.69 ppm, three carbinol protons at 4.48, 4.03, and 3.12 
ppm, nine aliphatic protons between 2.97 and 1.22 ppm, and three methyl 
groups at 1.02, 0.90, and 0.87 ppm in the shielded region. The 13C NMR and 
HSQC spectra of 20 displayed one ketone carbonyl at 200.3 ppm, one 
carboxylic acid carbon at 177.8 ppm, 12 sp2 carbons between 155.5 and 
114.6 ppm, three oxygenated sp3 carbons at 80.8, 74.3, and 70.5 ppm, six 
aliphatic sp3 carbons between 44.5 and 34.5 ppm, and three methyl carbons 
at dC 18.4, 15.5, and 14.2. Because 12 olefinic carbon signals (six double 
bonds) and two carbonyl carbons accounted for eight of the nine degrees of 
unsaturation deduced from the molecular formula of 20, mohangic acid A 
(20) must contain a ring structure. 
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All 1JCH correlations were fully assigned by analysis of HSQC 
spectroscopic data (Table 9). Interpretation of the COSY and HMBC spectra 
elucidated two partial structures (Figure 15). First, the COSY correlations 
from H2-2 (dH 2.41) to H-3 (dH 4.48) showed connectivity from C-2 (dC
44.5) to C-3 (dC 70.5). The oxygenated carbon C-3 was deduced to be 
directly connected to sp2 carbon C-4 (dC 135.7) on the basis of the COSY 
correlation between H-3 and H-4 (dH 5.69). Further analysis of the COSY 
correlations of the six olefinic protons resulted in the construction of a triene 
moiety running from C-4 to C-9 (dC 138.4). The geometries of the double 
bonds in the triene structure were determined to be 4E, 6E, and 8E on the 
basis of the trans 1H–1H coupling constants (J = 15.0 Hz) observed in the 
olefinic proton peaks. The COSY correlation between H-9 (dH 5.72) and H-
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10 (dH 2.42) revealed that the triene moiety was connected to the C-10 
aliphatic carbon (dC 41.6). In addition, COSY correlations from H-10 to H2-
16 (dH 2.97, 2.95) expanded the chain from C-10 to C-16 (dC 42.4). Three 
doublet methyl groups (C-18, C-19, and C-20; dC 18.4, 14.2, and 15.5) were 
located at C-10, C-12 (dC 34.5), and C-14 (dC 37.4), respectively, according 
to the H3-18 (dH 1.02)/H-10, H3-19 (dH 0.87)/H-12, and H3-20 (dH 0.90)/H-
14 (dH 1.71) homonuclear correlations. The 
2JCH couplings from H2-2 to C-1 
(dC 177.8) and from H2-16 to C-17 (dC 200.3) established the first partial 
structure, a chain composed of 20 carbons bearing three branch methyl 
groups.
Figure 15. Key COSY and HMBC correlations of mohangic acid A (20).
The 1H NMR spectroscopic data of 20 displayed a typical feature of 
para-substituted aromatic ring protons, H-2’/H-6’ (dH 7.77/dH 7.77) and H-
3’/H-5’ (dH 6.64/dH 6.64). Strong COSY correlations between H-2’/H-6’ and 
H-3’/H-5’ and HMBC correlations from these protons indicated an aromatic 
ring. HMBC correlations from H-2’/H-6’ to C-17 indicated connectivity 
between the chain and the aromatic ring via the carbonyl carbon C-17. A 
primary amine group deduced from the molecular formula was assigned at 
C-4’ (dC 155.5), which was the last open position requiring a functional 
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group based on the chemical shift of C-4’, thus completing the planar 
structure of 20. The assigned structure was further confirmed by the analysis 
of 1D and 2D NMR data of 20 acquired in pyridine–d5 (Table10). 
Mohangic acid B (21) was obtained as a yellow gum, and its molecular 
formula was deduced to be C27H39NO6 on the basis of HRFABMS data 
combined with 1H and 13C NMR spectroscopic data (Table 9). Careful 
comparison of NMR spectroscopic data revealed that the 1H NMR spectrum 
of 21 in CD3OD was very similar to that of 20. Careful analysis of the 1D 
and 2D NMR spectroscopic data of 21 revealed that mohangic acid B (21) 
differs from 20 by one N-methyl group (dH 2.83; dC 30.4). A 
3JCH correlation 
from the N-methyl protons (dH 2.83) to C-4’ (dC 155.0) assigned the methyl 
group C-7’’ to the amine at C-4’ in the para-substituted aromatic ring. Thus, 
the structure of mohangic acid B (21) was determined as an N-methyl 
analogue of 20. 
Mohangic acid C (22) was purified as a yellow gum determined to possess 
a molecular formula of C28H39NO7 on the basis of HRFABMS data in 
combination with 1H and 13C NMR data (Table 9). The 1D and 2D NMR 
spectroscopic data of 22 displayed features analogous to those of 21 except 
for the absence of an N-methyl group (dH 2.83; dC 30.4) in 21 and the 
presence of a singlet methyl group (dH 2.13; dC 22.5) and an additional 
carbonyl carbon (dC 171.0) in 22. Further analysis of 2D NMR spectra 
indicated the presence of an N-acetyl group, thus elucidating the structure of 
22 as the N-acetylated congener of 20. 
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Mohangic acid D (23) was isolated as a yellow gum. The molecular 
formula was assigned as C28H41NO7 on the basis of HRFABMS and 
1H and 
13C spectroscopic data (Table 9). Although the NMR spectra of 23 were 
similar to those of 22, an additional signal of a carbinol proton (dH 4.85) 
directly bound to an oxygenated carbon (dC 71.5) and the lack of the ketone 
carbonyl signal (dC 200.0) previously observed in the 
13C spectrum of 22
indicated distinct a difference between 22 and 23. Analysis of 2D NMR 
spectra indicated that the C-17 ketone carbonyl in 22 was reduced to a 
hydroxy group in 23, subsequently establishing the planar structure of 23. 
Mohangic acid E (24) was obtained as a yellow gum with a molecular 
formula of C32H47NO11 on the basis of the HRFABMS and 
1H and 13C 
spectroscopic data (Table 1). In contrast to the mohangic acids B–D (21–23), 
the molecular weight of 24 is 162 Da larger than that of 20. In addition, 
mohangic acid E (24) is much more hydrophilic than the other congeners 
based on reversed-phase HPLC analysis. These observations led us to 
speculate that mohangic acid E (24) should be a glycosylated version of 20. 
Careful analysis of the 1D and 2D NMR spectra revealed that mohangic 
acid E possesses one hexose. This hexose was determined to be a b-glucose 
by analysis of the coupling constants 3JHH and 
1JCH (154 Hz)
32 and on the 
basis of ROESY NMR correlations among the axially oriented sugar protons. 
Further analysis of HMBC correlation from dH 4.63, dH 7.84 to dC 153.6 and 
ROESY correlation between dH 4.63 and dH 6.82 revealed that the 
b-glucose is located on the aromatic nitrogen. To determinate the absolute 
80
configuration of the glucose moiety in 24, it was subjected to acid 
hydrolysis. The hydrolysate and authentic L- and D-glucose samples were 
respectively derivatized with hexamethyldisilazane (HMDS) and TMS-Cl.33
GC/MS analysis of the derivatives clarified that the glucose in mohangic 
acid E (24) has a D-configuration because the derivative of the glucose in 24
exhibited a retention time consistent with that of authentic D-glucose 
derivative. 
Mohangic acids A-E (20–24) have several stereogenic centers in their 
chains. To determine their configurations, I performed comprehensive 
spectroscopic analyses and various chemical derivatizations. I first 
conducted homo-decoupling spectroscopic experiments of mohangic acid A 
(20) to extract exact 3JHH values for H-10/H-11, H-11/H-12, H-12/H2-13, 
H2-13/H-14, and H-14/H-15 couplings; the 
1H–1H coupling constants for 
these protons were not measurable in the ordinary 1H NMR spectra because 
of their complicated multiplicities. After 1H-1H coupling constants were 
clearly measured, long-range heteronuclear coupling constants were 
acquired by a HETLOC (hetero half-filtered TOCSY) NMR experiment.34
J–based configuration analysis was performed using the obtained 3JHH,
3JCH, 
and 2JCH values and ROESY NMR correlations (Figure 16).
15 On the basis 
of the J–based configuration analysis, the most appropriate rotamers from 
C-10 to C-15 were selected. 
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Figure 16. J–based configuration analysis of mohangic acid A (20) at (a) C-
10 and C-11, (b) C-11 and C-12, (c) C-12 and C-13, (d) C-13 and C-14, and 
(e) C-14 and C-15.
The relationship between C-9 and H-11 was deduced as anti because of 
the large corresponding 3JC9H11 value (7.3 Hz). The 
3JH10H11 (5.0 Hz),
3JC12H10 (4.0 Hz), and 
3JC18H11 (2.0 Hz) values indicated gauche relationships 
between H-10/H-11, C-12/H-10, and C-18/H-11. The 2JC11H10 value (1.8 Hz) 
indicated an anti relationship between the hydroxy group at C-11 and H-10, 
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and ROESY correlations between the H-10/H-11, H-10/H-12, and H-11/H3-
18 supported the rotamer depicted in Figure 16a. An anti relationship 
between H-11 and H-12 was established on the basis of the large 3JH11H12
value (9.0 Hz). The 3JC10H12 (2.0 Hz), 
3JC13H11 (2.2 Hz), and 
3JC19H11 (3.2 Hz) 
completely assigned the relationships of C-10/H-12, C-13/H-11, and C-
19/H-11 as gauche. Moreover, the large 2JC11H12 (5.2 Hz) value and observed 
ROESY correlations supported the rotamer shown in Figure 16b. The 
methylene group at C-13 is not a stereogenic center. However, the two 
protons bound to this carbon are distinguishable in the 1H NMR spectrum, 
thus allowing for consecutive J–based analysis to relate configurations from 
C-12 to C-14 through C-13. The 3JH12H13a (8.5 Hz) and 
3JC19H13b (7.0 Hz) 
values implied anti relationships of H-12/H-13a and C-19/H-13b. Gauche
relationships of C-14/H-12, C-11/H-13b, C-11/H-13a, and C19/H-13a were 
deduced on the basis of the small 3JCH values (2.2–3.4 Hz). A strong 
ROESY correlation between H3-19 and H-13a supported a gauche
relationship between C-19 and H-13a, clarifying the proper rotamer depicted 
in Figure 16c. This rotamer was consistent with the observed ROESY 
correlations around C-12 and C-13. The 3JH13bH14 (8.0 Hz) and 
3JC20H13a (7.0 
Hz) values indicated anti relationships of H-13b/H-14 and C-20/H-13a. The 
other coupling constants supported the rotamer depicted in Figure 16d. The 
H3-20/H-13b ROESY correlation, along with the other observed ROESY 
correlations, further supported this rotamer structure. An anti relationship 
between H-14 and H-15 was indicated by the 3JH14H15 (8.0 Hz) value. The C-
83
16/H-14, C-13/H-15, and C-20/H-15 relationships were deduced as gauche
on the basis of the 3JC16H14 (2.4 Hz), 
3JC13H15 (4.0 Hz), and 
3J C20H15 (3.0 Hz) 
values. The large 2JC15H14 value (5.4 Hz) and the ROESY NMR signals 
between H-13 and H-16 indicated that the rotamer in Figure 2e was the most 
appropriate structure. Overall, detailed J–based configuration analysis 
revealed that the relative configurations of the stereogenic centers in the 
chain moiety are 10S*, 11S*, 12R*, 14R*, and 15S*.
Because mohangic acid D (23) bears an additional stereogenic center at 
C-17, further chemical derivatization and NMR spectroscopic analysis were 
required to establish its configuration. I first hydrogenated mohangic acid D 
(23) with 10% Pd/C under 1 atm of H2 at room temperature to increase its 
stability for further derivatization. The hydrogenated product (25) was then 
derivatized with 2,2-dimethoxy propane to furnish an acetonide derivative 
(26) for the 1,3-diol moiety at C-15 and C-17. The 1H and HSQC NMR 
spectra of the acetonide derivative (26) showed that the 1H and 13C chemical 
shifts of two acetonide methyl groups are almost identical (dC 24.6−dH 1.39; 
dC 24.6−dH 1.39), indicating an anti relationship of the 1,3-hydroxy groups 
(Figure 17).21
Figure 17. (a) Acetonide formation of hydrogenation product (25) of 
mohangic acid D (23) (b) 1H and 13C NMR chemical shifts of acetonide 
derivative (26) indicating anti relationship of 1,3-diol.
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For the assignment of the absolute configurations of the asymmetric 
carbons at C-3, C-10, C-11, C-14, and C-15 in 20, I initially attempted 
MTPA derivatization on the secondary alcohol groups in mohangic acid A to 
apply the modified Mosher’s method. However, mohangic acid A (20) was 
degraded as soon as S- or R-MTPA-Cl reagent was added to 20. We 
therefore attempted to stabilize 20 by hydrogenation of the triene; however, 
the hydrogenated product was also degraded during MTPA derivatization. 
Therefore, I used an alternative method developed by Kishi and co-workers 
that involves bidentate chiral NMR solvents, (R,R)- and (S,S)-bis-a-
methylbenzylamine-p-Me (BMBA).35 The NH groups in the bidentate chiral 
NMR solvents build N··H–O hydrogen bonds through interactions with 
isolated alcohols, resulting in the discrimination of the chemical shifts of the 
carbons adjacent to the secondary hydroxy groups. The analysis of these 13C 
chemical shift behaviors in (R,R)- and (S,S)-bidentate chiral NMR solvents 
by calculation of Dd(R,R)-(S,S) values can establish the relative and absolute 
configurations of secondary alcohols.36 Because the bidentate chiral solvents 
were not commercially available, I synthesized the solvents (R,R)- and 
(S,S)-bis-a-methylbenzylamine-p-Me (BMBA).36 The 13C NMR spectra of 
15 mg of mohangic acid A (1) in a 5:2 mixture of (R,R)-BMBA and 
pyridine–d5 and in a 5:2 mixture of (S,S)-BMBA and pyridine–d5 were 
recorded. Careful comparison of the 13C NMR spectra in the bidentate 
solvents enabled clear detection of shifts of the 13C signals associated with 
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the carbons flanking C-3, C-11, and C-15 each with a secondary hydroxy 
group (Figures 18). By calculating Dd(R,R)-(S,S) values at C-4/C-2, C-12/C-10, 
and C-14/C-16, I determined the absolute configurations of the stereogenic 
centers of C-3, C-11, and C-15 as 3R, 11S, and 15S. Subsequently, I
assigned the absolute configurations of the other stereogenic centers in 
mohangic acid (20) as 10S, 12R, and 14R on the basis of the relative 
configuration determined vide supra. 
Figure 18. Chemical shift differences [Dd = d (R,R) - d (S,S)] observed for 
the indicated carbons in a 5:2 mixture of (R,R)- and (S,S)-BMBA and 
pyridine–d5.
Mohangic acids B-E (21–24) were proposed to possess configurations 
identical to those of 20 at the common stereogenic centers because of the 
strong similarity among the NMR data for their chains and because of their 
common biosynthetic origin. In addition, circular dichroism (ECD) spectra 
of mohangic acids A-E displayed almost identical features, with a strong 
Cotton effect at 220 nm, clearly supporting their identical absolute 
configurations of 3R, 10S, 11S, 14R, and 15S (Figure 19). The additional 
stereogenic center at C-17 of mohangic acid D was also deduced as 17R on 
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the basis of the relative configuration established by acetonide derivatization, 
as previously mentioned.  
l (nm)























Figure 19. ECD spectra of mohangic acids A–E (20–24). 
The biological activities of mohangic acids A-E (20–24) were evaluated 
in several ways. In a cytotoxicity assay against human cancer cell lines such 
as A549 (lung cancer), HCT116 (colon cancer), SNU638 (gastric cancer), 
K562 (leukemia), SK-HEP1 (liver cancer), and MDA-MB231 (breast 
cancer), mohangic acids A-E did not display significant cytotoxic activities 
(IC50 > 10 mM). The mohangic acids (20–24) were also evaluated for growth 
inhibition activity against pathogenic bacteria (Staphylococcus aureus, 
Bacillus subtilis, Kocuria rhizophila, Salmonella enterica, Proteus hauseri, 
and Escherichia coli) and fungi (Candida albicans and Aspergillus 
fumigatus). However, no antimicrobial effects were observed (MIC > 128 
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mM).
Because the mohangic acids exhibited no cytotoxicity, their biological 
activities were tested with respect to cancer chemoprevention. Cancer 
chemoprevention is considered to play an important role in decreasing the 
risk of cancer development, involving prevention, delay or reversal of the 
process of carcinogenesis.37 In particular, one important cancer prevention 
strategy is to enhance the deactivation of radicals and electrophiles via 
phase II enzymes.38 Quinone reductase (QR), one of the representative 
phase II detoxification enzymes, is known to function as a cancer 
chemopreventative.39 A QR induction assay was conducted for evaluating 
the bioactivities of 20–24 in the cultured Hepa-1c1c7 murine hepatoma cell 
line. In this assay, 0.1% dimethyl sulfoxide (DMSO) was used as a control 
and β-naphthoflavone (2 μM) was used as a positive control. As shown in 
Figure 6, mohangic acid E (24) at a concentration of 20 μM displayed a 
significant 2.1-fold increase in QR induction activity compared with control. 
However, mohangic acids A-D (20–23) exhibited no remarkable activities. 
Mohangic acid E (24) induced QR activity in a concentration-dependent 
manner without cytotoxicity and with QR activity enhancements of 1.3-, 
1.5-, 1.8-, 2.1-, and 2.2-fold at 2, 5, 10, 20, and 30 μM of 24, respectively 
(Figure 20, 21). These results suggest that the glucose moiety in 24 is 
particularly important for the QR activity in this class of the compounds.
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Figure 20. Effect of 20–24 on the induction of quinone reductase in 
murine Hepa1c1c7 cells. Cells were grown for 24 h, and then exposed to 
20–24 for 24 h. Quinone reductase activities were measured in cell lysates 
by reduction of a tetrazolium dye and expressed as nmol/min/mg protein. 
Values represent the mean ±SD of four determinations. *P < 0.001 indicates 
statistically significant differences from the control group.
Mohangic acids A-E commonly bear a para-substituted aromatic ring 
with an amine and an alkyl chain. The structural feature of the mohangic 
acids is related to (2E)-11-(4’-aminophenyl)-5,9-dihydroxy-4,6,8-trimethyl-
11-oxo-undec-2-enoic acid16 and (5E)-7-(4’-aminophenyl)-2,4-dimethyl-7-
oxo-hept-5-enoic acid,17 both of which were independently isolated from 
mangrove-derived Streptomyces griseus strains. However, these known 
compounds have different chain lengths and do not incorporate the triene 
moiety in the mohangic acids. In addition, modification at the amine group 
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of 21–24 by substitution with a methyl, acetyl, or glycosyl group has not 
previously been reported in this class.
Mohangic acid E (24)
Figure 21. Effect of 24 on the induction of quinone reductase in murine 
Hepa1c1c7 cells. Cells were grown for 24 h, and then exposed to 24 for 24 h. 
Quinone reductase activities were measured in cell lysates by reduction of a 
tetrazolium dye and expressed as nmol/min/mg protein. Values represent the 
mean ±SD of four determinations. *P < 0.001 indicates statistically 
significant differences from the control group.
The absolute configurations of the natural products belonging to this class 
have not been determined,38,39 possibly as a consequence of the structural 
instability of the aminoacetophenonic group during chemical derivatizations. 
my extensive spectroscopic analysis using bidentate chiral NMR solvents 
enabled us to determine the absolute configurations of the mohangic acids 
by avoiding chemical derivatizations. To my best knowledge, candicidins 
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D,40 which has been reported as an antifungal antibiotics in a recent, has an 
identical p-aminoacetophenonic moiety at the terminal position of macrolide 
ring structure but its relative and absolute configurations were dissimilar 
from that of mohangic acids A-E (20-24). The biological activities of the 
compounds belonging to the p-aminoacetophenonic acids have not been 
reported previously.40,41 My report of QR activity induced by treatment of 
mohangic acid E (24), which is a glycosylated version of p-
aminoacetophenonic acid, represents the first biological evaluation of this 
class of the compounds and reveals the biological importance of 
glycosylation at the amino group in 24. The discovery of the mohangic acids, 
along with the results of my previous studies,42 highlights that 
microorganisms inhabiting relatively uninvestigated marine environments, 
such as an intertidal mudflat, could be a promising source of structurally and 
biologically active new secondary metabolites.
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II. QM-HiFSA-aided structure determination of 
succinilenes A-D, triene polyols from a marine-derived 
Streptomyces sp. SAK1
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II. I. Results and discussion
Succinilene A (27) was isolated as a yellow gum, and its molecular 
formula was deduced as C24H38O7 based on HR-FAB mass spectrometry 
(obsd [M-H]- at m/z 437.2550, calcd [M-H]- 437.2539) in combination with 
1H and 13C NMR data (Table 11). The 1H NMR spectrum of 27 in pyridine-
d5 exhibited typical signatures of polyenes and polyols, with seven olefinic 
protons (δH 6.3664, 6.3158, 6.2929, 6.2885, 6.1280, 5.9506, and 5.5426) 
and four protons attached to oxygen-bearing carbons (δH 5.0898, 4.3745, 
3.9176, and 3.7579). Further analysis of the 1H NMR spectrum of 27
revealed the existence of eleven aliphatic protons between δH 2.9046 and δH
1.8105, a singlet methyl group bound to an olefinic carbon (δH 1.8616), two 
doublet methyl groups (δH 1.1907 and 0.9973), and a triplet methyl group 
(δH 1.1619) bound to an sp
3 aliphatic carbon. The 13C and gHSQC NMR 
spectra displayed two carbonyl carbons (δC 175.7 and 172.7), seven olefinic 
sp2 carbons (δC 132.8, 132.6, 132.5, 132.0, 131.7, 131.6, and 127.2), one 
quaternary olefinic carbon (δC 140.1), four oxygen-bound methine carbons 
(δC 76.8, 75.5, 74.2, and 74.1), six aliphatic carbons (δC 39.8, 38.0, 37.1, 
30.4, 30.3, and 27.5), and four methyl group carbons (δC 17.2, 16.6, 12.2, 
and 10.9). Based on the UV absorption maximum at 270 nm and the eight 
olefinic carbon signals, succinilene A (27) was expected to bear three 
conjugated double bonds and an isolated double bond. These four double 
bonds along with two carbonyl functional groups accounted for all of the six 
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double bond equivalents inherently calculated from the molecular formula, 
thus indicating that succinilene A (27) is a linear compound. 
Figure 22. Structures of succinilenes A-D (27–30).
Given this information, all 13C-1H one-bond correlations were assigned 
by analysis of the gHSQC NMR spectrum (Table 1). Interpretation of COSY 
and HMBC NMR spectroscopic data readily led to the elucidation of the 
gross structure of succinilene A (27). First, the COSY signals from a 
terminal triplet methyl group (H3-17 at δH 1.1619) to aliphatic methylene 
protons (H2-16 at δH 1.8578 and δH 1.8105) connected C-17 (δC 10.9) to C-
16 (δC 27.5). The aliphatic carbon C-16 was elucidated to be directly 
connected to the oxygenated carbon C-15 (δC 75.5) based on the COSY 
correlations between H-15 (δH 3.7579) and H-16. The homonuclear 
correlation between H-15 and H-14 (δH 3.9176) revealed that an oxygen-
bound methine carbon (C-14 at δC 74.2) was connected to C-15, indicating 
the existence of a diol moiety. Further COSY analysis verified the 
connectivity between H-14 and H2-13 (δH 2.7253 and 2.6745), identifying 
the C-14–C-13 bond. The aliphatic carbon C-13 was connected to the sp2
carbon C-12 (δC 132.8) based on a 3-bond 
1H-1H coupling signal between 
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H-12 (δH 6.1280) and H-13. Additional COSY correlations among the six 
olefinic protons from H-12 to H-7 (δH 5.9506) indicated the construction of 
a triene moiety from C-12 to C-7 (δC 132.8 to δC 132.0), which is consistent 
with the UV absorption maximum at 270 nm. The triene moiety was located 
next to C-6 based on the 3JHH couplings between H2-6 (δH 2.6519 and 
2.5631) and H-7. The homonuclear correlations of H2-6 with the oxygenated 
proton (H-5 at δH 4.3745) showed C-6-C-5 (δC 76.8) connectivity. The 
HMBC correlations from a singlet methyl proton (H3-4-Me; δH 1.8616) to 
C-5, C-4 (δC 140.1), and C-3 (δC 127.2) indicated expansion of the chain 
from C-5 to C-3 through C-4. The olefinic methine C-3 was assigned next to 
C-2 (δC 37.1), with a branched methyl group (H3-2-Me; δH 0.9973/δC 16.6) 
attached to C-2. The COSY correlation from H-1 (δH 5.0898) to H-2 and H3-
1-Me identified the connectivity of C-1 (δC 74.1) and C-2, establishing the 
first partial structure from C-17 to C-1, a chain composed of 20 carbons 
bearing three hydroxyl groups and a treiene moiety. Based on additional 2D 
NMR analysis, the aliphatic H2-2’ (δH 2.8516 and δH 2.8436) displayed 
3JHH
and 3JCH correlations to adjacent aliphatic H2-3’ peaks (δH 2.9015, and δH 
2.8990) and two carbonyl carbons C-1’ and C-4’ (δC 172.7 and 175.7), 
completing the second partial structure as a succinic acid. These two partial 
structures were connected based on a key HMBC correlation from H-1, of 
which deshielded chemical shift (δH 5.0898) is indicative for the existence of 
an ester linkage, to C-1’, resulting in the gross structure of 27 (Figure 23a). 
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Figure 23. (a) Determination of the planar structure of succinilene A based 
on the analysis of key COSY and HMBC correlations. (b) J-based 
configuration analysis of succinilene A (27) at C-1 and C-2. 
Succinilene B (28) was obtained as a yellow gum. The molecular 
formula was determined as C24H38O7 on the basis of HR-FABMS data (obsd 
[M-H]- at m/z 437.2550, calcd [M-H]- 437.2539) along with 1H and 13C 
NMR spectroscopic data (Table 11). The molecular formula and the UV 
spectrum of 2 were identical to those of 27, indicating that succinilene B 
(28) is structurally analogous to succinilene A (27). The 1D and 2D NMR 
data of 28 also displayed very similar patterns to those of 27, as expected. 
Further analysis of NMR spectroscopic data resulted in the construction of 
the gross structure of 28, which was identical to that of 27. Actually, most of 
the 13C chemical shifts of 28 were very similar to those of 27, within 0.2 
ppm. However, the 13C peaks of C-13 to C-16 around the oxymethine group 
located adjacent to the terminal ethyl group differed by 0.5~1 ppm 
compared to the same peaks in 27, indicating that succinilene B (28) is a 
diastereomer of 27 that possesses different stereochemistry at C-13 or/and 
C-14.
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Succinilene C (29) was purified as a yellow gum and determined to 
possess a molecular formula of C24H36O7 on the basis of HR-FABMS data 
(obsd [M+H]+ at m/z 437.2562, calcd [M+H]+ 437.2545) combined with 1H 
and 13C NMR spectral data (Table 12). Based on the molecular weight and 
UV spectrum of 29, it was expected that one of the hydroxyl groups in 
succinilene C (29) had been oxidized to a ketone group. According to the 
comparison of the 1D and 2D NMR spectroscopic data of 29 with those of 
27, the oxygen-bound proton (H-15, δH 3.7579) in 27 was absent in 29, and 
a ketone carbon signal (δC 214.0) was detected instead, clarifying that the 
hydroxyl group at the C-15 position in 27 had been oxidized to the ketone 
group in 29. This assignment was also supported by the 3-bond HMBC 
correlations from H3-17 (δH 1.0890) and H2-13 (δH 2.7803 and 2.6591) to C-
15 and H3-17/H-16 and H2-13/H-14 COSY correlations.
Succinilene D (30) was isolated as a yellow gum, and its molecular 
formula was deduced to be C20H34O4 based on the corresponding HR-
FABMS data (obsd [M+Na]+ at m/z 361.2347, calcd [M+Na]+ 361.2355) 
and 1H and 13C NMR spectroscopic data (Table 12). The molecular weight 
of 30 was 100 Da lower than those of 27 and 28, possibly indicating that the 
terminal succinic acid moiety in 27 and 28 might have been cleaved. 
Through the careful analysis of the 1D and 2D NMR spectral data, the gross 
structure of succinilene D (30) was elucidated to be the left part of 27 or 28, 
which is the methanolysis product of 27 or 28 that lacks the succinic acid 
moiety. 
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The relative configurations of 27 were established by analyzing the 1H–
1H coupling constants and hetero half-filtered TOCSY (HETLOC) NMR 
data.34 To determine the relationship between C-1 and C-2, J-based 
configuration analysis was performed with 3JHH, 
3JCH, and 
2JCH values and 
ROESY NMR data, 15 selecting the most suitable rotamer between C-1 and 
C-2 (Figure 23b). The relationship between H-1 and 2-Me was elucidated as 
anti based on the high 3JCH value (5.5 Hz). The 
3JH1H2 (5.5 Hz), 
3JC1-MeH2 
(2.0 Hz), and 3JC3H1 (1.7 Hz) values indicated gauche relationships for H-
1/H-2, 1-Me/H-2, and C-3/H-1. Moreover, the small 2JC1H2 (3.0 Hz) value 
and the ROESY NMR signals between the H-1/H-2, H-1/H-3, H-2/1-Me, 
and 1-Me/2-Me led to elucidation of the rotamer depicted in Figure 2b. 
ROESY correlations also supported the rotamer, thus proposing 1R* and 
2R* configuration (Figure 23b). 
To determine the absolute configurations of the stereogenic centers at 
C-1, C-2, C-5, C-14, and C-15 in succinilene A (27), the modified Mosher’s 
method was applied. Methanolysis was performed to detach the succinic 
acid moiety, which enabled derivatization of the hydroxyl group at C-1 with 
MTPA-Cl (a-methoxy-(trifluoromethyl) phenyl acetyl chloride). After 
purifying the methanolysis product (31) of succinilene A, the secondary
alcohols in 31 were derivatized using R- and S-MTPA-Cl. Analysis of the 1H 
and COSY NMR spectroscopic data for these S- and R-MTPA esters (34 and 
35) led to the assignment of the DdS-R values, establishing 1R, 5S, 14R, and 
15R configurations (Figure 24a). Based on the established relative 
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configuration, the absolute configuration of C-2 was determined to be 2R. 
The relative configurations and absolute configurations of succinilene B 
(28) were determined to be 1R, 2R, 5S, 14R, and 15S using the same 
procedure applied for 27 (Figure 3b). The relative and absolute 
configurations of succinilene C (29) were analogously established as 1R, 2R, 
5S, and 15R through application of the modified Mosher’s method to the 
methanolysis product (33) of 29 (Figure 24c). Because the gross structure of 
succinilene D (30) was identical to the methanolysis products (31 and 32) of 
27 and 28, the 1H NMR and CD spectra of 30 were compared with those of 
31 and 32. The 1H NMR data for 32 was identical to those of 30 but was 
different from the 1H NMR spectrum of 31, indicating that the relative 
configuration of 30 is identical to that of 32. In addition, the CD spectra of 
30 and 32 were identical, thus leading to the assignment of 1R, 2R, 5S, 14R, 
and 15S configurations for 30 (Figure 25).
Figure 24. (a) ΔδS-R values of the MTPA esters (34 and 35) in pyridine-d5. 
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(b) ΔδS-R values of the MTPA esters (36 and 37) in pyridine-d5. (c) ΔδS-R
values of the MTPA esters (38 and 39) in pyridine-d5.
Even though the absolute configurations of the stereogenic centers in 
27-30 were completely assigned, the full assignments of the double bond 
geometries were not straightforward. The geometries of the double bonds of 
C-7/C-8 and C-11/C-12 in the succinilenes (27-30) were determined as 7E
and 11E based on the H-7/H-8 and H-11/H-12 trans-coupling constant 
values (14.5 Hz). However, it was virtually impossible to clarify the double 
bond geometry of C-9/C-10 in 27-30 because the H-9 and H-10 olefinic 
protons greatly overlap, displaying second-order peaks in the 1H NMR 
spectra and thus hampering the accurate deconvolution of the 1H-1H 
coupling constants between H-9 and H-10, even at higher magnetic field 
(900 MHz).
Therefore, a recently developed computational analysis system, QM-
HiFSA, was utilized to extract the H-9/H-10 coupling constants of the 
succinilenes using PERCH software.45 After geometry optimization and 
dynamic simulation of molecules using the MMS module, the basic 1H 
NMR parameters were predicted based on the 3D structural information. 
Then, the obtained initial parameters were optimized by iterative quantum 
mechanical simulation against experimental spectra. The iteration was
repeated until both the simulated and experimental spectra were in excellent 
agreement with each other, with root mean square (RMS) values below 0.1 
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(RMS = 0.075 for 27; RMS = 0.066 for 28; RMS = 0.093 for 29; RMS = 
0.091 for 30). Thus, the precise 1H NMR parameters were determined with 
high precision (chemical shifts: δH, 0.1 ppb; coupling constants: J, 10 mHz)
(Tables 11 and 12).46 The J couplings of the highly overlapped olefinic 
proton signals (H-9 and H-10) of 27-30 were calculated to be 14.03 Hz, 
14.79 Hz, 15.05 Hz, and 14.86 Hz (cis J couplings ca. 10-12 Hz; trans J
couplings ca. 14-18 Hz),47, 48 respectively. These results confirmed the 
geometry of the trans-olefinic protons (H-9 and H-10) in 27-30 (Figure 25).
Figure 25. 1H NMR fingerprints of compounds 27 (a) - 30 (d) generated by 
HiFSA. Comparison of the observed (red, obtained in pyridine-d5) and 
calculated (blue) 1H spectra.
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II. II. Bioactivities of succinilenes
Bioactivities of succinilenes A-D. The biological activities of the 
succinilenes (27-30) were primarily evaluated for cytotoxicity against 
human cancer cells. In this assay, succinilene A showed moderate 
cytotoxicity against the gastric carcinoma cell line SNU638, with an IC50
value of 12.1 μg/mL (27.6 μM), whereas succinilenes B–D did not display 
significant inhibitory activities against the tested cancer cell lines. As part of 
the efforts to search for biological activities, a nitrate assay was performed 
for 27–30. Overproduction of nitric oxide (NO) is highly associated with 
inflammation, and the pathway that regulates NO production is considered a
useful target for anti-inflammatory agents.49 RAW 264.7 cells were treated 
with LPS (1 µg/mL), which induces inflammatory responses. 50,51 When the 
cells were pretreated with various concentrations of the succinilenes (0, 20, 
or 40 µM) 30 min prior to LPS stimulation, NO production was gradually 
inhibited in a concentration-dependent manner, except for treatment with 
succinilene D (30). No significant effect on cell viability, as determined by 
the MTT assay (> 90% cell survival), was observed at the tested
concentrations, indicating that the inhibition of NO production by the tested 
compounds was not mediated by a cytotoxic effect. As a result, among the 
four compounds, succinilene C (29) exhibited the most remarkable 
inhibitory activity against NO production. By contrast, succinilene D, 
without succinic acid connected through an ester linkage, resulted in the 
overproduction of NO (Figure 26).
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Figure 26. Inhibitory effects of succinilenes A-D (27-30) on LPS-induced 
NO production. RAW 264.7 cells (3 × 105 cells/mL) were stimulated with 
LPS (1 µg/mL) in the presence or absence of 27-30. After 20 h, the cultured 
media were collected, and the nitrite concentrations were measured using 
the Griess reaction. * P < 0.05, ** P < 0.01, *** P < 0.001 are considered 
statistically significant compared to the control group.
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a mult (J in Hz) δC
b δH 
c mult (J in Hz) δC
d
1 5.0898 dq (6.35, 5.50) 74.1, d 5.0882 dq (6.35, 5.75) 74.1, d
1-Me 1.1907 d (6.35) 17.2, q 1.1862 d (6.35) 17.2, q
2 2.7397 ddq (9.74, 6.82, 5.50) 37.1, d 2.7356 ddq (9.60, 6.76, 5.75) 37.2, d
2-Me 0.9973 d (6.82) 16.6, q 0.9916 d (6.76) 16.7, q
3 5.5426 d (9.74) 127.2, d 5.5359 d (9.60) 127.2, d
4 – – 140.1, s – – 140.1, s
4-Me 1.8616 s 12.2, q 1.8618 s 12.1, q
5 4.3745 dd (7.04, 6.04) 76.8, d 4.3721 dd (6.69, 6.34) 76.9, d
6 2.6519 ddd (-14.00, 7.30, 7.04) 39.8, t 2.6498 ddd (-14.11, 7.47, 6.69) 39.8, t
2.5631 ddd (-14.00, 7.50, 6.04) 2.5587 ddd (-14.11, 7.10, 6.34)






















11 6.3664 dd (15.19, 10.49) 132.6, d 6.3913 dd (15.19, 10.53) 132.7, d
12 6.1280 ddd (15.19, 7.50, 7.12) 132.8, d 6.2145 ddd (15.19, 7.45, 7.24) 133.0, d
13 2.7253 ddd (-14.36, 7.50, 4.66) 38.0, t 2.8829 ddd (-14.13, 7.24, 3.36) 37.5, t
2.6745 ddd (-14.36, 8.02, 7.12) 2.7481 ddd (-14.13, 8.12, 7.45)
14 3.9176 ddd (8.02, 4.66, 4.33) 74.2, d 4.0324 ddd (8.12, 5.84, 3.36) 74.9, d
15 3.7579 ddd (8.68, 4.33, 3.88) 75.5, d 3.8871 ddd (8.72, 5.84, 2.69) 76.1, d
16 1.8578 ddq (-13.87, 7.38, 3.88) 27.5, t 2.0541 ddq (-13.61, 7.36, 2.69) 26.5, t
1.8105 ddq (-13.87, 8.68, 7.49) 1.8504 ddq (-13.61, 8.72, 7.42)
17 1.1619 dd (7.49, 7.38) 10.9, q 1.2234 dd (7.42, 7.36) 10.9, q
1’ – – 172.7, s – – 173.0, s
2’ 2.8516 ddd (-11.48, 7.29, 6.04) 30.3, t 2.8496 ddd (-18.10, 7.13, 6.33) 30.6, t
2.8436 ddd (-11.48, 7.54, 5.82) 2.8496 ddd (-18.10, 8.56, 4.83) 
3’ 2.9046 ddd (-16.39, 7.29, 5.82) 30.4, t 2.9078 ddd (-15.38, 8.56, 7.13) 30.8, t
2.8954 ddd (-16.39, 7.54, 6.04) 2.9022 ddd (-15.38, 6.33, 4.83)
4’ – – 175.7, s – – 176.2, s
a 1H and 13C NMR were recorded at 900 and 225 MHz, respectively.
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a mult (J in Hz) δC
b δH 
a mult (J in Hz) δC
b
1 5.1041 dq (6.33, 5.27) 74.2, d 3.9666 ddq (6.23, 5.00, 4.60) 70.8, d
1-Me 1.1944 d (6.33) 17.3, q 1.3158 d (6.23) 21.0, q
2 2.7403 ddq (9.97, 6.86, 5.27) 37.2, d 2.6988 ddq (9.62, 6.85, 5.00) 39.6, d
2-Me 1.0069 d (6.86) 16.6, q 1.1905 d (6.85) 17.0, q
3 5.5580 d (9.97) 127.4, d 5.8422 d (9.62) 128.6, d
4 – – 140.3, s – – 138.8, s
4-Me 1.8616 s 12.4, q 1.8782 s 12.1, q
5 4.3767 dd (7.10, 6.06) 76.9, d 4.4482 ddd (7.07, 5.51, 3.83) 77.2, d
6 2.6443 ddd (-13.79, 6.93, 6.06) 39.8, t 2.6890 ddd (-13.68, 7.07, 7.00) 39.9, t
2.5606 ddd (-13.79, 7.12, 7.10) 2.6130 ddd (-13.68, 7.99, 5.51)






















11 6.3255 dd (15.14, 10.72) 133.7, d 6.3706 dd (15.21, 10.55) 133.0, d
12 5.9778 ddd (15.14, 7.41, 7.00) 129.8, d 6.2091 ddd (15.21, 7.38, 7.16) 133.2, d
13 2.7803 ddd (-13.49, 7.27, 7.00) 38.2, t 2.8870 ddd (-14.32, 7.38, 3.45) 37.6, t
2.6591 ddd (-13.49, 7.41, 4.88) 2.7460 ddd (-14.32, 8.46, 7.16) 
14 4.4922 dd (7.27, 4.88) 77.2, d 4.0282 dddd (8.46, 5.85, 5.74, 3.45) 75.0, d
15 – – 214.0, s 3.8872 dddd (8.87, 5.85, 5.90, 3.10) 76.2, d
16 2.7549 dq (-14.89, 7.05) 31.7, t 2.0620 ddq (-13.56, 7.35, 3.10) 26.5, t
2.7206 dq (-14.89, 7.45) 1.8533 ddq (-13.56, 8.87, 7.37)
17 1.0890 dd (7.45, 7.05) 7.8, q 1.2266 dd (7.37, 7.35) 10.8, q
1’ – – 172.7, s
2’ 2.8525 ddd (-16.88, 7.01, 6.26) 30.3, t
2.8525 ddd (-16.88, 8.79, 4.47)
3’ 2.9172 ddd (-16.89, 8.79, 7.01) 30.0, t
2.9060 ddd (-16.89, 6.26, 4.47) 
4’ – – 175.3, s
OH-1 5.7021 d (4.60)
OH-5 6.4159 d (3.83)
OH-14 6.1408 d (5.74)
OH-15 6.0448 d (5.90)
a 1H and 13C NMR were recorded at 600 and 150 MHz, respectively.
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III. Ullengacenes A and B, dimeric benz[a]anthracenes 
linked by a mono-sulfide bond derived from volcanic island 
Streptomyces sp. SUD119
107
III. I. Result and discussion
Ullengacene A (40) was isolated as a yellow gum, and its molecular 
formula was determined as C42H42O10S on the basis of HRFABMS data 
(obsd. [M+Na]+ at m/z 761.2394, calcd. [M+Na]+ at m/z 761.2396) in 
combination with 1H and 13C NMR spectroscopic data (Table 13). 
Interpretation of 1H, 13C and HSQC NMR data of 40 in DMSO-d6 identified 
four aromatic protons and carbons (dH 7.59, dC 130.6; dH 7.40, dC 130.0; 
dH 7.11, dC 121.9, dH 7.05, dC 110.3) and eight quaternary carbons (dC 157.2, 
148.9, 141.7, 141.5, 141.4, 136.8, 128.5, and 122.4), indicating the 
existence of aromatic ring. Further analysis of 1D and HSQC NMR data 
revealed that the existence of one carbonyl signal at dC 199.8, three protons 
bound to oxygen-bearing carbons (dH 6.44, dC 64.1; dH 6.32, dC 67.2; dH 4.19, 
dC 72.2), two exchangeable protons attached to oxygen (dH 5.69 and 
dH 4.99), two methoxy groups (dH 3.81, dC 55.6; dH 2.98, dC 53.7), three 
aliphatic protons and carbons (dH 2.71, dH 2.55, dC 67.2; dH 2.08, dC 37.3), 
and one methyl group (dH 1.02, dC 18.0).Interestingly, the sum of proton and 
carbon signals showed half amount of its molecular weight, indicating that 
the structure of 40 should be assembled as dimer feature. Despite is dimeric 
feature, the number of 1H and 13C signals were still not enough to meet its 
molecular weight, dedicating the existence of other elements except proton, 
carbon, and oxygen. For identification of exact component of 40, energy 
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dispersive X-ray (EDX) was performed. This experiment relies on an 
interaction of X-ray excitation with the target compound. This is 
characterized due to the fundamental principle that each element has a 
unique atomic structure permitting a unique set of peaks on its 
electromagnetic emission spectrum. Based on the EDX experiment 
connected with field emission scanning electron microscope (FE-SEM) 
which enable to probe surface of target compound, elements consist of 
ullengacene A (40) was completely identified to have one sulfur including 
protons, carbons, and oxygens. 
Figure 26. Key COSY and HMBC correlations of ullengacenes A and B (40
and 41). 
Given these information, interpretation of COSY and HMBC NMR 
spectroscopic data led us to elucidate the gross structure of ullengacene A 
(40).  First, the COSY signals from a aliphatic methylene protons (H2-2 at 
dH 2.71 and 2.55) to aliphatic methine proton (H-3 at dH 2.08) connected C-2 
(dC 46.1) to C-3 (dC 37.3). The homonuclear correlation between doublet 
methyl group (H3-3-Me at dH 1.02) and H-3 revealed connectivity of methyl 
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carbon (C-3-Me at dC 18.0) and C-3. The aliphatic carbon C-3 was verified 
to be directly connected to the oxygen-bound carbon C-4 (dC 72.2) based on 
the COSY signals between H-3 and H-4 (dH 4.19).Further COSY analysis 
identified the connectivity between H-4 and H-4-OH (dH 5.69), indicating 
oxygenated carbon C-4 did not expand to other ester bond. The HMBC 
correlations from H2-2 to ketone carbon (C-1 at dC 199.8) and quaternary 
carbon (C-12b at dC 128.5), and from H-4 to C-4a (dC 148.9) and C-12b 
clarified that carbon frame from C-1 to C-12b formed a six-membered ring 
for first partial structure. Additional HMBC correlations from H-4 to C-5 
(dC 130.6) and from H-5 (dH 7.59) to four quaternary carbon including C-4a, 
C-6 (dC 136.8), C-6a (dC 141.4), and C-12b exhibited connectivity of six-
membered ring to uncovered aromatic ring. The hetero nuclear correlation 
from H-7 (dH 6.32) to C-6a and C-12a (dC 141.5), and from H-12 (dH 6.44)
to C-12a and C-12b led to construction of six-membered aromatic ring 
structure connected adjacent to first partial structure. 
Additional aromatic ring was established easily by 1H-1H homonuclear 
correlations of aromatic protons from H-10 (dH 7.40) to H-9 and H-11 
(dH 7.05 and dH 7.11), connecting the aromatic carbons C-9, C-10, and C-11 
(dC 110.3, 130.0, and 121.9). In this spin system, the vicinal coupling 
constants were measured as 7.5 Hz, supporting these protons are originated 
from a 6-membermed aromatic ring. This spin system was completely 
identified based on the HMBC correlations from H-9 to C-7a (dC 122.4) and 
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C-11, from H-10 to C-8 (dC 157.2) and C-11a (dC 141.7), and from H-11 to 
C-9 and C-7a. In the HMBC spectrum, the methoxy group (H3-8-OMe at 
dH 3.81) also displayed connectivity of aromatic quaternary carbon at C-8 
constructing anisole moiety. The 3JCH correlations from H-7 to C-6a and C-
7a, and from H-12 to C-11a, C-12a, and C-12b established complete 
benz[a]anthracene moiety, connecting four six-membered ring systems. 
Further COSY correlation between H-12 and H-12-OH (dH 4.99) and 
HMBC correlation from H3-7-OMe resulted in construction of monomer 
structure of 40. Because of dimer feature of ullengacene A (40) including 
one sulfur based on the molecular weight and EDX experiments, the full 
structure of 40 was dedicated to dimer linked by sulfur bridge. In a 
comprehensive assignments of NMR spectroscopic data, we found out that 
the quaternary carbon C-6 was not occupied due to lack of signal, indicating 
the position C-6 have to be connected to a sulfur bridge. Consequently, 
these benz[a]anthracene monomers were linked by the one sulfur bond 
bridge attached adjacent to each of C-6 sites. Therefore, the planar structure 
of ullengacene A (40) was established as a structurally new dimer feature of 
benz[a]anthracene satisfying the 22 degree of unsaturation (Figure 26). 
Ullengacene B (41) was obtained as a yellow gum with molecular formula 
as C41H38O10S based on the HRFABMS data (obsd. [M+H]
+ at m/z
723.2275, calcd. [M+H]+ at m/z 723.2264), 1H, and 13C NMR spectroscopic 
data (Table 13). The molecular formula and the UV spectrum of 41 were 
similar to those of 40, indicating the ullengacene B (41) is structurally 
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analogous to ullengacene A (40). Further EDX experiment for 41 was 
performed and I found out the elements spectrum of 41 displayed similar 
pattern of 1, including protons, carbons, oxygens, and one sulfur. However, 
careful comparison of the 1H and 13C NMR data of 41 noticed that the 
number of protons and carbons of 41 exhibited almost double amount of 
those of 40. Given these information, ullengacene B (41) was speculated as 
derivative of 40 with feature of pseudo-dimer, not dimer. The 
comprehensive 1D and 2D NMR analysis revealed that methoxy group 
signal of 40 at dH 2.98 (H3-7-OMe) was replaced by proton signal of 41 at 
dH 5.96 (H-7-OH). Additional difference of 40 and 41 was due to the 
absence of carbinol signal (H-12 at dH 6.44; C-12 at dC 64.1) and the 
presence of ketone signal (C-12 at dC 196.8), establishing pseudo-dimer 
feature of 41 with shifting of chemical signals from those of 40. The 
pseudo-dimer structure of 41 was completely confirmed by the analysis of 
ROESY signals between H-4 (dH 4.32)/H-4’-OH (dH 5.71), H-4-OH (dH 
5.51)/H-4’ (dH 4.30), H-5 (dH 7.57)/H-5’ (dH 7.81), and H-7 (dH 6.35)/H-7’ 
(dH 6.18). 
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Figure 27. (a) Key ROESY correlations of ullengacene A (40). (b) Key 
ROESY correlations of ullengacene B (41).
The scheme for determination of the absolute configuration of 
benz[a]anthraquinones and benz[a]anthacenes were previously reported 
using crystallography and ECD calculation. The chemical reactions for 
stereogenic centers has not been described because the steric hindrance of 
the structure disrupted chemical derivatization to act on. Therefore, ECD 
calculation was performed to determine the absolute configuration of 40. 
First, the relative configuration of 40 was established by the analysis of 3JHH
values and ROESY NMR spectroscopic data (Figure 27a). The relationship 
between H-3 and H-4 was deduced as anti due to the large corresponding 
3JH3H4 value (8.5 Hz). The ROESY correlation between H-2b, H-3-Me, H-4, 
H-7, H-7’, and H-12 were observed. For identification of clear the long-
range ROESY signals, I performed 1D ROESY NMR experiment. As a 
result, 1D ROESY NMR experiment on H-4 exhibited exact peaks of H-2b, 
H-3-Me and H-7’, establishing the relative configuration of 40 as 3R*, 3’R*, 
4S*, 4’S*, 7R*, 7’R*, 12S*, and 12’S*. Furthermore, additional 
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computational analysis for prediction of NMR shielding tensor was applied 
to support the relative configuration of 40 using DP4 analysis. However, it 
was difficult to apply DP4 analysis onto the full structure of 40 for accuracy 
of DP4 modeling calculation (<500 dalton). Accordingly, DP4 possibility 
analysis was conducted on monomer feature of 40 with experimental and 
predicted CS values of the two diastereomer A and B. The outcome 
indicated that diastereomer A with 7R, 12S was the most relevant with a 
probability of 91.6 %, as I expected. This result shows application of DP4 
possibility analysis can be powerful tools for determination of relative 
configuration between chiral centers with long distance. 
The relative configuration of 41 was also established by careful analysis 
of 1H-1H coupling constants and ROESY data. The relationship between H-
3 and H-4 was revealed as anti with the large corresponding 3JH3H4 value 
(8.0 Hz). Also, the relationship between H-3’ and H-4’ was elucidated as 
anti based on the high 3JH3’H4’ value (8.0 Hz). However, the ROESY signals 
of 41 displayed slightly different patterns from those of 40. First, the 
ROESY correlations between H-2b (dH 2.58), H-3-Me (dH 1.02), and H-4 
(dH 2.03) displayed identical signals with those of 40. Further ROESY 
analysis with 1D ROESY experiments on H-7’ (dH 6.18) revealed that H-7, 
H-7’, H-12’ (dH 6.43), H-2’b (dH 2.54), H-3’-Me (dH 1.04), and H-4’ (dH 
4.30) were located in the same direction, establishing the relative 
configuration of 2 as 3R*, 3’R*, 4S*, 4’S*, 7S*, 7’R*, 12’S*  (Figure 27b). 
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Interestingly, careful ROESY analysis discovered the key correlation from 
H-4 to H-4’-OH which was not detected in that of 40 indicating the relative 
configuration of 41 was identical that of 40 except C-7 but the arrangement 
of two of ring structures was reversed in three dimensional space. 
For determination of the absolute configuration of 40, an energy-minimized 
structure of each conformer was calculated on the basis of the relative 
configuration of 40. Then, ECD (electronic circular dichroism) calculations 
for the conformers of the two enantiomers of 40 were conducted by time-
dependent density-functional theory (TD-DFT) at the B3LYP/def2-
TZVPP//B3LYP/def-SVP level for all atoms. The experimental ECD 
spectrum of 40 showed a diagnostic positive Cotton effect at 324 nm and a 
negative Cotton effects at 292 nm and 350 nm, respectively. As depicted in 
Figure 3, the calculated ECD spectrum of the enantiomer with the 3R, 3’R, 
4S, 4’S, 7R, 7’R, 12S, and 12’S configuration corresponded with the 
experimental ECD spectrum (Figure 28), whereas the other enantiomer with 
3S, 3’S, 4R, 4’R, 7S, 7’S, 12R, and 12’R configuration displayed the 
opposite ECD spectrum, determining the absolute configuration of 40 as 3R, 
3’R, 4S, 4’S, 7R, 7’R, 12S, and 12’S. The absolute configuration of 41 was 
also determined as 3R, 3’R, 4S, 4’S, 7S, 7’R, 12’S by the comparison of the 
experimental ECD spectrum and the calculated ECD spectra of 41 using 
same procedure. However, I had to confirm the possibility for conversion of 
the absolute configuration of 40 at C-3’, 4’, 7’ and 12’ position because 
NMR chemical shifts of 40 will be identical even those of stereogenic center 
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were reversed. For determination of the exact absolute configuration, the 
modified Mosher’s method was applied to obtain enantiomer or 
diastereomer of 40. Due to its steric hinderence reported previously, S-
MTPA-Cl was used for derivatization with overdose of 
dimethylaminopyridine (DMAP). Fortunately, reaction was successfully act 
on successfully and 1H NMR spectrum of R-MTPA ester of 40 displayed 
feature of enantiomer, indicating the absolute configuration of 40 at C-3’, 4’, 
7’ and 12’ position are identical with that of C-3, 4, 7, and 12. Further 
derivatization of S-MTPA ester was also performed well and analysis of the 
1H and COSY NMR spectroscopic data for these S- and R-MTPA esters led 
to the assignment of the DS-R values, identifying 3S, 3’S configuration. 
Based on the relative configuration, the absolute configuration of C-4, 4’, 7, 
7’, 12 and 12’ were confirmed to be 3R, 3’R, 4S, 4’S, 7R, 7’R, 12S, and 12’S,
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Figure 28. ECD spectra of ullengacene A and B (40 and 41).
In search of monomer derivatives of 40 to compare the biological 
activities, ullengacene C (42) was finally obtained as a pure compound. U
llengacene C (42) was isolated as a yellow gum having molecular formula 
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as C20H20O5 on the basis of the HRFABMS data (obsd. [M+H]
+ at m/z
340.1324, calcd. [M+H]+ at m/z 340.1316), 1H, and 13C NMR spectroscopic 
data (Table S1). Careful comparison of 1D and 2D NMR data with 40
indicated the planar structure of 42 was almost identical with that of 40
except methoxy group signal of 40 at dH 2.98 (H3-7-OMe) which was 
disappeared in 42. Further analysis of J-based configuration and ROESY 
NMR data of 40 revealed that the relative configuration of 42 was 
completely identical with that of 40. The absolute configuration of 42 was 
determined by ECD calculation as 3R, 4S, 7R, and 12S, notifying compound 
42 should be a precursor of 40 in biosynthetic pathway. Furthermore, two 
kinds of known compounds belonging to benz[a]anthraquinone class, 
rubiginoneA2 and fujianmycin A were also prepared for the comparison of 
bioactivities with 40-42. 
The biological activities of benz[a]anthracene class compounds were 
reported to display moderate antibiotic activity previously. Therefore, I first 
evaluated ullengacene s A-C for antibacterial and antifungal activities. 
Unfortunately, ullengacene s A-C (40-42) did not display any significant 
inhibitory activity either. Additional bioassay for cytotoxicity effects against 
human carcinoma cell lines A549, HCT116, SNU638, K562, SK-HEP1, and 
MDA-MB231 were tested, however ullengacenes A-C (40-42) did not 
showed remarkable cytotoxicity against the human cancer cells (IC50 > 10 
mM). Because these compounds displayed no cytotoxicity, ullengacenes A-
B (40-42) were evaluated with respect to cancer chemoprevention. Cancer 
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chemoprevention has been regarded as prolific approach for decreasing the 
risk of cancer development, involving prevention, delay, or reversal of the 
process of carcinogenesis. We focused two strategies for cancer 
chemoprevention including enhancement of the deactivation of radicals and 
electrophiles via phase II enzymes, and inhibiting angiogenesis in growth of 
tumor cells. 
First, a QR induction assay was performed to evaluate the bioactivities 
of 40-42 in the cultured Hepa-1c1c7 murine hepatoma cell line using 0.1 % 
dimethyl sulfoxide (DMSO) as a control and β-naphthoflavone (2 μM) as a 
positive control. As shown in Figure 29a, ullengacene A (40) at a 
concentration of 20 mM exhibited a remarkable 2.4-fold increase in QR 
induction activity against the control. However, ullengacene B (41) 
displayed relatively weak activity compared with 40. Interestingly, further 
biological evaluation for antiangiogeneic activity showed opposite results. 
In this assay, I evaluated the capillary tube formation assay of HUVEC 
under VEGF induced condition using endothelial cells. The suppression 
ratio of the ullengacene B (41) at 40 μM displayed inhibition of endothelia 
cell network formation, which was similar with VEGF negative condition 
(Figure 4b) with no cytotoxicity. Ullengacene B (41) was observed to inhibit 
capillary tube formation of the HUVEC in dose dependent manner. On the
other hand, ullengacene A (40) exhibited no inhibition activity with same 
concentration. These results indicated that variation of chiral centers and 
existence of methoxy groups resulting in arrangement of ring formation 
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could be significant factor for cancer chemoprevention. Furthermore, 
monomer compounds were evaluated for QR induction and anti-
angiogenesis activities with same procedures but none of them displayed 
remarkable activity, supporting that the dimer feature of benz[a]anthracene 
can be a key scaffolds to exhibit biological activities. 
Figure 29. (a) Effect of 40 and 41 on the induction of quinone reductase in 
murine Hepa1c1c7 cells. Cells were grown for 24 h, and then exposed to 40
- 41 for 24 h. Quinone reductase activities were measured in cell lysates by 
reduction of a tetrazolium dye and expressed as nmol/min/mg protein. 
Values represent the mean ± SD of four determinations. ***P <0.001 
indicates statistically significant differences from the control group. (b) 
Effect of 40 and 41 on capillary tube formation by endothelial cells. In 96-
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well plate coated with matrigel, HUVECs and each concentration of 40 and 
41 were added and then incubation for 4-8 h at 37℃. The capillary 
structures were photographed and quantified.
In summary, new benz[a]anthracene class compounds, ullengacenes A, 
B and C (40, 41 and 42), were isolated from the Streptomyces sp. collected 
in sediment of volcanic island, Uleung-do. In natural products derived from 
bacteria, several dimeric compounds were reported very seldom with a 
sulfide bond bridge. Especially, dimeric compounds possessing a mono-
sulfide bond bridge were extremely rare. To my best knowledge, 
ullengacenes A and B (40 and 41) are first dimeric benz[a]anthracene class 
compounds linked by a mono-sulfide bond bridge derived from 
Streptomyces sp. Moreover, the biological activities of the compounds 
belonging to benz[a]anthracene class have been reported to display 
antibiotic activity. my report of QR induction activity and antiangiogenic 
activity evaluated by ullengacenes A and B (40 and 41), which are dimer 
version of benz[a]anthracene class, propose the first biological evaluation of 
this class of compounds and the biological importance of structural 
arrangement of ring formation and dimeric composition. Regarding the 
structural novelty and biological activity of the ullengacenes, my discovery 
provides the evidence that marine microorganisms derived from relatively 
uncommon environments could be a prolific source for inspiring structurally 
new scaffolds with novel biological activities. 
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Table 13. . 1H and 13C NMR Data of 40 and 41 in DMSO-d6
40 41
no. dH, mult (J in Hz) dC dH, mult (J in Hz) dC
1 – 199.8, s – 198.2, s
2 2.71, 1H, d (15.0, 46.1, t 2.75, 1H, d (14.0, 45.9, t
4.5) 4.5)
2.55, 1H, d (15.0, 2.58, 1H, d (14.0,
9.5) 8.0)
3 2.08, 1H, dddd 37.3, d 2.03, 1H, dddd 39.8, d
(9.5, 8.5, 6.5, 4.5) (8.5, 8.0, 6.5, 4.5)
3-Me 1.02, 3H, d (6.5) 18.0, q 1.02, 3H, d (6.5) 19.6, q
4 4.19, 1H, dd (8.5, 72.2, d 4.32, 1H, d (8.0) 72.4, d
4.0)
4a – 148.9, s – 145.2, s
4-OH 5.69, 1H, d (4.0) 5.51, 1H, br
5 7.59, 1H, s 130.6, d 7.57, 1H, s 130.2, d
6 – 136.8, s – 138.6, s
6a – 141.4, s – 141.3, s
7 6.32, 1H, s 67.2, d 6.35, 1H, s 59.1, d
7a – 122.4, s – 130.4, s
7-OMe/ 2.98, 3H, s 53.7, q
7-OH 5.96, 1H, br
8 – 157.2, s – 157.1, s
8-OMe 3.81, 3H, s 55.6, q 3.87, 3H, s 56.1, q
9 7.05, 1H, d (8.0) 110.3, d 7.38, 1H, d (8.0) 115.9, d
10 7.40, 1H, t (8.0) 130.0, d 7.56, 1H, t (8.0) 133.6, d
11 7.11, 1H, d (8.0) 121.9, d 7.42, 1H, d (8.0) 117.8, d
11a – 141.7, s – 141.5, s
12 6.44, 1H, d (6.0) 64.1, d – 196.8, s
12-OH 4.99, 1H, d (6.0)
12a – 141.5, s – 140.6, s
12b – 128.5, s – 129.8, s
1’ – 199.8, s – 199.9, s
2’ 2.71, 1H, d (15.0, 46.1, t 2.77, 1H, d (14.0, 46.1, t
4.5) 8.0)
2.55, 1H, d (15.0, 2.54, 1H, d (14.0,
4.5) 4.5)
3’ 2.08, 1H, dddd 37.3, d 2.15, 1H, dddd 37.4, d
(8.5, 6.5, 4.5, 4.5) (8.5, 8.0, 6.5, 4.5)
3’-Me 1.02, 3H, d (6.5) 18.0, q 1.04, 3H, d (6.5) 18.3, q
4’ 4.19, 1H, dd (8.5, 72.2, d 4.30, 1H, d (8.0) 72.6, d
4.0)
4’a – 148.9, s – 144.7, s
4’-OH 5.69, 1H, d (4.0) 5.71, 1H, br
5’ 7.59, 1H, s 130.6, d 7.81, 1H, s 132.2, d
6’ – 136.8, s – 155.7, s
6’a – 141.4, s – 138.9, s
7’ 6.32, 1H, s 67.2, d 6.18, 1H, s 68.0, d
7’a – 122.4, s – 123.1, s
7’-OMe 2.98, 3H, s 53.7, q 3.21, 3H, s 55.3, q
8’ – 157.2, s – 157.4, s
8’-OMe 3.81, 3H, s 55.6, q 3.51, 3H, s 55.6, q
9’ 7.05, 1H, d (8.0) 110.3, d 6.90, 1H, d (8.0) 110.6, d
10’ 7.40, 1H, t (8.0) 130.0, d 7.32, 1H, t (8.0) 130.2, d
11’ 7.11, 1H, d (8.0) 121.9, d 7.06, 1H, d (8.0) 122.3, d
11’a – 141.7, s – 142.2, s
12’ 6.44, 1H, d (6.0) 64.1, d 6.43, 1H, s 65.1, d
12’-OH 4.99, 1H, d (6.0) 4.74, 1H, br
12’a – 141.5, s – 135.5, s
12’b – 128.5, s – 133.3, s
a 1H and 13C NMR were recorded at 600 and 150 MHz, respectively.
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I. II. Experimental section
General experimental procedures. Optical rotations were recorded 
using a JASCO P-200 polarimeter with a 1 cm cell. UV spectra were 
obtained on a Perkin Elmer Lambda 35 UV/Vis spectrophotometer. ECD 
spectra were acquired on an Applied Photopysics Chirascan-plus circular 
dichroism spectrometer. IR spectra were obtained using a Thermo Nicolet 
iS10 detector. 1H, 13C and 2D NMR spectra were recorded on Bruker 
Avance 600 MHz spectrometers at the National Center for Inter-University 
Research Facilities (NCIRF) at Seoul National University and on a Bruker 
Avance II 900-MHz NMR spectrometer at the Korea Basic Science Institute 
(KBSI) at Ochang. Chemical shifts of all NMR spectra were referenced to 
residual protonated solvent peaks for CD3OD (δH/δC, 3.33/49.2) or pyridine–
d5 (δH/δC, 8.74, 7.58, 7.21/150.4, 135.9, 123.9). Electrospray ionization 
(ESI) low–resolution LC/MS data were acquired on an Agilent Technologies 
6130 quadrupole mass spectrometer coupled with an Agilent Technologies 
1200–series HPLC. High-resolution fast atom bombardment (HR–FAB) 
mass spectra were obtained using a Jeol JMS–600W high–resolution mass 
spectrometer at NCIRF. GC analysis was performed on an Agilent 6850–
series gas chromatograph using an HP-5 column (cross-linked 5% 
PHM/Siloxan, Macherey und Nagel) and a flame ionization detector. Instant 
Ocean sea-salt mix was used to prepare seawater-based media.
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Bacterial isolation. A mud sample was collected from the Mohang 
mudflat in Buan, Republic of Korea. The sample was dried at room 
temperature for (rt) 3 h, and the dry sediment (1 g) was diluted in 4 mL of st
erilized artificial seawater. The mixture was spread onto actinomycete 
isolation agar, A4 medium (1 L seawater, 18 g agar, 100 mg/L 
cycloheximide), A5 medium (750 mL seawater, 250 mL distilled water, 18 g 
agar, 100 mg/L cycloheximide), and chitin-based agar (1 L seawater, 18 g 
agar, 5 g chitin powder, 100 mg/L cycloheximide) by stamping, spreading, 
or both. The single-strain SNM31 was isolated on A5 medium. The strain 
SNM31 (GenBank accession #KT921418) was phylogenetically identified 
as a Streptomyces sp. on the basis of the 16S rDNA sequence analysis (most 
closely related to Streptomyces griseus, 99% identity).
Cultivation and extraction of the bacterial strain. The strain SNM31 
was cultivated in 50 mL of YEME medium (4 g yeast extract, 10 g malt 
extract, and 4 g glucose in 1 L artificial seawater) in a 125 mL Erlenmeyer 
flask. After cultivation for 3 days on a rotary shaker at 160 rpm at 30 °C, 10 
mL of the culture was inoculated directly to 1 L of YEME liquid medium in 
2.8 L Erlenmeyer flasks (12 ea × 1 L, total volume 12 L). After the bacteria 
were incubated for 4 days, the 12 L culture of the SNM31 strain was 
extracted with 18 L of EtOAc. The EtOAc layer was separated, and 
anhydrous sodium sulfate was added to remove residual water. The 
extraction procedure was repeated four times (total culture volume: 48 L). 
The extract in EtOAc was concentrated in vacuo to yield 4 g of dried 
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material in total. 
Isolation of mohangic acids (20–24). The organic extract of SNM31 
was filtered with a syringe filter and injected directly onto a semi-
preparative reversed-phase HPLC column (Kromasil C18 (2): 250 × 10 mm, 
5 μm) with a gradient solvent system (30% MeOH/H2O to 80% MeOH/H2O 
over 60 min, UV 280 nm detection, flow rate: 2 mL/min). Five major peaks 
at retention times of 44 min, 45 min, 48 min, 50 min, 54 min were observed. 
Each compound was further purified under gradient solvent conditions (10% 
CH3CN/H2O to 100% CH3CN over 40 min, UV 280 nm detection, flow rate: 
2 mL/min) using a reversed-phase C18 HPLC column (Kromasil C18 (2): 250 
× 10 mm, 5 μm). Mohangic acids A–E (20–24) were obtained in pure form 
at retention times of 24.0 (72 mg), 22.5 (12 mg), 23.5 (15 mg), 25 (13 mg), 
and 18.5 min (8 mg), respectively.
Mohangic acid A (20): Yellow gum; [α]25D -6.9 (c 0.5, MeOH); UV (MeOH) 
λmax (log ε) 270 (4.46) nm, 325 (4.15) nm; ECD (c 4.3 × 10
−4 M, MeOH) 
λmax (Δε) 218 (-39.5), 257 (-5.5) nm; IR (neat) νmax 3392, 2958, 1672, 1588, 
1541 cm-1; 1H and 13C NMR data, Table 1; HRFABMS m/z 482.2517 [M + 
Na]+ (calcd for C26H37NO6Na, 482.2519).
Mohangic acid B (21): Yellow gum; [α]25D -16.7 (c 0.5, MeOH); UV 
(MeOH) λmax (log ε) 270 (4.57) nm, 325 (4.26) nm; ECD (c 4.2 × 10
−4 M, 
MeOH) λmax (Δε) 218 (-39.5) nm; IR (neat) νmax 3410, 2964, 1602, 1546, 
1395 cm-1; 1H and 13C NMR data, Table 1; HRFABMS m/z 496.2681 [M + 
Na]+ (calcd for C27H39NO6Na, 496.2675).
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Mohangic acid C (22): Yellow gum; [α]25D -
7.1 (c 0.5, MeOH); UV (MeOH) λmax (log ε) 270 (4.63) nm; 325 (4.32) nm; 
ECD (c 4.0 × 10−4 M, MeOH) λmax (Δε) 218 (-39.1), 269 (-7.5), 275 (-
6.2), 282 (-9.2) nm; IR (neat) νmax 3402, 2967, 1675, 1593, 1536 cm
-
1; 1H and 13C NMR data, Table 1; HRFABMS m/z 524.2629 [M + Na]+ (calc
d for C28H39NO7Na, 524.2624).
Mohangic acid D (23): Yellow gum; [α]25D-11.7 (c 0.5, MeOH); UV 
(MeOH) λmax (log ε) 270 (4.46) nm; ECD (c 4.0 × 10
−4 M, MeOH) λmax (Δε) 
217 (-39.9), 259 (-4.4), 268 (-5.5), 280 (3.7) nm; IR (neat) νmax 3452, 2958, 
1737, 1598, 1366 cm-1; 1H and 13C NMR data, Table 1; HRFABMS m/z
526.2784 [M + Na]+ (calcd for C28H41NO7Na, 526.2781).
Mohangic acid E (24): Yellow gum; [α]25D -25.7 (c 0.5, MeOH); UV 
(MeOH) λmax (log ε) 270 (4.19) nm, 325 (3.91) nm; ECD (c 3.2 × 10
−4 M, 
MeOH) λmax (Δε) 218 (-41.3), 292 (-3.5),  nm; IR (neat) νmax 3368, 2968, 
1737, 1599, 1373 cm-1; 1H and 13C NMR data, Table 1; HRFABMS m/z
644.3052 [M + Na]+ (calcd for C32H47NO11Na, 644.3047).
Hydrogenation of mohangic acid D. Mohangic acid D (23) (4 mg) 
was lyophilized for 24 h and subsequently suspended, along with a 10% 
Pd/C catalyst, in absolute EtOH (1.5 mL). The mixture solution of 23 was 
stirred for 2 h under 1 atm of H2 at rt. The reaction mixture in EtOH was 
filtered using a PTFE syringe filter and evaporated in vacuo to yield the 
hydrogenation product (25) of 23. The product was isolated in pure form by 
reversed-phase HPLC (Phenomenex Luna 5 μm C18 (2) 250 × 10.0 mm, 
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flow rate 2 mL/min, UV 254 nm detection) using a gradient solvent system 
(10% to 100% ACN/H2O over 40 min). The hydrogenate product (6) was 
obtained at a retention time of 27 min (3 mg, 75 %) under HPLC conditions. 
The molecular formula of product (25) was confirmed as C28H47NO7 on the 
basis of ESIMS data ([M + H] + m/z at 510).
Hydrogenation product (25). 1H NMR (600 MHz, CD3OD) dH 7.49 (d, J =
8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 4.58 (m, 1H), 3.95 (m, 1H), 3.75 (m, 
1H), 3.04 (dd, J = 7.5 Hz, 4.5 Hz, 1H), 2.42 (dd, J = 15.5 Hz, 5.5 Hz, 1H), 
2.34 (dd, J = 15.5 Hz, 5.5 Hz, 1H), 2.10 (s, 3H), 1.75–1.72 (m, 2H), 1.66–
1.62 (m, 3H), 1.56 (m, 1H), 1.47–1.42 (m, 4H), 1.38–1.30 (m, 5H), 1.24–
1.20 (m, 2H), 1.12–1.05 (m, 2H), 0.88 (d, J = 6.5 Hz, 3H), 0.84 (d, J = 6.5 
Hz, 3H), 0.82 (d, J = 6.5 Hz, 3H).
Preparation of acetonide derivative of 25 (26). The hydrogenation 
product of 23 (25) (3 mg) was prepared in a 40 mL vial and dried under high 
vacuum for 24 h. After adding pyridinium p-toluenesulfonate (1 mg), the 
mixture was dissolved in anhydrous MeOH (200 μL) and anhydrous CH2Cl2
(2 mL) at rt. Then, 2,2-dimethoxypropane (4 mL) was added to the reaction 
vial. The solution was stirred at rt under argon for 48 h. To quench the 
reaction, a saturated NaHCO3 aqueous solution was added. The reaction 
mixture was fractionated by flash column reversed-phase chromatography 
using a gradient solvent system of MeOH/H2O (20%, 40%, 60%, 80%, and 
100%). The acetonide derivative (26) was eluted in the 80% and 100% 
MeOH/H2O fractions. The final product (26) was purified by reversed-phase 
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HPLC (Phenomenex Luna 5 μm C18 (2) 250 × 10.0 mm, flow rate 2 mL/min, 
UV 254 nm detection) with a gradient solvent system (10% to 100% 
MeOH/H2O) for 40 min. The acetonide product (7) eluted at a retention time 
of 35 min (2.5 mg, 83%) under the HPLC conditions. The molecular 
formula of 26 was confirmed as C31H51NO7 by ESIMS analysis ([M + H]
+ 
m/z at 550).
Acetonide product (26). 1H NMR (600 MHz, CD3OD) ) dH 7.52 (d, J = 8.0
Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 3.95 (dd, J = 10.0 Hz, 6.0 Hz, 1H), 3.92 
(m, 1H), 3.74 (m, 1H), 3.06 (dd, J = 7.0 Hz, 4.0 Hz, 1H), 2.38 (dd, J = 15.0 
Hz, 5.0 Hz, 1H), 2.30 (dd, J = 15.0 Hz, 8.5 Hz, 1H), 2.12 (s, 3H), 1.98 (m, 
1H), 1.87 (m, 1H), 1.77 (m, 1H), 1.69-1.67 (m, 2H), 1.57-1.55 (m, 2H), 
1.47–1.42 (m, 4H), 1.39 (s, 6H), 1.38–1.30 (m, 5H), 1.22 (m, 1H), 1.12-1.06 
(m, 2H), 0.89 (d, J = 6.5 Hz, 3H), 0.88 (d, J = 6.5 Hz, 3H), 0.84 (d, J = 6.5 
Hz, 3H).
Analysis of the absolute configuration of the glucose in mohangic 
acid E (24). Mohangic acid E (3 mg) was dissolved in 3 N HCl (0.5 mL) 
and stirred at 80 °C for 2 h. After the solution cooled to rt, the HCl was 
evaporated in vacuo to yield the hydrolysate. HMDS and TMSCl (50 μL, 
v/v = 2:1) were added to the hydrolysate with pyridine (0.5 mL). After being 
stirred at 60 °C for 30 min, the mixture was dried in vacuo and separated 
using H2O and CH2Cl2 (1 mL, v/v = 1:1). The CH2Cl2 layer was injected into 
a GC equipped with an HP5 column (0.32 mm × 30 m). The temperature of 
the injector and the detector in the GC was maintained at 200 °C. During 
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analysis, the temperature of the GC column was controlled (60 °C for 3 min, 
60–200 °C at 4 °C/min, and 200 °C for 3 min). The glucose derivative from 
the hydrolysate of 24 was detected at a retention time of 32.65 min. The 
authentic D-glucose and L-glucose samples were treated and analyzed using 
the same procedures. The derivatives of D-glucose and L-glucose were 
detected at 32.67 min and 32.85 min, respectively. Co-injection of the 
silylated derivative of the hydrolysate and authentic D-glucose gave a single 
peak at 32.64 min, thereby determining the absolute configuration of the 
glucose in 24 as the D-form.  
Synthesis of bidentate chiral NMR solvents. N-Bromosuccinimide 
(2.2 mmol) was added to a mixture of 2-methyl-1,3-propanediol (1.0 mmol) 
and triphenylphosphine (2.2 mmol) in CH2Cl2 (10.0 mL) at 0 °C. The 
reaction mixture was stirred at rt for 30 min. The solvent was removed, and 
the dibromopropane was purified by column chromatography (silica gel, 
40–63 μm, pentane). With the acquired dibromopropane, bidentate chiral 
solvents (R,R)-and (S,S)-bis-a-methylbenzylamine-p-Me (BMBA) were 
synthesized according to previously reported procedures.43
Quinone reductase (QR) assay. QR activities were determined 
spectrophotometrically according to a modified microtiter method.44 Hepa-
1c1c7 cells were plated at a density of 20,000 cells/mL and cultured for 24 h 
in a humidified incubator containing 5% CO2 at 37 °C. The cells were then 
exposed to mohangic acids (20–24) and incubated for an additional 24 h. 
The media was subsequently decanted, and the cells in each well were lysed 
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by incubation at 37 °C for 10 min with 250 μL of a solution containing 10 
mM Tris-HCl pH 8.0, 140 mM NaCl, 15 mM MgCl2, and 0.5 % NP-40 
(IGEPAL CA-630) (Sigma-Aldrich). The plates were then agitated on an 
orbital shaker for additional 10 min at 25 °C, after which 1 mL of the 
complete reaction mixture containing 12.5 mM Tris-HCl pH 7.4, 0.67 
mg/mL bovine serum albumin (BSA), 0.01% Tween-20, 50 μM flavin 
adenine dinucleotide (FAD), 1 mM glucose-6-phosphate, 2 U/mL glucose-6-
phosphate dehydrogenase, 30 μM NADP, 50 μg/mL 3-(4,5-dimethylthiazo-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), and 50 μM menadione were 
added. A blue color developed, and the reaction was stopped after 10 min. 
The rate of the NADPH-dependent, menadiol-mediated reduction of MTT 
was measured at 610 nm. Protein was detected by crystal violet staining of 
an identical set of test plates. The specific activity (SA) of quinone 
reductase (nmol/min/mg of protein) was calculated from the equation: 
SA = [MTTabs/CVabs] × 3,345, 
where MTTabs is the change in the absorbance of MTT per min, CVabs is 
the absorbance of crystal violet, and 3,345 is the ratio of the proportionality 
constant determined for crystal violet and the extinction coefficient of MTT 
and has units of nmol/mg. 
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II. III. Experimental section
Isolation of bacteria, cultivation, and extraction. A sediment sample 
was obtained from the southern area of Jeju Island in a 40-mL sterilized 
plastic tube. The sample (1 g) was dried at room temperature (rt) for 3 h and 
diluted in 4 mL of sterilized distilled water. The mixture was spread on 
actinomycete isolation agar, chitin-based agar, SC medium (1 L of distilled 
water, 10 g of starch, 0.3 g of casein, 2.0 g of KNO3, 2.0 g of K2HPO4, 0.05 
g of MgSO4·7H2O, 0.02 g of CaCO3, 0.01 g of FeSO4·7H2O, 16 g of agar, 
and 100 mg/L cycloheximide), and A4 medium (1 L of distilled water, 18 g 
of agar, and 100 mg/L cycloheximide). The strain SAK1 was isolated on SC 
medium. Based on the analysis of the 16S rDNA sequence, SAK1 was 
clarified to be most closely related to Streptomyces flavogriseus (99% 
identity, GenBank accession number: KY484916). For the production of the 
succinilenes, the strain SAK1 was initially cultivated in 50 mL of YEME 
media (4 g of yeast extract, 10 g of malt extract, and 4 g of glucose in 1 L of 
distilled water) in a 125 mL Erlenmeyer flask. This seed culture was 
cultivated for 3 days on a rotary shaker at 200 rpm at 30 °C. Ten milliliters 
of the seed culture was inoculated into 1 L of YEME medium in 2.8-L 
Fernbach flasks (12 ea × 1 L, total volume of 12 L). After 2 days of 
incubation, the whole culture (12 L) was extracted twice with 18 L of ethyl 
acetate. The ethyl acetate layer was separated by a fractionating funnel and 
dried over anhydrous sodium sulfate. The ethyl acetate extract was 
concentrated in vacuo to yield 2 g of dried material. This procedure was 
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repeated 6 times (72 L of culture; total amount of extract: 12 g) to obtain a 
sufficient amount of the succinilenes for the structure elucidation and 
bioassays.
Isolation of succinilenes A–D. The organic extract of the bacterial 
strain SAK1 culture was adsorbed on Celite, and the extract-Celite mixture 
was loaded onto a 2-g Sep-Pak C18 cartridge for flash column 
chromatography. Then, the mixture was fractionated with 20 mL each of 
20%, 40%, 60%, 80%, and 100% MeOH in water and 1:1 
MeOH/dichloromethane. Succinilenes A–D (27–30) were detected in the 
80% and 100% MeOH/water fractions by LC/MS analysis. To obtain pure 
succinilenes A-D (27–30), the fractions bearing 27–30 were subjected to 
reversed-phase HPLC (Kromasil C18 (2): 250 × 10 mm, 5 µm) with gradient 
elution (30% acetonitrile/water to 65% acetonitrile/water over 40 min; UV 
detection at 280 nm; flow rate: 2 mL/min). Four major HPLC peaks were 
collected at retention times of 20 min, 28 min, 29 min, and 35 min. These 
major compounds were further purified under isocratic solvent conditions 
(65% methanol/water; UV detection at 280 nm; flow rate: 2 mL/min) on a 
reversed-phase HPLC column (Kromasil C18 (2): 250 × 10 mm, 5 µm). 
Finally, succinilenes A–D (27–30) were isolated as pure compounds at 
retention times of 33 min (12 mg), 31 min (11 mg), 36 min (5 mg), and 14 
min (2 mg), respectively.
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Succinilene A (27) [α]D -5 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 270 
(3.92) nm; IR (neat) νmax 3405, 2935, 1647, 1450 cm
-1; for 1H and 13C NMR 
data, see Table 11; HRFABMS m/z 437.2550 [M-H]- (calcd for C24H37O7
437.2539).
Succinilene B (28) [α]D -8, (c 0.05, MeOH); UV (MeOH) λmax (log ε) 270 
(3.89) nm; IR (neat) νmax 3410, 2930, 1652, 1452 cm
-1; for 1H and 13C NMR 
data, see Table 11; HRFABMS m/z 437.2550 [M-H]- (calcd for C24H37O7
437.2539).
Succinilene C (29) [α]D -3, (c 0.05, MeOH); UV (MeOH) λmax (log ε) 270 
(3.94) nm; IR (neat) νmax 3392, 2944, 1647, 1452 cm
-1; for 1H and 13C NMR 
data, see Table 2; HRFABMS m/z 437.2545 [M+H]+ (calcd for C24H37O7 
437.2562).
Succinilene D (30) [α]D -6, (c 0.05, MeOH); UV (MeOH) λmax (log ε) 270 
(3.85) nm; IR (neat) νmax 3407, 2924, 1650, 1454 cm
-1; for 1H and 13C NMR 
data, see Table 12; HRFABMS m/z 361.2347 [M+Na]+ (calcd for 
C20H34O4Na 361.2355).
Methanolysis of succinilenes A–C. Succinilene A (27) (5 mg) was 
dissolved in 2 mL of MeOH, and 28 mg of NaOMe was added to the vial to 
prepare a 0.5 M NaOMe solution. The mixture was stirred at room 
temperature for 5 h. The reaction was quenched by the addition of 1 N HCl. 
The methanolysis product was extracted by water-ethyl acetate partitioning 
after evaporating the MeOH in vacuo. After removing the solvent, the 
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methanolysis product (31) was purified by HPLC using gradient elution 
conditions (10% – 100% acetonitrile/water over 40 min; UV detection at 
280 nm; flow rate: 2 mL/min) and a reversed-phase HPLC column 
(Kromasil C18 (2): 250 × 10 mm, 5 μm). The methanolysis product (31) 
eluted at a retention time of 25 min. The structure of 31 was confirmed by 
analysis of its 1H and 2D NMR spectral data and ESI mass spectra ([M+H]+
m/z at 339; molecular formula, C20H35O4). The same procedures were 
repeated for succinilenes B and C (32 and 33). The structures of the 
methanolysis products of 28 and 29 (32 and 33) were also assigned based on 
the analysis of 1H and 2D NMR spectral data and ESI mass spectra (for 32, 
[M+H]+ m/z at 339 and molecular formula of C20H33O4; for 33, [M+H]
+ m/z
at 337 and molecular formula of C20H33O4).
MTPA esterification of succinilenes A–C. The methanolysis products 
of succinilenes A–C (31–33) were prepared individually in 40-mL vials (two 
1-mg samples for each compound) and dried completely under high vacuum 
overnight. After adding catalytic amounts of crystalline 
dimethylaminopyridine (DMAP) to each reaction vial, freshly distilled 
anhydrous pyridine (1 mL) was added under argon gas. The reaction 
mixtures were stirred at room temperature for 5 min. After 5 min, R- and S-
-methoxy trifluoromethyl-phenylacetic acid (MTPA) chloride (20 µL) 
were added, respectively. The reactions were carried out for 3 h at room 
temperature with stirring. The reactions were quenched by adding 50 µL of 
MeOH. The reaction products were purified by HPLC using gradient elution 
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conditions of 40% to 100% aqueous acetonitrile over 20 min with a 
reversed-phase C18 column (Kromasil C18 (2): 250 × 10 mm, 5 μm; flow 
rate: 2 mL/min; UV detection at 280 nm). The tetra-S- and -R-MTPA esters 
(34 and 35) of 31 eluted at 34.3 and 35.2 min, respectively. The tetra-S- and 
-R-MTPA esters (36 and 37) of 32 eluted at 33.5 and 34.7 min. The tetra-S-
and -R-MTPA esters (38 and 39) of 33 were isolated at 36.1 and 37.3 min. 
The ΔδS-R values around the stereogenic centers of the MTPA esters were 
assigned based on the analysis of 1H and 1H-1H COSY NMR spectra.
Tetra S-MTPA Ester (34) of methanolysis product (31) of succinilene A (27)
1H NMR (600 MHz, pyridine-d5) δ 7.83–7.81 (m, 4H), 7.78–7.75 (m, 4H), 
7.48–7.45 (m, 12H), 6.32–6.17 (m, 4H), 5.73 (m, 1H), 5.67–5.60 (m, 4H), 
5.41 (d, J = 6.5, 1H), 5.26 (m, 1H), 3.67 (s, 3H), 3.62 (s, 9H), 2.75 (m, 1H), 
2.63–2.54 (m, 2H), 2.51–2.46 (m, 2H), 1.76 (s, 3H), 1.72 (m, 1H), 1.58 (m, 
1H), 1.32 (d, J = 6.5, 3H), 0.93 (d, J = 6.5, 3H), 0.88 (t, J = 6.5, 3H).  The 
molecular formula of 34 was confirmed as C60H62F12O12Na ([M+Na]
+ at m/z
1227).
Tetra-R-MTPA Ester (35) of methanolysis product (31) of succinilene A (27)
1H NMR (600 MHz, pyridine-d5) δ 7.82–7.81 (m, 4H), 7.79–7.76 (m, 4H), 
7.49–7.44 (m, 12H), 6.30–6.22 (m, 4H), 5.75–5.71 (m, 2H), 5.67 (t, J = 7.0, 
1H), 5.63 (d, J = 7.0, 1H), 5.56 (d, J = 9.5, 1H), 5.50 (t, J = 7.0, 1H ), 5.25 
(m, 1H), 3.65 (s, 3H), 3.63 (s, 3H), 3.62 (s, 3H), 3.59 (s, 3H), 2.77 (m, 1H), 
2.68 (m, 1H) 2.64–2.61 (m, 2H), 2.55 (m, 1H), 1.80–1.74 (m, 2H), 1.63 (s, 
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3H), 1.25 (d, J = 6.5, 3H), 1.00 (d, J = 6.5, 3H), 0.86 (t, J = 6.5, 3H). The 
molecular formula of 35 was confirmed as C60H62F12O12Na ([M+Na]
+ at m/z
1227).
Tetra-S-MTPA ester (36) of methanolysis product (32) of succinilene B (28)
1H NMR (600 MHz, pyridine-d5) δ 7.81–7.77 (m, 8H), 7.48–7.45 (m, 12H), 
6.32–6.25 (m, 3H), 6.19 (dd, J = 14.5, 10.5, 1H), 5.80–5.75 (br, 3H), 5.65 
(m, 1H), 5.64 (m, 1H), 5.61 (m, 1H), 5.58 (br, 1H), 3.67 (s, 6H), 3.61 (s, 
6H), 2.74 (br, 1H), 2.68–2.66 (m, 2H), 2.58 (m, 1H), 2.49 (m, 1H), 1.73 (m, 
3H), 1.67–1.62 (m, 2H), 0.94 (d, J = 6.5, 3H), 0.89 (d, J = 6.5, 3H), 0.86 (t, 
J = 7.5, 3H). The molecular formula of 36 was confirmed as 
C60H62F12O12Na ([M+Na]
+ at m/z 1227).
Tetra-R-MTPA Ester (37) of methanolysis product (32) of succinilene B (28)
1H NMR (600 MHz, pyridine-d5) δ 7.75–7.73 (m, 8H), 7.46–7.44 (m, 12H), 
6.30–6.29 (m, 2H), 6.24 (m, 1H), 6.17 (m, 1H), 5.76–5.72 (br, 3H), 5.67 (m, 
1H), 5.63 (m, 1H), 5.58 (br, 1H), 5.56 (d, J = 9.5, 1H), 3.66 (s, 3H), 3.63 (s, 
6H), 3.58 (s, 3H), 2.77 (br, 1H), 2.67 (m, 1H) 2.56–2.54 (m, 2H), 2.45 (m, 
1H), 1.76 (m, 2H), 1.68 (s, 3H), 0.98 (d, J = 6.5, 3H), 0.90 (t, J = 7.5, 3H), 
0.84 (d, J = 6.5, 3H). The molecular formula of 37 was confirmed as 
C60H62F12O12Na ([M+Na]
+ at m/z 1227).
Tetra-S-MTPA Ester (38) of methanolysis product (33) of succinilene C (29)
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1H NMR (600 MHz, pyridine-d5) δ 7.81–7.78 (m, 6H), 7.50–7.47 (m, 9H), 
6.25–6.15 (m, 3H), 6.02 (dd, J = 15.0, 9.5, 1H), 5.73 (m, 1H), 5.67–5.62 (m, 
2H), 5.57 (m, 1H), 5.55 (d, J = 9.5, 1H), 5.28 (m, 1H), 3.67 (s, 3H), 3.65 (s, 
3H), 3.63 (s, 3H), 2.92 (m, 1H), 2.82–2.73 (m, 2H), 2.69 (m, 1H), 2.58–2.50 
(m, 3H), 1.69 (s, 3H), 1.13 (d, J = 6.5, 3H), 1.05 (t, J = 7.5, 3H), 0.89 (d, J = 
6.5, 3H). The molecular formula of 38 was confirmed as C50H53F9O10Na 
([M+Na]+ at m/z 1007).
Tetra-R-MTPA Ester (39) of methanolysis product (33) of succinilene C (29)
1H NMR (600 MHz, pyridine-d5) δ 7.82–7.80 (m, 6H), 7.51–7.48 (m, 9H), 
6.23–6.15 (m, 4H), 5.74 (m, 1H), 5.66–5.60 (m, 2H), 5.58 (t, J = 6.5, 1H), 
5.42 (m, 1H), 5.26 (m, 1H), 3.69 (s, 3H), 3.65 (s, 3H), 3.63 (s, 3H), 2.91 (m, 
1H), 2.84–2.75 (m, 2H), 2.62 (m, 1H), 2.57–2.51 (m, 3H), 1.65 (s, 3H), 1.18 
(d, J = 6.5, 3H), 1.06 (t, J = 7.5, 3H), 0.85 (d, J = 6.5, 3H).  The molecular 
formula of 39 was confirmed as C50H53F9O10Na ([M+Na]
+ at m/z 1007).
Evaluation of antiproliferative activity. The effects of succinilenes A–
D (27–30) on cell proliferation were evaluated by the sulforhodamine B 
(SRB) cellular protein-staining assay, with slight modifications. Briefly, 
A549 (lung cancer), SNU638 (gastric cancer), and HCT116 (colon cancer) 
cells (1 × 104 cells in 190 µL of complete RPMI 1640 medium) were seeded 
in a 96-well plate with various concentrations of 27–30 and incubated at 
37 °C in a humidified atmosphere containing 5% CO2. After 72 h of 
treatment with succinilenes A–D (27–30), the cells were fixed with a 10% 
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TCA solution for 1 h, and cellular proteins were stained with 0.4% SRB in a 
1% acetic acid solution. The stained cells were dissolved in 10 mM Tris 
buffer (pH 10.0). The effects of 27–30 on cell viability were calculated as 
percentages relative to the solvent-treated control. The IC50 values were 
calculated using nonlinear regression analysis (percent survival versus 
concentration).
Evaluation of i-NOS Assay 
Materials
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), 
sodium pyruvate, L-glutamine, antibiotics-antimycotics solution, and 
trypsin-EDTA were purchased from Invitrogen Co. (Grand Island, NY, 
USA). Lipopolysaccharide (LPS, E. coli 0111:B4), 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), and other chemicals were 
purchased from Sigma (St. Louis, MO, USA). 
Cell culture
Mouse macrophage RAW 264.7 cells, provided from the American Type 
Culture Collection (ATCC, Rockville, MD, USA), were cultured in DMEM 
supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 
antibiotics-antimycotics (PSF; 100 units/ml penicillin G sodium, 100 μg/ml 
streptomycin, and 250 ng/mL amphotericin B). Cells was incubated in 
humidified atmosphere containing 5 % CO2 at 37°C. 
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Nitrite Assay
To evaluate the inhibitory activity of succinilenes A-D (27-30) on LPS-
induced NO production, RAW 264.7 cells were cultured in 10 % FBS-
DMEM without phenol red, plated in 24-well plates (3 × 105 cells/mL), and 
incubated for 24 h. Cells were washed with PBS, fresh medium was added, 
and the cells were incubated with 1 μg/mL LPS in the presence or absence 
of test compounds. After additional 20 h of incubation, the media were 
collected and analyzed for nitrite accumulation as an indicator of NO 
production by the Griess reaction. Briefly, 180 μL of Griess reagents (0.1 % 
N-(1-naphthyl) ethylenediamine dihydrochloride in H2O and 1 % 
sulfanilamide in 5 % H3PO4) was added to 100 μL of each supernatant from 
LPS or sample-treated cells in 96-well plates. The absorbance was measured 
at 540 nm, and nitrite concentration was determined by comparison with a 
sodium nitrite standard curve. Percent inhibition was expressed as [1-(NO 
level of test samples / NO levels of vehicle-treated control)] × 100. 
Statistical Analysis
Data are presented as the means ± SD for the indicated number of 
independently performed experiments. Statistical significance (p<0.05) was 
assessed by a one-way analysis of variation (ANOVA) coupled with the 
Dunnett’s t-test.
Computer-aided NMR spectral analysis. The PERCH NMR software 
package (ver. 2013.1, PERCH Solutions Ltd., Kuopio, Finland) was used for 
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HiFSA, as previously described.52,53,54 The final optimized NMR parameters 
of compounds 27 - 30 are provided as PERCH parameter text files (*.pms).
Conclusions. Succinilenes A–D (27–30) were discovered from a 
marine-derived Streptomyces sp. through chemical profiling of a marine 
actinomycete strain collection. Spectroscopic analysis of 27-30 was used to 
assign their structures as new polyene polyol compounds, each bearing a 
conjugated triene moiety. These compounds were biologically evaluated for 
inhibitory effects on LPS-induced NO production, indicating their anti-
inflammatory significance. Succinilenes A-C, commonly incorporating a 
succinic acid moiety, displayed significant inhibitory effects on NO 
production whereas succinilene D without succinic acid did not inhibit NO 
production, thus proposing that the succinic moiety is important for the 
inhibitory effects on LPS-induced NO production. Microbial metabolites 
having succinic acid are not common but a few microbial polyketide 
compounds are known to bear succinic acid in their structures such as 
macrolactin T from the marine bacterium Bacillus marinus,55 reveromycin A 
from Streptomyces sp.,56 and macrocyclic lactone A26771B from the fungus 
Penicillium turbatum.57 These succinic acid-bearing compounds have not 
been tested for the inhibitory activities on LPS-induced NO production. 
Because the chemical shifts of the olefinic protons belonging to the triene 
moieties, and thus coupling with each other, are close enough to generate 
second-order peaks, the triene geometries of the succinilenes could not be 
determined using conventional methods. My application of the spin 
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simulation of QM-HiFSA enabled us to calculate the 1H-1H coupling 
constants of these double bond protons and successfully determine the triene 
geometries. These results suggest that the QM-HiFSA technique is a useful 
tool for the detailed structural elucidation of complicated natural products 
displaying highly overlapped 1H NMR spectra.
III. II. Experimental section
Bacterial isolation. A mud sample was collected from the sediment in 
Ul-lengdo, Republic of Korea. The sample was dried at room temperature 
for (rt) 3 h, and the dry sediment (1 g) was diluted in 4 mL of sterilized artif
icial seawater. The mixture was spread onto actinomycete isolation agar, 
A4 medium (1 L seawater, 18 g agar, 100 mg/L cycloheximide), A5 medium 
(750 mL seawater, 250 mL distilled water, 18 g agar, 100 mg/L 
cycloheximide), and chitin-based agar (1 L seawater, 18 g agar, 5 g chitin 
powder, 100 mg/L cycloheximide) by stamping, spreading, or both. The 
single-strain SUD119 was isolated on A5 medium. 
Cultivation and extraction of the bacterial strain. The strain 
SUD119 was cultivated in 50 mL of YEME medium (4 g yeast extract, 10 g 
malt extract, and 4 g glucose in 1 L artificial seawater) in a 125 mL 
Erlenmeyer flask. After cultivation for 3 days on a rotary shaker at 160 rpm 
at 30 °C, 10 mL of the culture was inoculated directly to 1 L of YEME 
liquid medium in 2.8 L Erlenmeyer flasks (12 ea × 1 L, total volume 12 L). 
After the bacteria were incubated for 4 days, the 12 L culture of the SUD119 
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strain was extracted with 18 L of EtOAc. The EtOAc layer was separated, 
and anhydrous sodium sulfate was added to remove residual water. The 
extraction procedure was repeated twelve times (total culture volume: 144 
L). The extract in EtOAc was concentrated in vacuo to yield 12 g of dried 
material in total. 
Isolation of ullengacenes A and B (40 and 41). The organic extract of 
SUD119 was filtered with a syringe filter and injected directly onto a semi-
preparative reversed-phase HPLC column (Kromasil C18 (2): 250 × 10 mm, 
5 μm) with a gradient solvent system (20% MeOH/H2O to 80% MeOH/H2O 
over 40 min, UV 280 nm detection, flow rate: 2 mL/min). Two major peaks 
at retention times of 41.6 min, 43.5 min were observed. Each compound 
was further purified under gradient solvent conditions (35% CH3CN/H2O to 
60% CH3CN over 40 min, UV 280 nm detection, flow rate: 2 mL/min) 
using a reversed-phase C18 HPLC column (Kromasil C18 (2): 250 × 10 mm, 
5 μm). Ullengacenes A and B (40 and 41) were obtained in pure form at 
retention times of 37.2 (6.5 mg), and 24.6 min (3.3 mg), respectively.
Ullengacene A (40): Yellow gum; [α]25D -6.9 (c 0.5, MeOH); UV (MeOH) 
λmax (log ε) 270 (4.12) nm; ECD (c 4.3 × 10
−4 M, MeOH) λmax (Δε) 285 (-
3.92), 321 (+0.2) nm, 350 (-1.8); IR (neat) νmax 3282, 2978, 1656, 1592, 
1555 cm-1; 1H and 13C NMR data, Table 13; HRFABMS m/z 761.2394 [M + 
Na]+ (calcd for C42H42O10SNa, 761.2396).
Ullengacene B (41): Yellow gum; [α]25D +5.4 (c 0.5, MeOH); UV (MeOH) 
λmax (log ε) 270 (4.21) nm; ECD (c 4.2 × 10
−4 M, MeOH) λmax (Δε) 285 (-
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4.6) nm, 310 (+3.8) nm, 375 (+0.6) nm; IR (neat) νmax 3369, 2982, 1687, 
1588, 1546 cm-1; 1H and 13C NMR data, Table 13; HRFABMS m/z 723.2275
[M + H]+ (calcd for C41H39O10S, 723.2264).
MTPA Esterification of ullengacene A. Ullengacene A (40) were 
prepared individually in 40-mL vials (two 1-mg samples for each 
compound) and dried completely under high vacuum overnight. After 
adding catalytic amounts of crystalline dimethylaminopyridine (DMAP) to 
each reaction vial, freshly distilled anhydrous pyridine (1 mL) was added 
under argon gas. The reaction mixtures were stirred at room temperature for 
5 min. After 5 min, R- and S-a-methoxy trifluoromethyl-phenylacetic acid 
(MTPA) chloride (20 µL) were added, respectively. The reactions were 
carried out for 3 h at room temperature with stirring. The reactions were 
quenched by adding 50 µL of MeOH. The reaction products were purified
by HPLC using gradient elution conditions of 40% to 100% aqueous 
acetonitrile over 20 min with a reversed-phase C18 column (Kromasil C18
(2): 250 × 10 mm, 5 μm; flow rate: 2 mL/min; UV detection at 280 nm). 
The di-S- and -R-MTPA esters (42 and 43) of 40 eluted at 32.6 and 33.4 min, 
respectively. The ΔδS-R values around the stereogenic centers of the MTPA 
esters were assigned based on the analysis of 1H and 1H-1H COSY NMR 
spectra.
Di-S-MTPA Ester (42) of ullengacene A (40)
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1H NMR (600 MHz, pyridine-d5) δ 7.87 (s, 2H), 7.78 (t, J = 7.5, 2H), 7.57–
7.44 (m, 4H), 7.42-7.35 (m, 4H), 7.33-7.26 (m, 4H), 7.17-7.07 (m, 2H), 6.28
(s, 2H), 6.22 (s, 2H), 5.91 (m, 2H), 5.85 (m, 2H), 3.84 (s, 6H), 3.22 (s, 6H), 
3.09 (s, 6H), 2.75 (m, 2H), 2.58-2.53 (m, 4H), 1.24 (d, J = 6.5, 6H).  The 
molecular formula of 42 was confirmed as C62H56F6O14Na ([M+Na]
+ at m/z
1193).
Di-R-MTPA Ester (43) of ullengacene A (40)
1H NMR (600 MHz, pyridine-d5) δ 8.00 (s, 2H), 7.78 (t, J = 7.5, 2H), 7.50–
7.42 (m, 4H), 7.34-7.30 (m, 4H), 7.26-7.21 (m, 4H), 7.13-7.06 (m, 2H), 6.28 
(s, 2H), 6.26 (s, 2H), 5.94 (m, 2H), 5.92 (m, 2H), 3.89 (s, 6H), 3.25 (s, 6H), 
3.13 (s, 6H), 2.83 (m, 2H), 2.71-2.63 (m, 4H), 1.23 (d, J = 6.5, 6H).  The 
molecular formula of 43 was confirmed as C62H56F6O14Na ([M+Na]
+ at m/z
1193).
Computational analysis. The ground-state geometries were optimized 
with density functional theory (DFT) calculations, using Turbomole 6.5 at 
the basis set def-SV(P) for all atoms and functional B3LYP/DFT level, the 
ground states were further confirmed by the harmonic frequency calculation. 
The calculated ECD data corresponding to the optimized structures were 
obtained with TDDFT at the functional B3LYP/DFT level at the basis set 
def2-TZVPP for all atoms. The CD spectra were simulated by overlapping 
for each transition, where σ is the width of the band at 1/e height. ΔEi and Ri
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are the excitation energies and rotatory strengths for transition i, respectively. 
In the current work a value of σ was 0.10 eV.
DP4 analysis. For the DP4 application, conformers of diastereomers of 
four models within 10 kJ/mol found in the MMFF force field were regarded 
and the geometry of the conformers was optimized at the B3LYP/6-31G++ 
level in the gas phase. The shielding tensor values of the optimized 
conformers were computed at the B3LYP/6-31++ level. These values were 
averaged based on the Boltzmann population in the associated Gibbs free 
energy and utilized for DP4 analysis facilitated by an Excel sheet provided 
by the original authors.
In vitro capillary tube formation assay. Matrigel (70 μl/well) was 
coated on 96-well plate and polymerized for 30 min at 37 ℃. HUVECs (1.5 
× 104 cells/well) and WS9326A-E, WS9326F-I (7-10) (0-20μM) were 
seeded onto each well of the Matrigel-coated 96-well plate with EBM-2 
medium . Then, cells were incubated for 8hrs. The formation of endothelial 
cell tubular structure was visualized under an inverted microscope and 
photographed. Furthermore, tube formation was quantified by calculating 
the tube number and was expressed as a percentage by normalization with 
untreated control cells.
Quinone reductase (QR) assay. QR activities were determined 
spectrophotometrically according to a modified microtiter method.42 Hepa-
1c1c7 cells were plated at a density of 20,000 cells/mL and cultured for 24 h 
in a humidified incubator containing 5% CO2 at 37 °C. The cells were then 
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exposed to mohangic acids (20–24) and incubated for an additional 24 h. 
The media was subsequently decanted, and the cells in each well were lysed 
by incubation at 37 °C for 10 min with 250 μL of a solution containing 10 
mM Tris-HCl pH 8.0, 140 mM NaCl, 15 mM MgCl2, and 0.5 % NP-40 
(IGEPAL CA-630) (Sigma-Aldrich). The plates were then agitated on an 
orbital shaker for additional 10 min at 25 °C, after which 1 mL of the 
complete reaction mixture containing 12.5 mM Tris-HCl pH 7.4, 0.67 
mg/mL bovine serum albumin (BSA), 0.01% Tween-20, 50 μM flavin 
adenine dinucleotide (FAD), 1 mM glucose-6-phosphate, 2 U/mL glucose-6-
phosphate dehydrogenase, 30 μM NADP, 50 μg/mL 3-(4,5-dimethylthiazo-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), and 50 μM menadione were 
added. A blue color developed, and the reaction was stopped after 10 min. 
The rate of the NADPH-dependent, menadiol-mediated reduction of MTT 
was measured at 610 nm. Protein was detected by crystal violet staining of 
an identical set of test plates. The specific activity (SA) of quinone 
reductase (nmol/min/mg of protein) was calculated from the equation: 
SA = [MTTabs/CVabs] × 3,345, 
where MTTabs is the change in the absorbance of MTT per min, CVabs is 
the absorbance of crystal violet, and 3,345 is the ratio of the proportionality 
constant determined for crystal violet and the extinction coefficient of MTT 
and has units of nmol/mg. 
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Summary
In this thesis for the degree of doctor of philosophy, I described two 
parts of studies. In part A, I focused on new bioactive non-ribosomal 
peptides from marine Streptomyces spp., including three kinds of novel 
peptides. Mohangamides A and B were discovered from a marine 
Streptomyces sp. collected in an intertidal mud flat. The structures of the 
compounds were elucidated as novel dilactone-tethered pseudo-dimeric 
peptides bearing two unusual acyl chains and 14 amino acid residues based 
on comprehensive spectroscopic analysis. The absolute configurations of the 
mohangamides were determined by multiple step chemical derivatizations
(Figure 1). In particular, for the stereochemistry of the dihydropyridine-
bearing acyl chain, the double bond in the dihydropyridine ring was 
oxidized to yield diol functionality by using OsO4. The introduced diol in 
the ring was further derivatized with 4-(dimethylamino) benzoyl chloride 
(DMAB-Cl), which induced exciton coupling in circular dichroism enabling 
to establish the absolute stereochemistry of the ring. Mohangamide A 
displayed strong inhibitory activity against Candida albicans isocitrate lyase.
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Figure 1. (a) The structures of mohangamides A and B. (b) Four-step 
derivatization scheme to determine the absolute configuration of 
dihydropyridine in mohangamide A by exciton coupling CD.
A continuous chemical study of the mohangamide producer 
(Streptomyces sp. SNM55) led to the discovery of four new peptides, 
WS9326F-I, belonging to the WS9326 class. The planar structures of 
WS9326s were established by 1D and 2D NMR, mass, UV, and IR analyses. 
These compounds bear 6~7 amino acid units with a unique acyl chain. 
Interestingly, WS9326I incorporates an unprecedented 4-amino-2,4-
dihydro-3H-pyarzol-3-one and a sugar-derived moiety. The structure of the 
pyrazole-derived ring was further confirmed by comprehensive analysis of 
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the 15NHSQC spectrum of WS9326I. In addition, the analysis of COSY and 
HMBC spectra after selective hydrogenation of the carbon-nitrogen double 
bond in the ring by using NaBH3CN clearly supported the structure of 4-
amino-2,4-dihydro-3H-pyarzol-3-one. The absolute configurations of amino 
acids of WS9326F-I were established by advanced Marfey’s analysis. The 
determination of the absolute configuration of extreamly modified starting 
unit in WS9326I was established by four-step of chemical derivatizations 
and DP4 calculations (Figure 4). WS9326F-I displayed significant 
antiangiogenic activity with moderate cytotoxicity against human cancer 
cells.
Figure 3. (a) The structures of WS9326F-H. (b) The structure of WS9326I 
and the elucidation of the 4-amino-2,4-dihydro-3H-pyarzol-3-one ring by 
15NHSQC and imine-selective reduction followed by COSY and HMBC 
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experiments.
Figure 4. Four-step derivatization scheme to determine the absolute 
configuration of 4-amino-2,4-dihydro-3H-pyarzol-3-one with sugar moiety 
in WS9326I.
Alterations in microbial culture conditions may trigger the production 
of diverse bioactive secondary metabolites. While applying various culture 
conditions and monitoring secondary metabolite profiles using LC/MS, 
hormaomycins B and C were discovered from a marine mudflat-derived 
actinomycete, Streptomyces sp., collected in Mohang, Republic of Korea. 
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The planar structures of the hormaomycins, which bear structurally unique 
units, such as 4-(Z)-propenylproline, 3-(2-nitrocyclopropyl)alanine, 5-
chloro-1-hydroxypyrrol-2-carboxylic acid, and b-methylphenylalanine, were 
established as the first natural analogues belonging to the hormaomycin 
peptide class (Figure 5). The absolute configurations of hormaomycins B 
and C were deduced by comparing their CD spectra with that of 
hormaomycin. These hormaomycins exhibited significant inhibitory effects 
against various pathogenic Gram-positive bacteria including Staphylococcus 
aureus ATCC 25923, Bacillus subtilis ATCC 6633, Kocuria rhizophila
NBRC 12708, and Streptococcus pyogenes ATCC 19615. Further 
investigation revealed that these hormaomycins displayed remarkable 
activity against Salmonella enterica ATCC 14028 and Proteus hauseri




























Hormaomycin B : R1 = CH3, R2 = H




Figure 5. The structures of hormaomycins B and C.
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In part B, I focused on new bioactive non-ribosomal peptides from 
marine Streptomyces spp. including three of novel polyketides. Mohangic 
acids A–E were isolated from a marine Streptomyces sp. collected from a 
mudflat in Buan, Republic of Korea. Comprehensive spectroscopic analysis 
revealed that the mohangic acids are new members of the p-
aminoacetophenonic acid class (Figure 6). The relative and absolute 
configurations of the mohangic acids were determined by J–based 
configuration analysis and by the application of bidentate chiral NMR 
solvents, (R,R)- and (S,S)-bis-a-methylbenzylamine-p-Me (BAMA), 
followed by 13C NMR analysis, chemical derivatization, and circular 
dichroism spectroscopy. Mohangic acid E, which is the first glycosylated 
compound in the p-aminoacetophenonic acid family, displayed significant 
quinone reductase induction activity.
Figure 6. The structures of mohangic acids A-E.
Based on profiles of secondary metabolites produced by marine bacteria 
obtained using LC/MS, succinilenes A-D, new triene polyols, were 
discovered from a culture of a Streptomyces strain SAK1, which was 
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collected in the southern area of Jeju Island, Republic of Korea. The gross 
structures of succinilenes were primarily determined through analysis of 
NMR spectra. The double bond geometries of the succinilenes, which could 
not be established from conventional 1H NMR spectra because of the highly 
overlapped olefinic signals, were successfully deciphered using the recently 
developed quantum-mechanics-driven 1H iterative full spin analysis (Figure 
7). Succinilenes A-C displayed inhibitory effects against lipopolysaccharide 
(LPS)-induced nitric oxide (NO) production, indicating their significance as 
anti-inflammatory agents. The absolute configurations of succinilenes A-D 
were established through J-based configuration analysis, the modified 
Mosher’s method following methanolysis, and CD spectral analysis.
Figure 7. (a) The structure of succinilene A. (b) 1H NMR fingerprints of 
succinilene A generated by HiFSA. Comparison of the observed (red, 
obtained in pyridine-d5) and calculated (blue) 
1H spectra.
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The chemical analysis of Streptomyces strain SUD119, which was 
isolated from a sediment sample collected in Ul-leung Island, a Korean 
volcanic island, resulted in the discovery of new benz[a]anthracene dimers 
linked by a sulfide bond. The planar structure of uleungacenes A and B were 
clarified based on NMR, MS, UV, and EDX (energy dispersive X-ray) 
spectroscopic data (Figure 8). The stereochemistry of uleungacenes A and B 
were determined by the analysis of MTPA derivati-zations, DP4 calculation, 
and ROESY correlations with ECD calculations based on density functional 
theory. Uleungacenes A exhibited significant quinone reductase induction 
activity whereas uleungacenes B displayed remarkable anti-angiogenesis 
activity.
Figure 8. The structures of ulleungacenes A and B.
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Figure A3. 1H and 13C NMR spectra of compound 7.
165
Figure A4. 1H and 13C NMR spectra of compound 8. 
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Figure A15. 1H and 13C NMR spectra of compound 28. 
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해양 유래 방선균에서 분리한 peptides와




해양 유래 미생물로부터 신규 활성 물질을 발견하고자 하는 노력의
일환으로 생물학적 다양성의 집합지인 갯벌과 독특한 고유의 특성을
지닌 화산섬 지역에서 유력한 이차대사산물 생산 균주들을 분리하였다.
Part A. 기존에 연구가 충분히 이루어 지지 않았던 갯벌 유래
스트렙토마이시스 균주들로부터 분리한 신규 펩타이드 생리활성 물질의
탐색에 집중하여 총 8 개의 신규 펩타이드와 6 개의 기지 물질을
발견하였다. 이들의 구조는 분광학적 분석과 다양한 화학 반응 및
컴퓨터를 이용한 계산을 통해 규명 및 동정하였고 분리된 물질은
dilactone 으로 연결된 pseudo-dimeric peptide 2 종, WS9326
물질군에 속하는 peptide 4 종, cyclic depsipeptide 2 종인 것으로
밝혀졌다. 해당 물질들은 다양한 생리활성 실험을 실시하여 주목할만한
효소 저해활성, 혈관생성억제활성, 항박테리아 활성 결과를 얻었다.
Part B. 바다에 둘러쌓인 화산섬인 제주도 및 울릉도 지역에서 분리한
스트렙토마이시스 균주로부터 총 11 개의 신규 폴리케타이드 생리활성
물질을 발견하였다. 이들의 평면구조 및 입체구조는 분광학적 분석과
화학 반응 및 컴퓨터를 이용한 계산을 통해 규명하였고 분리된 물질은
p-aminophenonic acid 신규물질 5 종, succinic acid 를 포함하는
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triene polyol 4 종, dimeric benz[a]anthracene  2 종인 것으로
밝혀졌다. 이들 중 몇몇은 주목할만한 항염증 활성과 혈관생성억제
활성을 보였다. 
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